Research Sample bioBank
Can’t find what you’re looking for? Contact us.
Or, need help ordering? 805.528.4341
Get Weekly Research Sample Updates in your Inbox:
Longitudinal Hepatitis C (HCV) Drug Treatment Sample Set Clinical Research Samples
Discovery Life Sciences provides the highest quality Longitudinal Hepatitis C (HCV) Drug Treatment Sample Set Clinical Research Samples and Residual Diagnostic Specimens from the Life Science Industry’s only convenient online, open access Biobank.
- All Longitudinal Hepatitis C (HCV) Drug Treatment Sample Set Sample Orders are Packaged for Delivery within 24 Hours.
- All Specimens Ethically Obtained, De-Identified and provided with Highly Annotated Demographic and Clinical Data.
- Select from an HHS/OHRP Compliant Biorepository following ISBER/BBRB Guidelines.
- Packaged in Compliance with all UN Regulations (6.2) and U.S. DOT Hazmat regulations.
Advanced Data View:
Showing 775 of 775 total samples
Buy | Product ID | Sample | Origin | Matrix | Vial (ml) | Quantity | Price | Age | Gender | Ethnicity | Storage Temp | Sample Date | Test 1 | Test Data 1 | Detail 1 | Test 2 | Test Data 2 | Detail 2 | Test 3 | Test Data 3 | Detail 3 | Product Details | Price | Buy | Blood Type | Consent Status Date | Current Medications | Height | Weight | Date of HCV Diagnosis | HCV Risk Group | Liver Biopsy? | Fibroscan? | Medication Name | Additional Testing | 13-Dec-18 | 13-Jun-18 | 13-Jul-18 | 10-Aug-18 | 5-Mar-18 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| BBS0000-AO900053713110219DD | Longitudinal Hepatitis C (HCV) Drug Treatment Sample Set | South Africa | Serum | 1.00 | 14.00 | Special Order. Please Inquire | Male | Non-Hispanic | <-70C | 02-Nov-19 | Genotype | 5a | Special Order. Please Inquire | Unknown | ||||||||||||||||||||||||||
| BBS0000-AO900105701010515DD | Longitudinal Hepatitis C (HCV) Drug Treatment Sample Set | South Africa | Serum | 1.00 | 12.00 | Special Order. Please Inquire | 51 Y | Male | Non-Hispanic | <-70C | 05-Jan-15 | Genotype | 1a | Special Order. Please Inquire | Unknown | |||||||||||||||||||||||||
| BBS0000-AO900105701030915DD | Longitudinal Hepatitis C (HCV) Drug Treatment Sample Set | South Africa | Serum | 1.00 | 12.00 | Special Order. Please Inquire | 51 Y | Male | Non-Hispanic | <-70C | 09-Mar-15 | Genotype | 1a | Special Order. Please Inquire | Unknown | |||||||||||||||||||||||||
| BBS0000-AO900105701061915DD | Longitudinal Hepatitis C (HCV) Drug Treatment Sample Set | South Africa | Serum | 1.00 | 12.00 | Special Order. Please Inquire | 51 Y | Male | Non-Hispanic | <-70C | 19-Jun-15 | Genotype | 1a | Special Order. Please Inquire | Unknown | |||||||||||||||||||||||||
| BBS0000-AO900105701120814DD | Longitudinal Hepatitis C (HCV) Drug Treatment Sample Set | South Africa | Serum | 1.00 | 10.00 | Special Order. Please Inquire | 51 Y | Male | Non-Hispanic | <-70C | 08-Dec-14 | Genotype | 1a | Special Order. Please Inquire | Unknown | |||||||||||||||||||||||||
| BBS0000-CF900364878072717D4 | Longitudinal Hepatitis C (HCV) Drug Treatment Sample Set | United States | Serum | 3.00 | 1.00 | Special Order. Please Inquire | 57 Y | Male | Non-Hispanic | <-70C | 27-Jul-17 | Hep C Quant, Real Time PCR (non-graph) | 541,500 | 29-Jun-17 | Genotype | 2a | Additional Testing | ALT: 39 U/L | AST: 36 U/L | ALP: 89 U/L | Bilirubin (Total): 0.4 mg/dL | 29-Jun-17 | Special Order. Please Inquire | Unknown | 2017-07-27 | 72.00 | 322 | 16-Nov-2016 | Intravenous drug user (discontinued since 1980's) | No | Yes | Mild to moderate fibrosis 12-Jun-17 | Epclusa | |||||||||||
| BBS0000-CF900364878072717D5 | Longitudinal Hepatitis C (HCV) Drug Treatment Sample Set | United States | Serum | 4.50 | 1.00 | Special Order. Please Inquire | 57 Y | Male | Non-Hispanic | <-70C | 27-Jul-17 | Hep C Quant, Real Time PCR (non-graph) | 541,500 | 29-Jun-17 | Genotype | 2a | Additional Testing | ALT: 39 U/L | AST: 36 U/L | ALP: 89 U/L | Bilirubin (Total): 0.4 mg/dL | 29-Jun-17 | Special Order. Please Inquire | Unknown | 2017-07-27 | 72.00 | 322 | 16-Nov-2016 | Intravenous drug user (discontinued since 1980's) | No | Yes | Mild to moderate fibrosis 12-Jun-17 | Epclusa | |||||||||||
| BBS0000-CF900364878072717D6 | Longitudinal Hepatitis C (HCV) Drug Treatment Sample Set | United States | Serum | 3.50 | 1.00 | Special Order. Please Inquire | 57 Y | Male | Non-Hispanic | <-70C | 27-Jul-17 | Hep C Quant, Real Time PCR (non-graph) | 541,500 | 29-Jun-17 | Genotype | 2a | Additional Testing | ALT: 39 U/L | AST: 36 U/L | ALP: 89 U/L | Bilirubin (Total): 0.4 mg/dL | 29-Jun-17 | Special Order. Please Inquire | Unknown | 2017-07-27 | 72.00 | 322 | 16-Nov-2016 | Intravenous drug user (discontinued since 1980's) | No | Yes | Mild to moderate fibrosis 12-Jun-17 | Epclusa | |||||||||||
| BBS0000-CF900364878072717DD | Longitudinal Hepatitis C (HCV) Drug Treatment Sample Set | United States | Serum | 4.00 | 1.00 | Special Order. Please Inquire | 57 Y | Male | Non-Hispanic | <-70C | 27-Jul-17 | Hep C Quant, Real Time PCR (non-graph) | 541,500 | 29-Jun-17 | Genotype | 2a | Additional Testing | ALT: 39 U/L | AST: 36 U/L | ALP: 89 U/L | Bilirubin (Total): 0.4 mg/dL | 29-Jun-17 | Special Order. Please Inquire | Unknown | 2017-07-27 | 72.00 | 322 | 16-Nov-2016 | Intravenous drug user (discontinued since 1980's) | No | Yes | Mild to moderate fibrosis 12-Jun-17 | Epclusa | |||||||||||
| BBS0000-CF900364878121917D3 | Longitudinal Hepatitis C (HCV) Drug Treatment Sample Set | United States | Serum | 3.50 | 1.00 | Special Order. Please Inquire | 57 Y | Male | Non-Hispanic | <-70C | 19-Dec-17 | Not performed | Genotype | 2a | Additional Testing | ALT: 25 U/L | AST: 27 U/L | ALP: 88 U/L | Bilirubin (Total): 0.7 mg/dL | Serum Creatinine: 1.00 mg/dL | 14-Dec-17 | Special Order. Please Inquire | Unknown | 2017-07-27 | 72.00 | 322 | 16-Nov-2016 | Intravenous drug user (discontinued since 1980's) | No | Yes | Mild to moderate fibrosis 12-Jun-17 | Epclusa | |||||||||||||
| BBS0000-CF900364878121917D6 | Longitudinal Hepatitis C (HCV) Drug Treatment Sample Set | United States | Serum | 3.50 | 1.00 | Special Order. Please Inquire | 57 Y | Male | Non-Hispanic | <-70C | 19-Dec-17 | Not performed | Genotype | 2a | Additional Testing | ALT: 25 U/L | AST: 27 U/L | ALP: 88 U/L | Bilirubin (Total): 0.7 mg/dL | Serum Creatinine: 1.00 mg/dL | 14-Dec-17 | Special Order. Please Inquire | Unknown | 2017-07-27 | 72.00 | 322 | 16-Nov-2016 | Intravenous drug user (discontinued since 1980's) | No | Yes | Mild to moderate fibrosis 12-Jun-17 | Epclusa | |||||||||||||
| BBS0000-CF900364878121917D8 | Longitudinal Hepatitis C (HCV) Drug Treatment Sample Set | United States | Serum | 4.00 | 1.00 | Special Order. Please Inquire | 57 Y | Male | Non-Hispanic | <-70C | 19-Dec-17 | Not performed | Genotype | 2a | Additional Testing | ALT: 25 U/L | AST: 27 U/L | ALP: 88 U/L | Bilirubin (Total): 0.7 mg/dL | Serum Creatinine: 1.00 mg/dL | 14-Dec-17 | Special Order. Please Inquire | Unknown | 2017-07-27 | 72.00 | 322 | 16-Nov-2016 | Intravenous drug user (discontinued since 1980's) | No | Yes | Mild to moderate fibrosis 12-Jun-17 | Epclusa | |||||||||||||
| BBS0000-CF900364878121917DD | Longitudinal Hepatitis C (HCV) Drug Treatment Sample Set | United States | Serum | 3.00 | 1.00 | Special Order. Please Inquire | 57 Y | Male | Non-Hispanic | <-70C | 19-Dec-17 | Not performed | Genotype | 2a | Additional Testing | ALT: 25 U/L | AST: 27 U/L | ALP: 88 U/L | Bilirubin (Total): 0.7 mg/dL | Serum Creatinine: 1.00 mg/dL | 14-Dec-17 | Special Order. Please Inquire | Unknown | 2017-07-27 | 72.00 | 322 | 16-Nov-2016 | Intravenous drug user (discontinued since 1980's) | No | Yes | Mild to moderate fibrosis 12-Jun-17 | Epclusa | |||||||||||||
| BBS0000-CF900364879081717D2 | Longitudinal Hepatitis C (HCV) Drug Treatment Sample Set | United States | Serum | 4.50 | 1.00 | Special Order. Please Inquire | 55 Y | Female | Non-Hispanic | <-70C | 17-Aug-17 | Roche cobas Ampliprep | Taqman | 13,980,807 | 12-Dec-16 | Genotype | 3a | Additional Testing | ALT: 78 U/L | AST: 66 U/L | ALP: 80 U/L | Bilirubin (Total): 0.7 mg/dL | Serum Creatinine: 8.8 mg/dL | 17-Aug-17 | Special Order. Please Inquire | Unknown | 2017-08-17 | 64.00 | 143 | 12-Dec-2016 | Body piercing / tattooing; Intravenous drug user; Multiple sex partners; Occupational contact | No | Yes | Stage 4 Fibrosis, consistent with cirrhosis 27-Jun-17 | Epclusa | |||||||||||
| BBS0000-CF900364879081717D5 | Longitudinal Hepatitis C (HCV) Drug Treatment Sample Set | United States | Serum | 5.00 | 1.00 | Special Order. Please Inquire | 55 Y | Female | Non-Hispanic | <-70C | 17-Aug-17 | Roche cobas Ampliprep | Taqman | 13,980,807 | 12-Dec-16 | Genotype | 3a | Additional Testing | ALT: 78 U/L | AST: 66 U/L | ALP: 80 U/L | Bilirubin (Total): 0.7 mg/dL | Serum Creatinine: 8.8 mg/dL | 17-Aug-17 | Special Order. Please Inquire | Unknown | 2017-08-17 | 64.00 | 143 | 12-Dec-2016 | Body piercing / tattooing; Intravenous drug user; Multiple sex partners; Occupational contact | No | Yes | Stage 4 Fibrosis, consistent with cirrhosis 27-Jun-17 | Epclusa | |||||||||||
| BBS0000-CF900364879081717D6 | Longitudinal Hepatitis C (HCV) Drug Treatment Sample Set | United States | Serum | 4.50 | 1.00 | Special Order. Please Inquire | 55 Y | Female | Non-Hispanic | <-70C | 17-Aug-17 | Roche cobas Ampliprep | Taqman | 13,980,807 | 12-Dec-16 | Genotype | 3a | Additional Testing | ALT: 78 U/L | AST: 66 U/L | ALP: 80 U/L | Bilirubin (Total): 0.7 mg/dL | Serum Creatinine: 8.8 mg/dL | 17-Aug-17 | Special Order. Please Inquire | Unknown | 2017-08-17 | 64.00 | 143 | 12-Dec-2016 | Body piercing / tattooing; Intravenous drug user; Multiple sex partners; Occupational contact | No | Yes | Stage 4 Fibrosis, consistent with cirrhosis 27-Jun-17 | Epclusa | |||||||||||
| BBS0000-CF900364879081717DD | Longitudinal Hepatitis C (HCV) Drug Treatment Sample Set | United States | Serum | 4.50 | 1.00 | Special Order. Please Inquire | 55 Y | Female | Non-Hispanic | <-70C | 17-Aug-17 | Roche cobas Ampliprep | Taqman | 13,980,807 | 12-Dec-16 | Genotype | 3a | Additional Testing | ALT: 78 U/L | AST: 66 U/L | ALP: 80 U/L | Bilirubin (Total): 0.7 mg/dL | Serum Creatinine: 8.8 mg/dL | 17-Aug-17 | Special Order. Please Inquire | Unknown | 2017-08-17 | 64.00 | 143 | 12-Dec-2016 | Body piercing / tattooing; Intravenous drug user; Multiple sex partners; Occupational contact | No | Yes | Stage 4 Fibrosis, consistent with cirrhosis 27-Jun-17 | Epclusa | |||||||||||
| BBS0000-CF900364879113017D1 | Longitudinal Hepatitis C (HCV) Drug Treatment Sample Set | United States | Serum | 5.00 | 1.00 | Special Order. Please Inquire | 55 Y | Female | Non-Hispanic | <-70C | 30-Nov-17 | Roche cobas Ampliprep | Taqman | <15 Not Detected | 20-Nov-17 | Genotype | 3a | Additional Testing | ALT: 24 U/L | AST: 17 U/L | ALP: 90 U/L | Bilirubin (Total): 0.5 mg/dL | Serum Creatinine: 0.4 mg/dL | 20-Dec-17 | Special Order. Please Inquire | Unknown | 2017-08-17 | 64.00 | 143 | 12-Dec-2016 | Body piercing / tattooing; Intravenous drug user; Multiple sex partners; Occupational contact | No | Yes | Stage 4 Fibrosis, consistent with cirrhosis 27-Jun-17 | Epclusa | |||||||||||
| BBS0000-CF900364879113017D2 | Longitudinal Hepatitis C (HCV) Drug Treatment Sample Set | United States | Serum | 5.50 | 1.00 | Special Order. Please Inquire | 55 Y | Female | Non-Hispanic | <-70C | 30-Nov-17 | Roche cobas Ampliprep | Taqman | <15 Not Detected | 20-Nov-17 | Genotype | 3a | Additional Testing | ALT: 24 U/L | AST: 17 U/L | ALP: 90 U/L | Bilirubin (Total): 0.5 mg/dL | Serum Creatinine: 0.4 mg/dL | 20-Dec-17 | Special Order. Please Inquire | Unknown | 2017-08-17 | 64.00 | 143 | 12-Dec-2016 | Body piercing / tattooing; Intravenous drug user; Multiple sex partners; Occupational contact | No | Yes | Stage 4 Fibrosis, consistent with cirrhosis 27-Jun-17 | Epclusa | |||||||||||
| BBS0000-CF900364879113017D6 | Longitudinal Hepatitis C (HCV) Drug Treatment Sample Set | United States | Serum | 5.50 | 1.00 | Special Order. Please Inquire | 55 Y | Female | Non-Hispanic | <-70C | 30-Nov-17 | Roche cobas Ampliprep | Taqman | <15 Not Detected | 20-Nov-17 | Genotype | 3a | Additional Testing | ALT: 24 U/L | AST: 17 U/L | ALP: 90 U/L | Bilirubin (Total): 0.5 mg/dL | Serum Creatinine: 0.4 mg/dL | 20-Dec-17 | Special Order. Please Inquire | Unknown | 2017-08-17 | 64.00 | 143 | 12-Dec-2016 | Body piercing / tattooing; Intravenous drug user; Multiple sex partners; Occupational contact | No | Yes | Stage 4 Fibrosis, consistent with cirrhosis 27-Jun-17 | Epclusa | |||||||||||
| BBS0000-CF900364879113017DD | Longitudinal Hepatitis C (HCV) Drug Treatment Sample Set | United States | Serum | 5.00 | 1.00 | Special Order. Please Inquire | 55 Y | Female | Non-Hispanic | <-70C | 30-Nov-17 | Roche cobas Ampliprep | Taqman | <15 Not Detected | 20-Nov-17 | Genotype | 3a | Additional Testing | ALT: 24 U/L | AST: 17 U/L | ALP: 90 U/L | Bilirubin (Total): 0.5 mg/dL | Serum Creatinine: 0.4 mg/dL | 20-Dec-17 | Special Order. Please Inquire | Unknown | 2017-08-17 | 64.00 | 143 | 12-Dec-2016 | Body piercing / tattooing; Intravenous drug user; Multiple sex partners; Occupational contact | No | Yes | Stage 4 Fibrosis, consistent with cirrhosis 27-Jun-17 | Epclusa | |||||||||||
| BBS0000-CF900364879122617D4 | Longitudinal Hepatitis C (HCV) Drug Treatment Sample Set | United States | Serum | 4.00 | 1.00 | Special Order. Please Inquire | 55 Y | Female | Non-Hispanic | <-70C | 26-Dec-17 | Not performed | Genotype | 3a | Additional Testing | U/A | Special Order. Please Inquire | Unknown | 2017-08-17 | 64.00 | 143 | 12-Dec-2016 | Body piercing / tattooing; Intravenous drug user; Multiple sex partners; Occupational contact | No | Yes | Stage 4 Fibrosis, consistent with cirrhosis 27-Jun-17 | Epclusa | ||||||||||||||
| BBS0000-CF900364879122617D8 | Longitudinal Hepatitis C (HCV) Drug Treatment Sample Set | United States | Serum | 2.00 | 1.00 | Special Order. Please Inquire | 55 Y | Female | Non-Hispanic | <-70C | 26-Dec-17 | Not performed | Genotype | 3a | Additional Testing | U/A | Special Order. Please Inquire | Unknown | 2017-08-17 | 64.00 | 143 | 12-Dec-2016 | Body piercing / tattooing; Intravenous drug user; Multiple sex partners; Occupational contact | No | Yes | Stage 4 Fibrosis, consistent with cirrhosis 27-Jun-17 | Epclusa | ||||||||||||||
| BBS0000-CF900364879122617D9 | Longitudinal Hepatitis C (HCV) Drug Treatment Sample Set | United States | Serum | 2.50 | 1.00 | Special Order. Please Inquire | 55 Y | Female | Non-Hispanic | <-70C | 26-Dec-17 | Not performed | Genotype | 3a | Additional Testing | U/A | Special Order. Please Inquire | Unknown | 2017-08-17 | 64.00 | 143 | 12-Dec-2016 | Body piercing / tattooing; Intravenous drug user; Multiple sex partners; Occupational contact | No | Yes | Stage 4 Fibrosis, consistent with cirrhosis 27-Jun-17 | Epclusa | ||||||||||||||
| BBS0000-CF900364879122617DD | Longitudinal Hepatitis C (HCV) Drug Treatment Sample Set | United States | Serum | 4.50 | 1.00 | Special Order. Please Inquire | 55 Y | Female | Non-Hispanic | <-70C | 26-Dec-17 | Not performed | Genotype | 3a | Additional Testing | U/A | Special Order. Please Inquire | Unknown | 2017-08-17 | 64.00 | 143 | 12-Dec-2016 | Body piercing / tattooing; Intravenous drug user; Multiple sex partners; Occupational contact | No | Yes | Stage 4 Fibrosis, consistent with cirrhosis 27-Jun-17 | Epclusa | ||||||||||||||
| BBS0000-CF900364884041417D2 | Longitudinal Hepatitis C (HCV) Drug Treatment Sample Set | United States | Serum | 4.00 | 1.00 | Special Order. Please Inquire | 55 Y | Male | Non-Hispanic | <-70C | 14-Apr-17 | Roche cobas Ampliprep | Taqman | 12,832,996 | 29-Mar-17 | Genotype | 2 | Additional Testing | ALT: 126 U/L | AST: 85 U/L | ALP: 145 U/L | Bilirubin (Total): 0.7 mg/dL | Serum Creatinine: 0.7 mg/dL | 29-Mar-17 | Special Order. Please Inquire | Unknown | 2017-04-13 | 68.00 | 205 | 1990 | None | No | Yes | Cirrhosis, Steatosis Stage >3 21-Apr-2017 | U/A | |||||||||||
| BBS0000-CF900364884041417D3 | Longitudinal Hepatitis C (HCV) Drug Treatment Sample Set | United States | Serum | 3.50 | 1.00 | Special Order. Please Inquire | 55 Y | Male | Non-Hispanic | <-70C | 14-Apr-17 | Roche cobas Ampliprep | Taqman | 12,832,996 | 29-Mar-17 | Genotype | 2 | Additional Testing | ALT: 126 U/L | AST: 85 U/L | ALP: 145 U/L | Bilirubin (Total): 0.7 mg/dL | Serum Creatinine: 0.7 mg/dL | 29-Mar-17 | Special Order. Please Inquire | Unknown | 2017-04-13 | 68.00 | 205 | 1990 | None | No | Yes | Cirrhosis, Steatosis Stage >3 21-Apr-2017 | U/A | |||||||||||
| BBS0000-CF900364884041417D4 | Longitudinal Hepatitis C (HCV) Drug Treatment Sample Set | United States | Serum | 4.00 | 1.00 | Special Order. Please Inquire | 55 Y | Male | Non-Hispanic | <-70C | 14-Apr-17 | Roche cobas Ampliprep | Taqman | 12,832,996 | 29-Mar-17 | Genotype | 2 | Additional Testing | ALT: 126 U/L | AST: 85 U/L | ALP: 145 U/L | Bilirubin (Total): 0.7 mg/dL | Serum Creatinine: 0.7 mg/dL | 29-Mar-17 | Special Order. Please Inquire | Unknown | 2017-04-13 | 68.00 | 205 | 1990 | None | No | Yes | Cirrhosis, Steatosis Stage >3 21-Apr-2017 | U/A | |||||||||||
| BBS0000-CF900364884041417DD | Longitudinal Hepatitis C (HCV) Drug Treatment Sample Set | United States | Serum | 4.00 | 1.00 | Special Order. Please Inquire | 55 Y | Male | Non-Hispanic | <-70C | 14-Apr-17 | Roche cobas Ampliprep | Taqman | 12,832,996 | 29-Mar-17 | Genotype | 2 | Additional Testing | ALT: 126 U/L | AST: 85 U/L | ALP: 145 U/L | Bilirubin (Total): 0.7 mg/dL | Serum Creatinine: 0.7 mg/dL | 29-Mar-17 | Special Order. Please Inquire | Unknown | 2017-04-13 | 68.00 | 205 | 1990 | None | No | Yes | Cirrhosis, Steatosis Stage >3 21-Apr-2017 | U/A | |||||||||||
| BBS0000-CM900021605033018DD | Longitudinal Hepatitis C (HCV) Drug Treatment Sample Set | United States | Serum | 1.00 | 9.00 | Special Order. Please Inquire | 59 Y | Male | Non-Hispanic | <-70C | 30-Mar-18 | Abbott RealTime PCR Assay | 834,431 IU/mL | 8-Dec-17 | Genotype | 2b | Special Order. Please Inquire | Unknown | Epclusa | 8-Dec-17 | Intravenous drug user | No | Yes | Stage 2 Fibrosis 5-Mar-18 | ALT: 70 U/L | AST: 46 U/L | ALP: 61 U/L | Bilirubin (Total): 0.5 mg/dL | Bilirubin (Direct): 0.1 mg/dL | Creatinine: 0.8 mg/dL 8-Dec-17 | ||||||||||||||||
| BBS0000-CM900021605081018DD | Longitudinal Hepatitis C (HCV) Drug Treatment Sample Set | United States | Serum | 1.00 | 6.00 | Special Order. Please Inquire | 60 Y | Male | Non-Hispanic | <-70C | 10-Aug-18 | Abbott RealTime PCR Assay | <12 IU/mL | 10-Aug-18 | Genotype | 2b | Special Order. Please Inquire | Unknown | Epclusa | 8-Dec-17 | Intravenous drug user | No | Yes | Stage 2 Fibrosis 5-Mar-18 | ALT: 15 U/L | AST: 20 U/L | ALP: 54 U/L | Bilirubin (Total): 0.4 mg/dL | Bilirubin (Direct): 0.2 mg/dL | Creatinine: 0.87mg/dL 10-Aug-18 | ||||||||||||||||
| BBS0000-CM900021609072817DD | Longitudinal Hepatitis C (HCV) Drug Treatment Sample Set | United States | Serum | 1.00 | 9.00 | Special Order. Please Inquire | 62 Y | Female | Non-Hispanic | <-70C | 28-Jul-17 | Abbott RealTime PCR Assay | <12 IU/mL | 28-Jul-17 | Genotype | 2b | Special Order. Please Inquire | Unknown | Epclusa | 31-Mar-17 | Transfusion | No | No | ALT: 27 U/L | AST: 24 U/L | ALP: 109 U/L | Bilirubin (Total): 0.5 mg/dL | Bilirubin (Direct): 0.1 mg/dL | Creatinine: 0.86 mg/dL 28-Jul-17 | ||||||||||||||||
| BBS0000-CM900021609110117DD | Longitudinal Hepatitis C (HCV) Drug Treatment Sample Set | United States | Serum | 1.00 | 10.00 | Special Order. Please Inquire | 62 Y | Female | Non-Hispanic | <-70C | 01-Nov-17 | Abbott RealTime PCR Assay | <12 IU/mL | 1-Nov-17 | Genotype | 2b | Special Order. Please Inquire | Unknown | Epclusa | 31-Mar-17 | Transfusion | No | No | ALT: 17 U/L | AST: 19 U/L | ALP: 105 U/L | Bilirubin (Total): 0.4 mg/dL | Bilirubin (Direct): 0.1 mg/dL | Creatinine: 0.83 mg/dL 1-Nov-17 | ||||||||||||||||
| BBS0000-CM900021611061417DD | Longitudinal Hepatitis C (HCV) Drug Treatment Sample Set | United States | Serum | 1.00 | 12.00 | Special Order. Please Inquire | 59 Y | Male | Non-Hispanic | <-70C | 14-Jun-17 | Abbott RealTime PCR Assay | <12 IU/mL | 14-Jun-17 | Genotype | 3 | Special Order. Please Inquire | Unknown | Sofosbuvir / Velpatasvir / Ribavirin | 1990 | None | No | No | ALT: 15 U/L | AST: 29 U/L | ALP: 75 U/L | Bilirubin (Total): 5.6 mg/dL | Bilirubin (Direct): 1.2 mg/dL | Creatinine: 0.61 mg/dL 14-Jun-17 | ||||||||||||||||
| BBS0000-CM900080482072517DD | Longitudinal Hepatitis C (HCV) Drug Treatment Sample Set | United States | Serum | 1.00 | 8.00 | Special Order. Please Inquire | 30 Y | Male | Unknown | <-70C | 25-Jul-17 | Abbott RealTime PCR Assay | 262,735 IU/mL | 3-Jul-17 | Genotype | 2b | Special Order. Please Inquire | Unknown | Epclusa | 67.01 | 134 | 9-Sep-16 | Intravenous drug user | No | Yes | 10.5 kPa ; Liver stiffness 3-Apr-17 | ALT: 49 U/L | AST: 34 U/L | ALP: 110 U/L | Bilirubin (Total): 0.3 mg/dL | Bilirubin (Direct): 0.1 mg/dL | Creatinine: 0.73 mg/dL 25-Jul-17 | ||||||||||||||
| BBS0000-CM900093099041918DD | Longitudinal Hepatitis C (HCV) Drug Treatment Sample Set | United States | Serum | 1.00 | 4.00 | Special Order. Please Inquire | 40 Y | Male | Non-Hispanic | <-70C | 19-Apr-18 | Abbott RealTime PCR Assay | pending IU/mL | Genotype | 3 | Special Order. Please Inquire | Unknown | Sovaldi / Daklinza | 70.98 | 212 | 13-Apr-16 | Intravenous drug user | No | Yes | Moderate scarring in liver, but no cirrhosis 14-Sep-17 | ||||||||||||||||
| BBS0000-CM900093099100317DD | Longitudinal Hepatitis C (HCV) Drug Treatment Sample Set | United States | Serum | 1.00 | 9.00 | Special Order. Please Inquire | 40 Y | Male | Non-Hispanic | <-70C | 03-Oct-17 | Abbott RealTime PCR Assay | 26,653 IU/mL | 3-Oct-17 | Genotype | 3 | Special Order. Please Inquire | Unknown | Sovaldi / Daklinza | 70.98 | 212 | 13-Apr-16 | Intravenous drug user | No | Yes | Moderate scarring in liver, but no cirrhosis 14-Sep-17 | ALT: 289 U/L | AST: 200 U/L | ALP: 76 U/L | Bilirubin (Total): 1.2 mg/dL | Bilirubin (Direct): 0.4 mg/dL | 14-Sep-2017 | Serum Creatinine: 0.71 mg/dL 3-Oct-17 | ||||||||||||||
| BBS0000-CM900093322031419DD | Longitudinal Hepatitis C (HCV) Drug Treatment Sample Set | United States | Serum | 1.00 | 9.00 | Special Order. Please Inquire | 65 Y | Male | Non-Hispanic | <-70C | 14-Mar-19 | Abbott Rt-PCR | <12 IU/mL | 15-Dec-18 | Genotype | 4 | Special Order. Please Inquire | Unknown | Date of HCV Diagnosis U/A | Medication Name Epclusa | ||||||||||||||||||||
| BBS0000-CM900093322071818DD | Longitudinal Hepatitis C (HCV) Drug Treatment Sample Set | United States | Serum | 1.00 | 16.00 | Special Order. Please Inquire | 64 Y | Male | Non-Hispanic | <-70C | 18-Jul-18 | Abbott RealTime PCR Assay | 272,816 IU/mL | 13-Jul-18 | Genotype | N/A | Special Order. Please Inquire | Unknown | Epclusa | N/A | None | No | Yes | F4 Fibrosis S>1 Steatosis 13-Jun-18 | None | ||||||||||||||||
| BBS0000-CM900093322100418DD | Longitudinal Hepatitis C (HCV) Drug Treatment Sample Set | United States | Serum | 1.00 | 11.00 | Special Order. Please Inquire | 64 Y | Male | Non-Hispanic | <-70C | 04-Oct-18 | Abbott Rt-PCR | 272,816 IU/mL | 13-Jul-18 | Genotype | 4 | Special Order. Please Inquire | Unknown | Medication Name Epclusa | Date of HCV Diagnosis U/A | ||||||||||||||||||||
| BBS0000-CM900093322122018DD | Longitudinal Hepatitis C (HCV) Drug Treatment Sample Set | United States | Serum | 1.00 | 14.00 | Special Order. Please Inquire | 64 Y | Male | Non-Hispanic | <-70C | 20-Dec-18 | Abbott Rt-PCR | <12 IU/mL | 17-Oct-18 | Genotype | 4 | Special Order. Please Inquire | Unknown | Medication Name Epclusa | |||||||||||||||||||||
| BBS0000-CM900097513071717DD | Longitudinal Hepatitis C (HCV) Drug Treatment Sample Set | United States | Serum | 1.00 | 10.00 | Special Order. Please Inquire | 67 Y | Male | Non-Hispanic | <-70C | 17-Jul-17 | Abbott RealTime PCR Assay | 1,321,672 IU/mL | 8-Jun-17 | Genotype | 2b | Special Order. Please Inquire | Unknown | Epclusa | 71.00 | 9-Mar-17 | Intravenous drug user | No | No | ALT: 55 U/L | AST: 67 U/L | ALP: 58 U/L | Bilirubin (Total): 1.0 mg/dL | Bilirubin (Direct): 0.4 mg/dL | Creatinine: 0.83 mg/dL 8-Jun-17 | |||||||||||||||
| BBS0000-CM900097752012418DD | Longitudinal Hepatitis C (HCV) Drug Treatment Sample Set | United States | Serum | 1.00 | 10.00 | Special Order. Please Inquire | 37 Y | Male | Non-Hispanic | <-70C | 24-Jan-18 | Abbott RealTime PCR Assay | <1.08 IU/mL | 25-Jan-18 | Genotype | 2b | Special Order. Please Inquire | Unknown | Epclusa | 72.01 | 251 | 23-Aug-17 | Intravenous drug user | No | Yes | 6.39 kPa 31-Aug-17 | ALT: 13 U/L | AST: 9 U/L | ALP: 83 U/L | Bilirubin (Total): 0.5 mg/dL | Bilirubin (Direct): 0.1 mg/dL 19-Jan-18 | ||||||||||||||
| BBS0000-CM900097752091217DD | Longitudinal Hepatitis C (HCV) Drug Treatment Sample Set | United States | Serum | 1.00 | 9.00 | Special Order. Please Inquire | 37 Y | Male | Non-Hispanic | <-70C | 12-Sep-17 | Abbott RealTime PCR Assay | 74,444 IU/mL | 23-Aug-17 | Genotype | 2b | Special Order. Please Inquire | Unknown | Epclusa | 72.01 | 251 | 23-Aug-17 | Intravenous drug user | No | Yes | 6.39 kPa 31-Aug-17 | ALT: 53 U/L | AST: 23 U/L | ALP: 69 U/L | Bilirubin (Total): 0.5 mg/dL | Bilirubin (Direct): 0.1 mg/dL | Creatinine: 0.87 mg/dL 23-Aug-17 | ||||||||||||||
| BBS0000-CM900097759091917DD | Longitudinal Hepatitis C (HCV) Drug Treatment Sample Set | United States | Serum | 1.00 | 11.00 | Special Order. Please Inquire | 33 Y | Female | Non-Hispanic | <-70C | 19-Sep-17 | Abbott RealTime PCR Assay | 3,443,834 IU/mL | 21-Aug-17 | Genotype | 2b | Special Order. Please Inquire | Unknown | Epclusa | 62.01 | 178 | 21-Aug-17 | Intravenous drug user | No | No | ALT: 126 U/L | AST: 78 U/L | ALP: 401 U/L | Bilirubin (Total): 0.3 mg/dL | Bilirubin (Direct): 0.0 mg/dL | Creatinine: 0.82 mg/dL 6-Dec-16 | ||||||||||||||
| BBS0000-CM900108640070317DD | Longitudinal Hepatitis C (HCV) Drug Treatment Sample Set | United States | Serum | 1.00 | 7.00 | Special Order. Please Inquire | 43 Y | Male | Non-Hispanic | <-70C | 03-Jul-17 | Abbott RealTime PCR Assay | 15,016,978 IU/mL | 2-Jun-17 | Genotype | 2b | Special Order. Please Inquire | Unknown | Epclusa | 67.00 | 185 | 2-Jun-17 | Body piercing / Tattooing; Intravenous drug user | No | No | ALT: 20 U/L | AST: 33 U/L | ALP: 67 U/L | Bilirubin (Total): 0.3 mg/dL | Bilirubin (Direct): 0.0 mg/dL | Creatinine: 0.85 mg/dL 2-Jun-17 | ||||||||||||||
| BBS0000-CV900053329070915DD | Longitudinal Hepatitis C (HCV) Drug Treatment Sample Set | Vietnam | Serum | 1.00 | 10.00 | Special Order. Please Inquire | 52 Y | Male | Non-Hispanic | <-70C | 09-Jul-15 | Genotype | U/A | Special Order. Please Inquire | Unknown | |||||||||||||||||||||||||
| BBS0000-DA900095569011217DD | Longitudinal Hepatitis C (HCV) Drug Treatment Sample Set | United States | Serum | 1.00 | 16.00 | Special Order. Please Inquire | 45 Y | Female | Non-Hispanic | <-70C | 12-Jan-17 | Hepatitis C RNA Quantitative | 7,006,081 IU/mL | 16-Nov-16 | Genotype | 1a | Special Order. Please Inquire | Unknown | Harvoni | 68.00 | 185 | 16-Nov-16 | Intravenous drug user | No | No | ALT: 54 U/L | AST: 34 U/L | ALP: 123 U/L | Bilirubin (Total): 1.1 mg/dL | Bilirubin (Direct): 0.4 mg/dL | Creatinine: 0.65 mg/dL 16-Nov-16 | ||||||||||||||
| BBS0000-DA900095569020917DD | Longitudinal Hepatitis C (HCV) Drug Treatment Sample Set | United States | Serum | 1.00 | 9.00 | Special Order. Please Inquire | 45 Y | Female | Non-Hispanic | <-70C | 09-Feb-17 | Hepatitis C RNA Quantitative | 39 IU/mL | 26-Jan-17 | Genotype | 1a | Special Order. Please Inquire | Unknown | Harvoni | 68.00 | 185 | 16-Nov-16 | Intravenous drug user | No | No | |||||||||||||||
| BBS0000-DA900095569031218DD | Longitudinal Hepatitis C (HCV) Drug Treatment Sample Set | United States | Serum | 1.00 | 8.00 | Special Order. Please Inquire | 46 Y | Female | Non-Hispanic | <-70C | 12-Mar-18 | Hepatitis C RNA Quantitative | Not Detected | 14-May-18 | Genotype | 1a | Special Order. Please Inquire | Unknown | Harvoni | 68.00 | 185 | 16-Nov-16 | Intravenous drug user | No | No | ALT: 10 U/L | AST: 20 U/L | ALP: 43 U/L | Bilirubin (Total): 0.6 mg/dL | Bilirubin (Direct): 0.2 mg/dL 10-Jan-18 | ||||||||||||||
| BBS0000-DA900095569032917DD | Longitudinal Hepatitis C (HCV) Drug Treatment Sample Set | United States | Serum | 1.00 | 14.00 | Special Order. Please Inquire | 45 Y | Female | Non-Hispanic | <-70C | 29-Mar-17 | Hepatitis C RNA Quantitative | Not Detected | 17-Mar-17 | Genotype | 1a | Special Order. Please Inquire | Unknown | Harvoni | 68.00 | 185 | 16-Nov-16 | Intravenous drug user | No | No | ALT: 17 U/L | AST: 23 U/L | ALP: 81 U/L | Bilirubin (Total): 0.7 mg/dL | Bilirubin (Direct): 0.2 mg/dL | Serum Creatinine: 0.81 mg/dL 29-Mar-17 | ||||||||||||||
| BBS0000-DA900097307031517DD | Longitudinal Hepatitis C (HCV) Drug Treatment Sample Set | United States | Serum | 1.00 | 16.00 | Special Order. Please Inquire | 66 Y | Male | Non-Hispanic | <-70C | 15-Mar-17 | Hepatitis C RNA Quantitative | 2,808 IU/mL | 9-Mar-17 | Genotype | 1a | Special Order. Please Inquire | Unknown | Harvoni | 71.00 | 178 | 14-Jan-15 | Transfusion (1980's) | No | No | ALT: 23 U/L | AST: 35 U/L | Bilirubin (Total): 1.3 mg/dL | Bilirubin (Direct): 0.6 mg/dL | Serum Creatinine: 1.4 mg/dL 9-Mar-17 | ||||||||||||||
| BBS0000-DA900097307041317DD | Longitudinal Hepatitis C (HCV) Drug Treatment Sample Set | United States | Serum | 1.00 | 13.00 | Special Order. Please Inquire | 66 Y | Male | Non-Hispanic | <-70C | 13-Apr-17 | Hepatitis C RNA Quantitative | 219 IU/mL | 6-Apr-17 | Genotype | 1a | Special Order. Please Inquire | Unknown | Harvoni | 71.00 | 178 | 14-Jan-15 | Transfusion (1980's) | No | No | |||||||||||||||
| BBS0000-DA900097307080718DD | Longitudinal Hepatitis C (HCV) Drug Treatment Sample Set | United States | Serum | 1.00 | 9.00 | Special Order. Please Inquire | 67 Y | Male | Non-Hispanic | <-70C | 07-Aug-18 | U/A | U/A | Genotype | 1a | Special Order. Please Inquire | Unknown | Harvoni | 71.00 | 178 | 14-Jan-15 | Transfusion (1980's) | No | No | U/A | |||||||||||||||
| BBS0000-DA900097307081617DD | Longitudinal Hepatitis C (HCV) Drug Treatment Sample Set | United States | Serum | 1.00 | 6.00 | Special Order. Please Inquire | 66 Y | Male | Non-Hispanic | <-70C | 16-Aug-17 | Hepatitis C RNA Quantitative | Not Detected | 20-Jul-17 | Genotype | 1a | Special Order. Please Inquire | Unknown | Harvoni | 71.00 | 178 | 14-Jan-15 | Transfusion (1980's) | No | No | ALT: 21 U/L | AST: 33 U/L | ALP: 91 U/L | Bilirubin (Total): 1.6 mg/dL | Bilirubin (Direct): 0.7 mg/dL | Serum Creatinine: 1.5 mg/dL 20-Jul-17 | ||||||||||||||
| BBS0000-DA900097984011717DD | Longitudinal Hepatitis C (HCV) Drug Treatment Sample Set | United States | Serum | 1.00 | 13.00 | Special Order. Please Inquire | 64 Y | Male | Non-Hispanic | <-70C | 17-Jan-17 | Hepatitis C RNA Quantitative | 2,822,367 IU/mL | 4-Nov-16 | Genotype | 1b | Special Order. Please Inquire | Unknown | Harvoni | 73.00 | 232 | 16-Dec-15 | STDs | No | Yes | 6.8 kPa 20-Dec-16 | ALT: 48 U/L | AST: 37 U/L | ALP: 91 U/L | Bilirubin (Total): 0.7 mg/dL | Bilirubin (Direct): 0.3 mg/dL 4-Nov-16 | ||||||||||||||
| BBS0000-DA900097984031017DD | Longitudinal Hepatitis C (HCV) Drug Treatment Sample Set | United States | Serum | 1.00 | 12.00 | Special Order. Please Inquire | 64 Y | Male | Non-Hispanic | <-70C | 10-Mar-17 | Hepatitis C RNA Quantitative | Not Detected | 10-Mar-17 | Genotype | 1b | Special Order. Please Inquire | Unknown | Harvoni | 73.00 | 232 | 16-Dec-15 | STDs | No | Yes | 6.8 kPa 20-Dec-16 | |||||||||||||||
| BBS0000-DA900097984082517DD | Longitudinal Hepatitis C (HCV) Drug Treatment Sample Set | United States | Serum | 1.00 | 12.00 | Special Order. Please Inquire | 65 Y | Male | Non-Hispanic | <-70C | 25-Aug-17 | Hepatitis C RNA Quantitative | Not Detected | 21-Jul-17 | Genotype | 1b | Special Order. Please Inquire | Unknown | Harvoni | 73.00 | 232 | 16-Dec-15 | STDs | No | Yes | 6.8 kPa 20-Dec-16 | ALT: 17 U/L | AST: 24 U/L | ALP: 73 U/L | Bilirubin (Total): 0.5 mg/dL | Bilirubin (Direct): 0.1 mg/dL | Creatinine: 1.36 mg/dL 21-Jul-17 | ||||||||||||||
| BBS0000-DA900097984112717DD | Longitudinal Hepatitis C (HCV) Drug Treatment Sample Set | United States | Serum | 1.00 | 13.00 | Special Order. Please Inquire | 65 Y | Male | Non-Hispanic | <-70C | 27-Nov-17 | Hepatitis C RNA Quantitative | Not Detected | 17-Nov-17 | Genotype | 1b | Special Order. Please Inquire | Unknown | Harvoni | 73.00 | 232 | 16-Dec-15 | STDs | No | Yes | 6.8 kPa 20-Dec-16 | ALT: 12 U/L | AST: 21 U/L | ALP: 93 U/L | Bilirubin (Total): 0.8 mg/dL | Bilirubin (Direct): 0.1 mg/dL | Creatinine: 1.18 mg/dL 17-Nov-17 | ||||||||||||||
| BBS0000-DA900098764041117DD | Longitudinal Hepatitis C (HCV) Drug Treatment Sample Set | United States | Serum | 1.00 | 6.00 | Special Order. Please Inquire | 66 Y | Male | Non-Hispanic | <-70C | 11-Apr-17 | Hepatitis C RNA Quantitative | 3,036,643 IU/mL | 14-Feb-17 | Genotype | 1a | Special Order. Please Inquire | Unknown | Harvoni | 65.75 | 176 | 28-Sep-16 | Intravenous drug user | No | No | ALT: 32 U/L | AST: 62 U/L | ALP: 144 U/L | Bilirubin (Total): 1.4 mg/dL | Bilirubin (Direct): 0.6 mg/dL 14-Feb-17 | ||||||||||||||
| BBS0000-DA900098764051617DD | Longitudinal Hepatitis C (HCV) Drug Treatment Sample Set | United States | Serum | 1.00 | 13.00 | Special Order. Please Inquire | 66 Y | Male | Non-Hispanic | <-70C | 16-May-17 | Hepatitis C RNA Quantitative | HCV RNA Not detected | 10-May-17 | Genotype | 1a | Special Order. Please Inquire | Unknown | Harvoni | 65.75 | 176 | 28-Sep-16 | Intravenous drug user | No | No | U/A | ||||||||||||||
| BBS0000-DA900098764071217DD | Longitudinal Hepatitis C (HCV) Drug Treatment Sample Set | United States | Serum | 1.00 | 12.00 | Special Order. Please Inquire | 66 Y | Male | Non-Hispanic | <-70C | 12-Jul-17 | Hepatitis C RNA Quantitative | Not Detected | 20-Jul-17 | Genotype | 1a | Special Order. Please Inquire | Unknown | Harvoni | 65.75 | 176 | 28-Sep-16 | Intravenous drug user | No | No | ALT: 21 U/L | AST: 32 U/L | ALP: 174 U/L | Bilirubin (Total): 0.9 mg/dL | Bilirubin (Direct): 0.3 mg/dL 27-Jun-17 | ||||||||||||||
| BBS0000-DA900098764082118DD | Longitudinal Hepatitis C (HCV) Drug Treatment Sample Set | United States | Serum | 1.00 | 10.00 | Special Order. Please Inquire | 67 Y | Male | Non-Hispanic | <-70C | 21-Aug-18 | U/A | U/A | Genotype | 1a | Special Order. Please Inquire | Unknown | Harvoni | 65.75 | 176 | 28-Sep-16 | Intravenous drug user | No | No | U/A | |||||||||||||||
| BBS0000-DA900108538061517DD | Longitudinal Hepatitis C (HCV) Drug Treatment Sample Set | United States | Serum | 1.00 | 6.00 | Special Order. Please Inquire | 66 Y | Male | Non-Hispanic | <-70C | 15-Jun-17 | Hepatitis C RNA Quantitative | 4,080,170 IU/mL | 19-Apr-17 | Genotype | 3a | Special Order. Please Inquire | Unknown | Epclusa | 70.00 | 192 | 2-Jan-15 | Intravenous drug user | No | Yes | 7.9 kPa 4-Jan-16 | ALT: 26 U/L | AST: 38 U/L | ALP: 94 U/L | Bilirubin (Total): 0.9 mg/dL | Bilirubin (Direct): 0.3 mg/dL 19-Apr-17 | ||||||||||||||
| BBS0000-DA900108538062917DD | Longitudinal Hepatitis C (HCV) Drug Treatment Sample Set | United States | Serum | 1.00 | 7.00 | Special Order. Please Inquire | 66 Y | Male | Non-Hispanic | <-70C | 29-Jun-17 | Hepatology Test Group 1 | HCV RNA Not detected | 7-Jun-17 | Genotype | 3a | Special Order. Please Inquire | Unknown | Epclusa | 70.00 | 192 | 2-Jan-15 | Intravenous drug user | No | Yes | 7.9 kPa 4-Jan-16 | |||||||||||||||
| BBS0000-DA900108538081717DD | Longitudinal Hepatitis C (HCV) Drug Treatment Sample Set | United States | Serum | 1.00 | 9.00 | Special Order. Please Inquire | 66 Y | Male | Non-Hispanic | <-70C | 17-Aug-17 | Hepatology Test Group 1 | HCV RNA Not detected | 18-Jul-17 | Genotype | 3a | Special Order. Please Inquire | Unknown | Epclusa | 70.00 | 192 | 2-Jan-15 | Intravenous drug user | No | Yes | 7.9 kPa 4-Jan-16 | ALT: 13 U/L | AST: 23 U/L | ALP: 85 U/L | Bilirubin (Total): 0.6 mg/dL | Bilirubin (Direct): 0.2 mg/dL | Creatinine: 1.09 mg/dL 18-Jul-17 | ||||||||||||||
| BBS0000-DA900108538102417DD | Longitudinal Hepatitis C (HCV) Drug Treatment Sample Set | United States | Serum | 1.00 | 8.00 | Special Order. Please Inquire | 66 Y | Male | Non-Hispanic | <-70C | 24-Oct-17 | Hepatitis C RNA Quantitative | HCV RNA Not detected | 19-Sep-17 | Genotype | 3a | Special Order. Please Inquire | Unknown | Epclusa | 70.00 | 192 | 2-Jan-15 | Intravenous drug user | No | Yes | 7.9 kPa 4-Jan-16 | ALT: 10 U/L | AST: 20 U/L | ALP: 86 U/L | Bilirubin (Total): 0.6 mg/Dl | Bilirubin (Direct): 0.1 mg/dL | Serum Creatinine: 1.12 mg/dL 17-Aug-17 | ||||||||||||||
| BBS0000-EM900046723110413DD | Longitudinal Hepatitis C (HCV) Drug Treatment Sample Set | Estonia | Serum | 1.00 | 1.00 | Special Order. Please Inquire | Male | Non-Hispanic | <-70C | 04-Nov-13 | Genotype | 3 | Special Order. Please Inquire | Unknown | ||||||||||||||||||||||||||
| BBS0000-EM900062428012014DD | Longitudinal Hepatitis C (HCV) Drug Treatment Sample Set | Estonia | Serum | 1.00 | 6.00 | Special Order. Please Inquire | 37 Y | Male | Non-Hispanic | <-70C | 20-Jan-14 | Genotype | 3 | Special Order. Please Inquire | Unknown | |||||||||||||||||||||||||
| BBS0000-EM900062429100813DD | Longitudinal Hepatitis C (HCV) Drug Treatment Sample Set | Estonia | Serum | 1.00 | 8.00 | Special Order. Please Inquire | Male | Non-Hispanic | <-70C | 08-Oct-13 | Genotype | 3 | Special Order. Please Inquire | Unknown | ||||||||||||||||||||||||||
| BBS0000-EM900108100092413DD | Longitudinal Hepatitis C (HCV) Drug Treatment Sample Set | Estonia | Serum | 1.00 | 11.00 | Special Order. Please Inquire | 60 Y | Male | Non-Hispanic | <-70C | 24-Sep-13 | Genotype | 3 | Special Order. Please Inquire | Unknown | |||||||||||||||||||||||||
| BBS0000-EM900108100102513DD | Longitudinal Hepatitis C (HCV) Drug Treatment Sample Set | Estonia | Serum | 1.00 | 17.00 | Special Order. Please Inquire | 60 Y | Male | Non-Hispanic | <-70C | 25-Oct-13 | Genotype | 3 | Special Order. Please Inquire | Unknown | |||||||||||||||||||||||||
| BBS0000-FC900056202071217DD | Longitudinal Hepatitis C (HCV) Drug Treatment Sample Set | United States | Serum | 1.00 | 16.00 | Special Order. Please Inquire | 64 Y | Male | Non-Hispanic | <-70C | 12-Jul-17 | Genotype | 1b | Special Order. Please Inquire | Unknown | |||||||||||||||||||||||||
| BBS0000-FC900104757013117DD | Longitudinal Hepatitis C (HCV) Drug Treatment Sample Set | United States | Serum | 1.00 | 12.00 | Special Order. Please Inquire | 59 Y | Male | Non-Hispanic | <-70C | 31-Jan-17 | Genotype | 1a | Special Order. Please Inquire | Unknown | |||||||||||||||||||||||||
| BBS0000-FC900104757031317DD | Longitudinal Hepatitis C (HCV) Drug Treatment Sample Set | United States | Serum | 1.00 | 13.00 | Special Order. Please Inquire | 59 Y | Male | Non-Hispanic | <-70C | 13-Mar-17 | Genotype | 1a | Special Order. Please Inquire | Unknown | |||||||||||||||||||||||||
| BBS0000-FC900104757051817DD | Longitudinal Hepatitis C (HCV) Drug Treatment Sample Set | United States | Serum | 1.00 | 16.00 | Special Order. Please Inquire | 59 Y | Male | Non-Hispanic | <-70C | 18-May-17 | Genotype | 1a | Special Order. Please Inquire | Unknown | |||||||||||||||||||||||||
| BBS0000-FC900104757081617DD | Longitudinal Hepatitis C (HCV) Drug Treatment Sample Set | United States | Serum | 1.00 | 14.00 | Special Order. Please Inquire | 60 Y | Male | Non-Hispanic | <-70C | 16-Aug-17 | Genotype | 1a | Special Order. Please Inquire | Unknown | |||||||||||||||||||||||||
| BBS0000-FD900040752110219DD | Longitudinal Hepatitis C (HCV) Drug Treatment Sample Set | Canada | Serum | 1.00 | 13.00 | Special Order. Please Inquire | Male | Non-Hispanic | <-70C | 02-Nov-19 | Genotype | 2 | Special Order. Please Inquire | Unknown | ||||||||||||||||||||||||||
| BBS0000-FD900040753051618DD | Longitudinal Hepatitis C (HCV) Drug Treatment Sample Set | Canada | Serum | 1.00 | 7.00 | Special Order. Please Inquire | 71 Y | Male | Non-Hispanic | <-70C | 16-May-18 | Roche cobas Ampliprep | Taqman | Not Detected | 16-Mar-18 | Genotype | 2 | Special Order. Please Inquire | Unknown | N/A | 2007 | Transfusions in 1960's; Injections as a child in Germany | No | Yes | 10.3 kPa | 29-Jan-18 | |||||||||||||||||
| BBS0000-FD900040754100318DD | Longitudinal Hepatitis C (HCV) Drug Treatment Sample Set | Canada | Serum | 1.00 | 5.00 | Special Order. Please Inquire | 51 Y | Male | Non-Hispanic | <-70C | 03-Oct-18 | Roche cobas Taqman | Ampliprep | Not Detected | 22-Aug-2018 | Genotype | 3 | Special Order. Please Inquire | Unknown | Epclusa | 2014 | U/A | No | Yes | 5.8 kPa 6-Sep-16 | ALT: 11 U/L | AST: 16 U/L | ALP: 52 U/L | Bilirubin (Total): 10 umol/L | Creatinine: 103 umol/L | 3-Oct-18 | ||||||||||||||||
| BBS0000-FD900040755061418DD | Longitudinal Hepatitis C (HCV) Drug Treatment Sample Set | Canada | Serum | 1.00 | 16.00 | Special Order. Please Inquire | 57 Y | Female | Non-Hispanic | <-70C | 14-Jun-18 | Roche cobas Taqman | Ampliprep | <12 IU/mL | 14-Jun-18 | Genotype | 3a | Special Order. Please Inquire | Unknown | Epclusa and Ribavirin | 1993 | Intravenous drug user | Yes | Grade I , Stage I 15-Nov-93 | Yes | 27.7 kPa 19-Feb-18 | ALT: 21 U/L | AST: 26 U/L | ALP: 73 U/L | Bilirubin (Total): 21 umol/L | Bilirubin (Direct): 8 umol/ | Creatinine: 55 umol/L 23-Mar-18 | ||||||||||||||||
| BBS0000-FD900051707040915DD | Longitudinal Hepatitis C (HCV) Drug Treatment Sample Set | Canada | Serum | 1.00 | 9.00 | Special Order. Please Inquire | 60 Y | Male | Non-Hispanic | <-70C | 09-Apr-15 | Genotype | 1b | Special Order. Please Inquire | Unknown | |||||||||||||||||||||||||
| BBS0000-FD900072769110119DD | Longitudinal Hepatitis C (HCV) Drug Treatment Sample Set | Canada | Serum | 1.00 | 14.00 | Special Order. Please Inquire | Female | Non-Hispanic | <-70C | 02-Nov-19 | Genotype | 1a | Special Order. Please Inquire | Unknown | ||||||||||||||||||||||||||
| BBS0000-FD900076138110119DD | Longitudinal Hepatitis C (HCV) Drug Treatment Sample Set | Canada | Serum | 1.00 | 11.00 | Special Order. Please Inquire | Male | Non-Hispanic | <-70C | 02-Nov-19 | Genotype | 1a | Special Order. Please Inquire | Unknown | ||||||||||||||||||||||||||
| BBS0000-FD900076141110119DD | Longitudinal Hepatitis C (HCV) Drug Treatment Sample Set | Canada | Serum | 1.00 | 12.00 | Special Order. Please Inquire | Female | Non-Hispanic | <-70C | 02-Nov-19 | Genotype | 1a | Special Order. Please Inquire | Unknown | ||||||||||||||||||||||||||
| BBS0000-FD900078727110119DD | Longitudinal Hepatitis C (HCV) Drug Treatment Sample Set | Canada | Serum | 1.00 | 8.00 | Special Order. Please Inquire | Male | Non-Hispanic | <-70C | 02-Nov-19 | Genotype | 1 | Special Order. Please Inquire | Unknown | ||||||||||||||||||||||||||
| BBS0000-FD900078733110119DD | Longitudinal Hepatitis C (HCV) Drug Treatment Sample Set | Canada | Serum | 1.00 | 8.00 | Special Order. Please Inquire | Male | Non-Hispanic | <-70C | 02-Nov-19 | Genotype | 1a | Special Order. Please Inquire | Unknown | ||||||||||||||||||||||||||
| BBS0000-FD900078734110119DD | Longitudinal Hepatitis C (HCV) Drug Treatment Sample Set | Canada | Serum | 1.00 | 8.00 | Special Order. Please Inquire | Male | Non-Hispanic | <-70C | 02-Nov-19 | Genotype | 3a | Special Order. Please Inquire | Unknown | ||||||||||||||||||||||||||
| BBS0000-FD900078735110119DD | Longitudinal Hepatitis C (HCV) Drug Treatment Sample Set | Canada | Serum | 1.00 | 7.00 | Special Order. Please Inquire | Male | Non-Hispanic | <-70C | 02-Nov-19 | Genotype | 1a | Special Order. Please Inquire | Unknown | ||||||||||||||||||||||||||
| BBS0000-FD900080469042418DD | Longitudinal Hepatitis C (HCV) Drug Treatment Sample Set | Canada | Serum | 1.00 | 10.00 | Special Order. Please Inquire | 65 Y | Male | Non-Hispanic | <-70C | 24-Apr-18 | Roche cobas Ampliprep | Taqman | 285,411 IU/mL | 1-Mar-18 | Genotype | 3a | Special Order. Please Inquire | Unknown | Epclusa | 60.00 | 200 | 2000 | Transfusion | No | Yes | 2.5 kPa 27-Jun-17 | ALT: 28 U/L | AST: 24 U/L | ALP: 118 U/L | Bilirubin (Total): 13 umol/L | Bilirubin (Direct): 4 umol/L 21-Feb-18 | ||||||||||||||
| BBS0000-FD900080469110219DD | Longitudinal Hepatitis C (HCV) Drug Treatment Sample Set | Canada | Serum | 1.00 | 3.00 | Special Order. Please Inquire | 65 Y | Male | Non-Hispanic | <-70C | 02-Nov-19 | Abbott RealTime PCR Assay | Genotype | 3a | Special Order. Please Inquire | Unknown | Epclusa | 60.00 | 200 | 2000 | Transfusion | No | Yes | 2.5 kPa 27-Jun-17 | ALT: 19 U/L | AST: 17 U/L | ALP: 101 U/L | Bilirubin (Total): 15 umol/L | Bilirubin (Direct): 5 umol/L | Creatinine: 76 umol/L 19-Dec-18 | ||||||||||||||||
| BBS0000-FD900090771071018DD | Longitudinal Hepatitis C (HCV) Drug Treatment Sample Set | Canada | Serum | 1.00 | 9.00 | Special Order. Please Inquire | 65 Y | Male | Non-Hispanic | <-70C | 10-Jul-18 | Roche cobas Taqman | Ampliprep | 40,158 IU/mL | 10-Jul-18 | Genotype | 2 | Special Order. Please Inquire | Unknown | Epclusa | 70.00 | 175 | 2002 | U/A | No | Yes | 27.0 KpA 20-Jun-18 | ALT: 131 U/L | AST: 90 U/L | ALP: 91 U/L | Bilirubin (Total): 11 umol/L | Bilirubin (Direct): 5 umol/L | Creatinine: 71 umol/L 10-Jul-18 | ||||||||||||||
| BBS0000-FD900090771080218DD | Longitudinal Hepatitis C (HCV) Drug Treatment Sample Set | Canada | Serum | 1.00 | 12.00 | Special Order. Please Inquire | 65 Y | Male | Non-Hispanic | <-70C | 02-Aug-18 | Roche cobas Taqman | Ampliprep | Not Detected | 2-Aug-18 | Genotype | 2 | Special Order. Please Inquire | Unknown | Epclusa | 70.00 | 175 | 2002 | U/A | No | Yes | 27.0 KpA 20-Jun-18 | U/A | ||||||||||||||
| BBS0000-FD900090771100218DD | Longitudinal Hepatitis C (HCV) Drug Treatment Sample Set | Canada | Serum | 1.00 | 10.00 | Special Order. Please Inquire | 65 Y | Male | Non-Hispanic | <-70C | 02-Oct-18 | Roche cobas Taqman | Ampliprep | Not Detected | 2-Oct-18 | Genotype | 2 | Special Order. Please Inquire | Unknown | Epclusa | 70.00 | 175 | 2002 | U/A | No | Yes | 27.0 KpA 20-Jun-18 | ALT: 19 U/L | AST: 20 U/L | ALP: 78 U/L | Bilirubin (Total): 8 umol/L | Bilirubin (Direct): 3 umol/L | Creatinine: 79 umol/L 2-Oct-18 | ||||||||||||||
| BBS0000-FD900097527051618DD | Longitudinal Hepatitis C (HCV) Drug Treatment Sample Set | Canada | Serum | 1.00 | 11.00 | Special Order. Please Inquire | 65 Y | Female | Non-Hispanic | <-70C | 16-May-18 | Roche cobas Ampliprep | Taqman | 70,441 IU/mL | 16-May-18 | Genotype | 2 | Special Order. Please Inquire | Unknown | Epclusa | 62.00 | 138 | 2017 | Transfusion | No | Yes | 12.5 kPa 1-Mar-18 | ALT: 218 U/L | AST: 186 U/L | ALP: 86 U/L | Bilirubin (Total): 11 umol/L | Bilirubin (Direct): 6 umol/L | Creatinine: 60 umol/L 16-May-18 | ||||||||||||||
| BBS0000-FD900097527071118DD | Longitudinal Hepatitis C (HCV) Drug Treatment Sample Set | Canada | Serum | 1.00 | 11.00 | Special Order. Please Inquire | 65 Y | Female | Non-Hispanic | <-70C | 11-Jul-18 | Genotype | 2 | Special Order. Please Inquire | Unknown | Epclusa | 62.00 | 138 | 2017 | Transfusion | No | Yes | 12.5 kPa 1-Mar-18 | U/A | |||||||||||||||||
| BBS0000-FD900097527082218DD | Longitudinal Hepatitis C (HCV) Drug Treatment Sample Set | Canada | Serum | 1.00 | 12.00 | Special Order. Please Inquire | 65 Y | Female | Non-Hispanic | <-70C | 22-Aug-18 | Roche cobas Taqman | Ampliprep | Not Detected | 22-Aug-18 | Genotype | 2 | Special Order. Please Inquire | Unknown | Epclusa | 62.00 | 138 | 2017 | Transfusion | No | Yes | 12.5 kPa 1-Mar-18 | ALT: 19 U/L | AST: 30 U/L | ALP: 72 U/L | Bilirubin (Total): 12 umol/L | Bilirubin (Direct): 6 umol/L | Creatinine: 53 umol/L 22-Aug-18 | ||||||||||||||
| BBS0000-FD900098596052318DD | Longitudinal Hepatitis C (HCV) Drug Treatment Sample Set | Canada | Serum | 1.00 | 14.00 | Special Order. Please Inquire | 56 Y | Male | Non-Hispanic | <-70C | 23-May-18 | Roche cobas Taqman | Ampliprep | 3,378,264 IU/mL | 25-Apr-18 | Genotype | 3a | Special Order. Please Inquire | Unknown | Epclusa | 61.00 | 178 | 1993 | Body piercing / Tattooing | No | Yes | 6.7 kPa 28-Jun-16 | ALT: 30 U/L | AST: 22 U/L | ALP: 80 U/L | Bilirubin (Total): 6 umol/L | Bilirubin (Direct): 2 umol/L | Creatinine: 70 umol/L 25-Apr-18 | ||||||||||||||
| BBS0000-FD900098596061818DD | Longitudinal Hepatitis C (HCV) Drug Treatment Sample Set | Canada | Serum | 1.00 | 13.00 | Special Order. Please Inquire | 56 Y | Male | Non-Hispanic | <-70C | 18-Jun-18 | Roche cobas Taqman | Ampliprep | <12 IU/mL | 18-Jun-18 | Genotype | 3a | Special Order. Please Inquire | Unknown | Epclusa | 61.00 | 178 | 1993 | Body piercing / Tattooing | No | Yes | 6.7 kPa 28-Jun-16 | U/A | ||||||||||||||
| BBS0000-FD900098596082318DD | Longitudinal Hepatitis C (HCV) Drug Treatment Sample Set | Canada | Serum | 1.00 | 11.00 | Special Order. Please Inquire | 56 Y | Male | Non-Hispanic | <-70C | 23-Aug-18 | Roche cobas Taqman | Ampliprep | Not Detected | 23-Aug-18 | Genotype | 3a | Special Order. Please Inquire | Unknown | Epclusa | 61.00 | 178 | 1993 | Body piercing / Tattooing | No | Yes | 6.7 kPa 28-Jun-16 | ALT: 13 U/L | AST: 15 U/L | ALP: 74 U/L | Bilirubin (Total): 6 umol/L | Bilirubin (Direct): 2 umol/L | Creatinine: 63 umol/L 23-Aug-18 | ||||||||||||||
| BBS0000-FD900105807040715DD | Longitudinal Hepatitis C (HCV) Drug Treatment Sample Set | Canada | Serum | 1.00 | 8.00 | Special Order. Please Inquire | 45 Y | Male | Non-Hispanic | <-70C | 07-Apr-15 | Genotype | 3a | Special Order. Please Inquire | Unknown | |||||||||||||||||||||||||
| BBS0000-FD900105807092315DD | Longitudinal Hepatitis C (HCV) Drug Treatment Sample Set | Canada | Serum | 1.00 | 9.00 | Special Order. Please Inquire | 45 Y | Male | Non-Hispanic | <-70C | 23-Sep-15 | Genotype | 3a | Special Order. Please Inquire | Unknown | |||||||||||||||||||||||||
| BBS0005-AO900053713053017DD | Longitudinal Hepatitis C (HCV) Drug Treatment Sample Set | South Africa | 0.5 mL Serum | 1.00 | 9.00 | Special Order. Please Inquire | Male | Non-Hispanic | <-70C | 30-May-17 | Genotype | 5a | Special Order. Please Inquire | Unknown | ||||||||||||||||||||||||||
| BBS0005-AO900053713080817DD | Longitudinal Hepatitis C (HCV) Drug Treatment Sample Set | South Africa | 0.5 mL Serum | 1.00 | 6.00 | Special Order. Please Inquire | Male | Non-Hispanic | <-70C | 08-Aug-17 | Genotype | 5a | Special Order. Please Inquire | Unknown | ||||||||||||||||||||||||||
| BBS0005-AO900053713110119DD | Longitudinal Hepatitis C (HCV) Drug Treatment Sample Set | South Africa | 0.5 mL Serum | 1.00 | 8.00 | Special Order. Please Inquire | Male | Non-Hispanic | <-70C | 01-Nov-19 | Genotype | 5a | Special Order. Please Inquire | Unknown | ||||||||||||||||||||||||||
| BBS0005-AO900061279012716DD | Longitudinal Hepatitis C (HCV) Drug Treatment Sample Set | South Africa | 0.5 mL Serum | 1.00 | 12.00 | Special Order. Please Inquire | 53 Y | Male | Non-Hispanic | <-70C | 27-Jan-16 | Genotype | 4k | Special Order. Please Inquire | Unknown | |||||||||||||||||||||||||
| BBS0005-AO900061279061615DD | Longitudinal Hepatitis C (HCV) Drug Treatment Sample Set | South Africa | 0.5 mL Serum | 1.00 | 11.00 | Special Order. Please Inquire | 53 Y | Male | Non-Hispanic | <-70C | 16-Jun-15 | Genotype | 4k | Special Order. Please Inquire | Unknown | |||||||||||||||||||||||||
| BBS0005-AO900061279110315DD | Longitudinal Hepatitis C (HCV) Drug Treatment Sample Set | South Africa | 0.5 mL Serum | 1.00 | 13.00 | Special Order. Please Inquire | Male | Non-Hispanic | <-70C | 03-Nov-15 | Genotype | 4k | Special Order. Please Inquire | Unknown | ||||||||||||||||||||||||||
| BBS0005-AO900061283030816DD | Longitudinal Hepatitis C (HCV) Drug Treatment Sample Set | South Africa | 0.5 mL Serum | 1.00 | 9.00 | Special Order. Please Inquire | 67 Y | Female | Non-Hispanic | <-70C | 08-Mar-16 | Genotype | 4b | Special Order. Please Inquire | Unknown | |||||||||||||||||||||||||
| BBS0005-AO900061283072015DD | Longitudinal Hepatitis C (HCV) Drug Treatment Sample Set | South Africa | 0.5 mL Serum | 1.00 | 6.00 | Special Order. Please Inquire | 66 Y | Female | Non-Hispanic | <-70C | 20-Jul-15 | Genotype | 4b | Special Order. Please Inquire | Unknown | |||||||||||||||||||||||||
| BBS0005-AO900061283082415DD | Longitudinal Hepatitis C (HCV) Drug Treatment Sample Set | South Africa | 0.5 mL Serum | 1.00 | 13.00 | Special Order. Please Inquire | 66 Y | Female | Non-Hispanic | <-70C | 24-Aug-15 | Genotype | 4b | Special Order. Please Inquire | Unknown | |||||||||||||||||||||||||
| BBS0005-AO900061284081417DD | Longitudinal Hepatitis C (HCV) Drug Treatment Sample Set | South Africa | 0.5 mL Serum | 1.00 | 6.00 | Special Order. Please Inquire | Female | Non-Hispanic | <-70C | 14-Aug-17 | Genotype | 5a | Special Order. Please Inquire | Unknown | ||||||||||||||||||||||||||
| BBS0005-AO900061284122116DD | Longitudinal Hepatitis C (HCV) Drug Treatment Sample Set | South Africa | 0.5 mL Serum | 1.00 | 4.00 | Special Order. Please Inquire | 75 Y | Female | Non-Hispanic | <-70C | 21-Dec-16 | Genotype | 5a | Special Order. Please Inquire | Unknown | |||||||||||||||||||||||||
| BBS0005-AO900061285030217DD | Longitudinal Hepatitis C (HCV) Drug Treatment Sample Set | South Africa | 0.5 mL Serum | 1.00 | 4.00 | Special Order. Please Inquire | 62 Y | Male | Non-Hispanic | <-70C | 02-Mar-17 | Genotype | 5a | Special Order. Please Inquire | Unknown | |||||||||||||||||||||||||
| BBS0005-AO900061285040317DD | Longitudinal Hepatitis C (HCV) Drug Treatment Sample Set | South Africa | 0.5 mL Serum | 1.00 | 8.00 | Special Order. Please Inquire | Male | Non-Hispanic | <-70C | 03-Apr-17 | Genotype | 5a | Special Order. Please Inquire | Unknown | ||||||||||||||||||||||||||
| BBS0005-AO900061285082817DD | Longitudinal Hepatitis C (HCV) Drug Treatment Sample Set | South Africa | 0.5 mL Serum | 1.00 | 4.00 | Special Order. Please Inquire | Male | Non-Hispanic | <-70C | 28-Aug-17 | Genotype | 5a | Special Order. Please Inquire | Unknown | ||||||||||||||||||||||||||
| BBS0005-AO900061285112017DD | Longitudinal Hepatitis C (HCV) Drug Treatment Sample Set | South Africa | 0.5 mL Serum | 1.00 | 4.00 | Special Order. Please Inquire | Male | Non-Hispanic | <-70C | 20-Nov-17 | Genotype | 5a | Special Order. Please Inquire | Unknown | ||||||||||||||||||||||||||
| BBS0005-AO900066354051017DD | Longitudinal Hepatitis C (HCV) Drug Treatment Sample Set | South Africa | 0.5 mL Serum | 1.00 | 2.00 | Special Order. Please Inquire | Male | Non-Hispanic | <-70C | 10-May-17 | Genotype | 5a | Special Order. Please Inquire | Unknown | ||||||||||||||||||||||||||
| BBS0005-AO900066354081617DD | Longitudinal Hepatitis C (HCV) Drug Treatment Sample Set | South Africa | 0.5 mL Serum | 1.00 | 4.00 | Special Order. Please Inquire | Male | Non-Hispanic | <-70C | 16-Aug-17 | Genotype | 5a | Special Order. Please Inquire | Unknown | ||||||||||||||||||||||||||
| BBS0005-AO900066354110916DD | Longitudinal Hepatitis C (HCV) Drug Treatment Sample Set | South Africa | 0.5 mL Serum | 1.00 | 5.00 | Special Order. Please Inquire | 71 Y | Male | Non-Hispanic | <-70C | 09-Nov-16 | Genotype | 5a | Special Order. Please Inquire | Unknown | |||||||||||||||||||||||||
| BBS0005-AO900066354120716DD | Longitudinal Hepatitis C (HCV) Drug Treatment Sample Set | South Africa | 0.5 mL Serum | 1.00 | 2.00 | Special Order. Please Inquire | 71 Y | Male | Non-Hispanic | <-70C | 07-Dec-16 | Genotype | 5a | Special Order. Please Inquire | Unknown | |||||||||||||||||||||||||
| BBS0005-CF900031761030215DD | Longitudinal Hepatitis C (HCV) Drug Treatment Sample Set | United States | 0.5 mL Serum | 1.00 | 9.00 | Special Order. Please Inquire | 71 Y | Female | Non-Hispanic | <-70C | 02-Mar-15 | Genotype | 1b | Special Order. Please Inquire | Unknown | |||||||||||||||||||||||||
| BBS0005-CF900031761081815DD | Longitudinal Hepatitis C (HCV) Drug Treatment Sample Set | United States | 0.5 mL Serum | 1.00 | 14.00 | Special Order. Please Inquire | 72 Y | Female | Non-Hispanic | <-70C | 18-Aug-15 | Genotype | 1b | Special Order. Please Inquire | Unknown | |||||||||||||||||||||||||
| BBS0005-CF900031761092815DD | Longitudinal Hepatitis C (HCV) Drug Treatment Sample Set | United States | 0.5 mL Serum | 1.00 | 10.00 | Special Order. Please Inquire | 72 Y | Female | Non-Hispanic | <-70C | 28-Sep-15 | Genotype | 1b | Special Order. Please Inquire | Unknown | |||||||||||||||||||||||||
| BBS0005-CF900031761101514DD | Longitudinal Hepatitis C (HCV) Drug Treatment Sample Set | United States | 0.5 mL Serum | 1.00 | 10.00 | Special Order. Please Inquire | 71 Y | Female | Non-Hispanic | <-70C | 15-Oct-14 | Genotype | 1b | Special Order. Please Inquire | Unknown | |||||||||||||||||||||||||
| BBS0005-CF900031762033015DD | Longitudinal Hepatitis C (HCV) Drug Treatment Sample Set | United States | 0.5 mL Serum | 1.00 | 10.00 | Special Order. Please Inquire | 57 Y | Female | Non-Hispanic | <-70C | 30-Mar-15 | Genotype | 3a | Special Order. Please Inquire | Unknown | |||||||||||||||||||||||||
| BBS0005-CF900031762070615DD | Longitudinal Hepatitis C (HCV) Drug Treatment Sample Set | United States | 0.5 mL Serum | 1.00 | 3.00 | Special Order. Please Inquire | 57 Y | Female | Non-Hispanic | <-70C | 06-Jul-15 | Genotype | 3a | Special Order. Please Inquire | Unknown | |||||||||||||||||||||||||
| BBS0005-CF900031762100614DD | Longitudinal Hepatitis C (HCV) Drug Treatment Sample Set | United States | 0.5 mL Serum | 1.00 | 6.00 | Special Order. Please Inquire | 56 Y | Female | Non-Hispanic | <-70C | 06-Oct-14 | Genotype | 3a | Special Order. Please Inquire | Unknown | |||||||||||||||||||||||||
| BBS0005-CF900031762110314DD | Longitudinal Hepatitis C (HCV) Drug Treatment Sample Set | United States | 0.5 mL Serum | 1.00 | 11.00 | Special Order. Please Inquire | 56 Y | Female | Non-Hispanic | <-70C | 03-Nov-14 | Genotype | 3a | Special Order. Please Inquire | Unknown | |||||||||||||||||||||||||
| BBS0005-CF900031763022615DD | Longitudinal Hepatitis C (HCV) Drug Treatment Sample Set | United States | 0.5 mL Serum | 1.00 | 10.00 | Special Order. Please Inquire | 55 Y | Female | Hispanic | <-70C | 26-Feb-15 | Genotype | 1a | Special Order. Please Inquire | Unknown | |||||||||||||||||||||||||
| BBS0005-CF900031763060815DD | Longitudinal Hepatitis C (HCV) Drug Treatment Sample Set | United States | 0.5 mL Serum | 1.00 | 15.00 | Special Order. Please Inquire | 55 Y | Female | Hispanic | <-70C | 08-Jun-15 | Genotype | 1a | Special Order. Please Inquire | Unknown | |||||||||||||||||||||||||
| BBS0005-CF900031763101614DD | Longitudinal Hepatitis C (HCV) Drug Treatment Sample Set | United States | 0.5 mL Serum | 1.00 | 9.00 | Special Order. Please Inquire | 54 Y | Female | Hispanic | <-70C | 16-Oct-14 | Genotype | 1a | Special Order. Please Inquire | Unknown | |||||||||||||||||||||||||
| BBS0005-CF900031763120314DD | Longitudinal Hepatitis C (HCV) Drug Treatment Sample Set | United States | 0.5 mL Serum | 1.00 | 15.00 | Special Order. Please Inquire | 55 Y | Female | Hispanic | <-70C | 03-Dec-14 | Genotype | 1a | Special Order. Please Inquire | Unknown | |||||||||||||||||||||||||
| BBS0005-CF900031764021616DD | Longitudinal Hepatitis C (HCV) Drug Treatment Sample Set | United States | 0.5 mL Serum | 1.00 | 12.00 | Special Order. Please Inquire | 49 Y | Male | Non-Hispanic | <-70C | 16-Feb-16 | Genotype | 1a | Special Order. Please Inquire | Unknown | |||||||||||||||||||||||||
| BBS0005-CF900031764052615DD | Longitudinal Hepatitis C (HCV) Drug Treatment Sample Set | United States | 0.5 mL Serum | 1.00 | 14.00 | Special Order. Please Inquire | 49 Y | Male | Non-Hispanic | <-70C | 26-May-15 | Genotype | 1a | Special Order. Please Inquire | Unknown | |||||||||||||||||||||||||
| BBS0005-CF900031764100815DD | Longitudinal Hepatitis C (HCV) Drug Treatment Sample Set | United States | 0.5 mL Serum | 1.00 | 10.00 | Special Order. Please Inquire | 49 Y | Male | Non-Hispanic | <-70C | 08-Oct-15 | Genotype | 1a | Special Order. Please Inquire | Unknown | |||||||||||||||||||||||||
| BBS0005-CF900031764101614DD | Longitudinal Hepatitis C (HCV) Drug Treatment Sample Set | United States | 0.5 mL Serum | 1.00 | 5.00 | Special Order. Please Inquire | 48 Y | Male | Non-Hispanic | <-70C | 16-Oct-14 | Genotype | 1a | Special Order. Please Inquire | Unknown | |||||||||||||||||||||||||
| BBS0005-CF900031765022615DD | Longitudinal Hepatitis C (HCV) Drug Treatment Sample Set | United States | 0.5 mL Serum | 1.00 | 5.00 | Special Order. Please Inquire | 59 Y | Female | Hispanic | <-70C | 26-Feb-15 | Genotype | 3 | Special Order. Please Inquire | Unknown | |||||||||||||||||||||||||
| BBS0005-CF900031765100214DD | Longitudinal Hepatitis C (HCV) Drug Treatment Sample Set | United States | 0.5 mL Serum | 1.00 | 13.00 | Special Order. Please Inquire | 58 Y | Female | Hispanic | <-70C | 02-Oct-14 | Genotype | 3 | Special Order. Please Inquire | Unknown | |||||||||||||||||||||||||
| BBS0005-CF900031765120315DD | Longitudinal Hepatitis C (HCV) Drug Treatment Sample Set | United States | 0.5 mL Serum | 1.00 | 13.00 | Special Order. Please Inquire | 59 Y | Female | Hispanic | <-70C | 03-Dec-15 | Genotype | 3 | Special Order. Please Inquire | Unknown | |||||||||||||||||||||||||
| BBS0005-CF900043056032516DD | Longitudinal Hepatitis C (HCV) Drug Treatment Sample Set | United States | 0.5 mL Serum | 1.00 | 10.00 | Special Order. Please Inquire | 50 Y | Female | Non-Hispanic | <-70C | 25-Mar-16 | Genotype | 1b | Special Order. Please Inquire | Unknown | |||||||||||||||||||||||||
| BBS0005-CF900043056032615DD | Longitudinal Hepatitis C (HCV) Drug Treatment Sample Set | United States | 0.5 mL Serum | 1.00 | 7.00 | Special Order. Please Inquire | 49 Y | Female | Non-Hispanic | <-70C | 26-Mar-15 | Genotype | 1b | Special Order. Please Inquire | Unknown | |||||||||||||||||||||||||
| BBS0005-CF900043056062515DD | Longitudinal Hepatitis C (HCV) Drug Treatment Sample Set | United States | 0.5 mL Serum | 1.00 | 11.00 | Special Order. Please Inquire | 49 Y | Female | Non-Hispanic | <-70C | 25-Jun-15 | Genotype | 1b | Special Order. Please Inquire | Unknown | |||||||||||||||||||||||||
| BBS0005-CF900043056092415DD | Longitudinal Hepatitis C (HCV) Drug Treatment Sample Set | United States | 0.5 mL Serum | 1.00 | 9.00 | Special Order. Please Inquire | 49 Y | Female | Non-Hispanic | <-70C | 24-Sep-15 | Genotype | 1b | Special Order. Please Inquire | Unknown | |||||||||||||||||||||||||
| BBS0005-CF900043240021015DD | Longitudinal Hepatitis C (HCV) Drug Treatment Sample Set | United States | 0.5 mL Serum | 1.00 | 1.00 | Special Order. Please Inquire | 54 Y | Female | Hispanic | <-70C | 10-Feb-15 | Genotype | 3 | Special Order. Please Inquire | Unknown | |||||||||||||||||||||||||
| BBS0005-CF900043240042616DD | Longitudinal Hepatitis C (HCV) Drug Treatment Sample Set | United States | 0.5 mL Serum | 1.00 | 7.00 | Special Order. Please Inquire | 55 Y | Female | Hispanic | <-70C | 26-Apr-16 | Genotype | 3 | Special Order. Please Inquire | Unknown | |||||||||||||||||||||||||
| BBS0005-CF900043240051915DD | Longitudinal Hepatitis C (HCV) Drug Treatment Sample Set | United States | 0.5 mL Serum | 1.00 | 6.00 | Special Order. Please Inquire | 54 Y | Female | Hispanic | <-70C | 19-May-15 | Genotype | 3 | Special Order. Please Inquire | Unknown | |||||||||||||||||||||||||
| BBS0005-CF900043240122915DD | Longitudinal Hepatitis C (HCV) Drug Treatment Sample Set | United States | 0.5 mL Serum | 1.00 | 3.00 | Special Order. Please Inquire | 55 Y | Female | Hispanic | <-70C | 29-Dec-15 | Genotype | 3 | Special Order. Please Inquire | Unknown | |||||||||||||||||||||||||
| BBS0005-CF900051876031115DD | Longitudinal Hepatitis C (HCV) Drug Treatment Sample Set | United States | 0.5 mL Serum | 1.00 | 10.00 | Special Order. Please Inquire | 61 Y | Female | Hispanic | <-70C | 11-Mar-15 | Genotype | 2a | 2c | Special Order. Please Inquire | Unknown | |||||||||||||||||||||||||
| BBS0005-CF900051876051815DD | Longitudinal Hepatitis C (HCV) Drug Treatment Sample Set | United States | 0.5 mL Serum | 1.00 | 15.00 | Special Order. Please Inquire | 61 Y | Female | Hispanic | <-70C | 18-May-15 | Genotype | 2a | 2c | Special Order. Please Inquire | Unknown | |||||||||||||||||||||||||
| BBS0005-CF900051876081115DD | Longitudinal Hepatitis C (HCV) Drug Treatment Sample Set | United States | 0.5 mL Serum | 1.00 | 15.00 | Special Order. Please Inquire | 61 Y | Female | Hispanic | <-70C | 11-Aug-15 | Genotype | 2a | 2c | Special Order. Please Inquire | Unknown | |||||||||||||||||||||||||
| BBS0005-CF900051876101315DD | Longitudinal Hepatitis C (HCV) Drug Treatment Sample Set | United States | 0.5 mL Serum | 1.00 | 15.00 | Special Order. Please Inquire | 62 Y | Female | Hispanic | <-70C | 13-Oct-15 | Genotype | 2a | 2c | Special Order. Please Inquire | Unknown | |||||||||||||||||||||||||
| BBS0005-CF900051877020915DD | Longitudinal Hepatitis C (HCV) Drug Treatment Sample Set | United States | 0.5 mL Serum | 1.00 | 6.00 | Special Order. Please Inquire | 61 Y | Female | Non-Hispanic | <-70C | 09-Feb-15 | Genotype | 2 | Special Order. Please Inquire | Unknown | |||||||||||||||||||||||||
| BBS0005-CF900051877032315DD | Longitudinal Hepatitis C (HCV) Drug Treatment Sample Set | United States | 0.5 mL Serum | 1.00 | 8.00 | Special Order. Please Inquire | 61 Y | Female | Non-Hispanic | <-70C | 23-Mar-15 | Genotype | 2 | Special Order. Please Inquire | Unknown | |||||||||||||||||||||||||
| BBS0005-CF900051877060115DD | Longitudinal Hepatitis C (HCV) Drug Treatment Sample Set | United States | 0.5 mL Serum | 1.00 | 4.00 | Special Order. Please Inquire | 62 Y | Female | Non-Hispanic | <-70C | 01-Jun-15 | Genotype | 2 | Special Order. Please Inquire | Unknown | |||||||||||||||||||||||||
| BBS0005-CF900051877081815DD | Longitudinal Hepatitis C (HCV) Drug Treatment Sample Set | United States | 0.5 mL Serum | 1.00 | 8.00 | Special Order. Please Inquire | 62 Y | Female | Non-Hispanic | <-70C | 18-Aug-15 | Genotype | 2 | Special Order. Please Inquire | Unknown | |||||||||||||||||||||||||
| BBS0005-CF900051878020615DD | Longitudinal Hepatitis C (HCV) Drug Treatment Sample Set | United States | 0.5 mL Serum | 1.00 | 1.00 | Special Order. Please Inquire | 64 Y | Male | Hispanic | <-70C | 06-Feb-15 | Genotype | 2b | Special Order. Please Inquire | Unknown | |||||||||||||||||||||||||
| BBS0005-CF900051878051415DD | Longitudinal Hepatitis C (HCV) Drug Treatment Sample Set | United States | 0.5 mL Serum | 1.00 | 7.00 | Special Order. Please Inquire | 64 Y | Male | Hispanic | <-70C | 14-May-15 | Genotype | 2b | Special Order. Please Inquire | Unknown | |||||||||||||||||||||||||
| BBS0005-CF900051878071515DD | Longitudinal Hepatitis C (HCV) Drug Treatment Sample Set | United States | 0.5 mL Serum | 1.00 | 2.00 | Special Order. Please Inquire | 65 Y | Male | Hispanic | <-70C | 15-Jul-15 | Genotype | 2b | Special Order. Please Inquire | Unknown | |||||||||||||||||||||||||
| BBS0005-CF900051878110515DD | Longitudinal Hepatitis C (HCV) Drug Treatment Sample Set | United States | 0.5 mL Serum | 1.00 | 6.00 | Special Order. Please Inquire | 65 Y | Male | Hispanic | <-70C | 05-Nov-15 | Genotype | 2b | Special Order. Please Inquire | Unknown | |||||||||||||||||||||||||
| BBS0005-CF900051879012115DD | Longitudinal Hepatitis C (HCV) Drug Treatment Sample Set | United States | 0.5 mL Serum | 1.00 | 10.00 | Special Order. Please Inquire | 77 Y | Female | Non-Hispanic | <-70C | 21-Jan-15 | Genotype | 1a | Special Order. Please Inquire | Unknown | |||||||||||||||||||||||||
| BBS0005-CF900051879033015DD | Longitudinal Hepatitis C (HCV) Drug Treatment Sample Set | United States | 0.5 mL Serum | 1.00 | 3.00 | Special Order. Please Inquire | 77 Y | Female | Non-Hispanic | <-70C | 30-Mar-15 | Genotype | 1a | Special Order. Please Inquire | Unknown | |||||||||||||||||||||||||
| BBS0005-CF900051879062215DD | Longitudinal Hepatitis C (HCV) Drug Treatment Sample Set | United States | 0.5 mL Serum | 1.00 | 6.00 | Special Order. Please Inquire | 77 Y | Female | Non-Hispanic | <-70C | 22-Jun-15 | Genotype | 1a | Special Order. Please Inquire | Unknown | |||||||||||||||||||||||||
| BBS0005-CF900051879111214DD | Longitudinal Hepatitis C (HCV) Drug Treatment Sample Set | United States | 0.5 mL Serum | 1.00 | 1.00 | Special Order. Please Inquire | 76 Y | Female | Non-Hispanic | <-70C | 12-Nov-14 | Genotype | 1a | Special Order. Please Inquire | Unknown | |||||||||||||||||||||||||
| BBS0005-CF900051880072015DD | Longitudinal Hepatitis C (HCV) Drug Treatment Sample Set | United States | 0.5 mL Serum | 1.00 | 9.00 | Special Order. Please Inquire | 57 Y | Male | Non-Hispanic | <-70C | 20-Jul-15 | Genotype | 1a | Special Order. Please Inquire | Unknown | |||||||||||||||||||||||||
| BBS0005-CF900051880101915DD | Longitudinal Hepatitis C (HCV) Drug Treatment Sample Set | United States | 0.5 mL Serum | 1.00 | 8.00 | Special Order. Please Inquire | 57 Y | Male | Non-Hispanic | <-70C | 19-Oct-15 | Genotype | 1a | Special Order. Please Inquire | Unknown | |||||||||||||||||||||||||
| BBS0005-CF900051880111014DD | Longitudinal Hepatitis C (HCV) Drug Treatment Sample Set | United States | 0.5 mL Serum | 1.00 | 6.00 | Special Order. Please Inquire | 56 Y | Male | Non-Hispanic | <-70C | 10-Nov-14 | Genotype | 1a | Special Order. Please Inquire | Unknown | |||||||||||||||||||||||||
| BBS0005-CF900051880123114DD | Longitudinal Hepatitis C (HCV) Drug Treatment Sample Set | United States | 0.5 mL Serum | 1.00 | 5.00 | Special Order. Please Inquire | 56 Y | Male | Non-Hispanic | <-70C | 31-Dec-14 | Genotype | 1a | Special Order. Please Inquire | Unknown | |||||||||||||||||||||||||
| BBS0005-CF900052447020116DD | Longitudinal Hepatitis C (HCV) Drug Treatment Sample Set | United States | 0.5 mL Serum | 1.00 | 13.00 | Special Order. Please Inquire | 58 Y | Female | Non-Hispanic | <-70C | 01-Feb-16 | Genotype | 1a | Special Order. Please Inquire | Unknown | |||||||||||||||||||||||||
| BBS0005-CF900052447040815DD | Longitudinal Hepatitis C (HCV) Drug Treatment Sample Set | United States | 0.5 mL Serum | 1.00 | 1.00 | Special Order. Please Inquire | 57 Y | Female | Non-Hispanic | <-70C | 08-Apr-15 | Genotype | 1a | Special Order. Please Inquire | Unknown | |||||||||||||||||||||||||
| BBS0005-CF900052447083115DD | Longitudinal Hepatitis C (HCV) Drug Treatment Sample Set | United States | 0.5 mL Serum | 1.00 | 14.00 | Special Order. Please Inquire | 57 Y | Female | Non-Hispanic | <-70C | 31-Aug-15 | Genotype | 1a | Special Order. Please Inquire | Unknown | |||||||||||||||||||||||||
| BBS0005-CF900052447110215DD | Longitudinal Hepatitis C (HCV) Drug Treatment Sample Set | United States | 0.5 mL Serum | 1.00 | 14.00 | Special Order. Please Inquire | 57 Y | Female | Non-Hispanic | <-70C | 02-Nov-15 | Genotype | 1a | Special Order. Please Inquire | Unknown | |||||||||||||||||||||||||
| BBS0005-CF900052448032615DD | Longitudinal Hepatitis C (HCV) Drug Treatment Sample Set | United States | 0.5 mL Serum | 1.00 | 9.00 | Special Order. Please Inquire | 56 Y | Female | Non-Hispanic | <-70C | 26-Mar-15 | Genotype | 3a | Special Order. Please Inquire | Unknown | |||||||||||||||||||||||||
| BBS0005-CF900052449020216DD | Longitudinal Hepatitis C (HCV) Drug Treatment Sample Set | United States | 0.5 mL Serum | 1.00 | 9.00 | Special Order. Please Inquire | 58 Y | Male | Non-Hispanic | <-70C | 02-Feb-16 | Genotype | 2 | Special Order. Please Inquire | Unknown | |||||||||||||||||||||||||
| BBS0005-CF900052449031715DD | Longitudinal Hepatitis C (HCV) Drug Treatment Sample Set | United States | 0.5 mL Serum | 1.00 | 4.00 | Special Order. Please Inquire | 58 Y | Male | Non-Hispanic | <-70C | 17-Mar-15 | Genotype | 2 | Special Order. Please Inquire | Unknown | |||||||||||||||||||||||||
| BBS0005-CF900052449051215DD | Longitudinal Hepatitis C (HCV) Drug Treatment Sample Set | United States | 0.5 mL Serum | 1.00 | 15.00 | Special Order. Please Inquire | 58 Y | Male | Non-Hispanic | <-70C | 12-May-15 | Genotype | 2 | Special Order. Please Inquire | Unknown | |||||||||||||||||||||||||
| BBS0005-CF900052449100615DD | Longitudinal Hepatitis C (HCV) Drug Treatment Sample Set | United States | 0.5 mL Serum | 1.00 | 15.00 | Special Order. Please Inquire | 58 Y | Male | Non-Hispanic | <-70C | 06-Oct-15 | Genotype | 2 | Special Order. Please Inquire | Unknown | |||||||||||||||||||||||||
| BBS0005-CF900052450012616DD | Longitudinal Hepatitis C (HCV) Drug Treatment Sample Set | United States | 0.5 mL Serum | 1.00 | 4.00 | Special Order. Please Inquire | 64 Y | Male | Non-Hispanic | <-70C | 26-Jan-16 | Genotype | 1a | Special Order. Please Inquire | Unknown | |||||||||||||||||||||||||
| BBS0005-CF900052450060915DD | Longitudinal Hepatitis C (HCV) Drug Treatment Sample Set | United States | 0.5 mL Serum | 1.00 | 10.00 | Special Order. Please Inquire | 64 Y | Male | Non-Hispanic | <-70C | 09-Jun-15 | Genotype | 1a | Special Order. Please Inquire | Unknown | |||||||||||||||||||||||||
| BBS0005-CF900052450101415DD | Longitudinal Hepatitis C (HCV) Drug Treatment Sample Set | United States | 0.5 mL Serum | 1.00 | 6.00 | Special Order. Please Inquire | 64 Y | Male | Non-Hispanic | <-70C | 14-Oct-15 | Genotype | 1a | Special Order. Please Inquire | Unknown | |||||||||||||||||||||||||
| BBS0005-CF900053640013015DD | Longitudinal Hepatitis C (HCV) Drug Treatment Sample Set | United States | 0.5 mL Serum | 1.00 | 11.00 | Special Order. Please Inquire | 63 Y | Male | Unknown | <-70C | 30-Jan-15 | Genotype | 4 | Special Order. Please Inquire | Unknown | |||||||||||||||||||||||||
| BBS0005-CF900053640062215DD | Longitudinal Hepatitis C (HCV) Drug Treatment Sample Set | United States | 0.5 mL Serum | 1.00 | 8.00 | Special Order. Please Inquire | 64 Y | Male | Unknown | <-70C | 22-Jun-15 | Genotype | 4 | Special Order. Please Inquire | Unknown | |||||||||||||||||||||||||
| BBS0005-CF900053640092815DD | Longitudinal Hepatitis C (HCV) Drug Treatment Sample Set | United States | 0.5 mL Serum | 1.00 | 11.00 | Special Order. Please Inquire | 64 Y | Male | Unknown | <-70C | 28-Sep-15 | Genotype | 4 | Special Order. Please Inquire | Unknown | |||||||||||||||||||||||||
| BBS0005-CF900053640102914DD | Longitudinal Hepatitis C (HCV) Drug Treatment Sample Set | United States | 0.5 mL Serum | 1.00 | 7.00 | Special Order. Please Inquire | 63 Y | Male | Unknown | <-70C | 29-Oct-14 | Genotype | 4 | Special Order. Please Inquire | Unknown | |||||||||||||||||||||||||
| BBS0005-CF900057179032315DD | Longitudinal Hepatitis C (HCV) Drug Treatment Sample Set | United States | 0.5 mL Serum | 1.00 | 3.00 | Special Order. Please Inquire | 50 Y | Male | Non-Hispanic | <-70C | 23-Mar-15 | Genotype | 1 | Special Order. Please Inquire | Unknown | |||||||||||||||||||||||||
| BBS0005-CF900057179071315DD | Longitudinal Hepatitis C (HCV) Drug Treatment Sample Set | United States | 0.5 mL Serum | 1.00 | 4.00 | Special Order. Please Inquire | 50 Y | Male | Non-Hispanic | <-70C | 13-Jul-15 | Genotype | 1 | Special Order. Please Inquire | Unknown | |||||||||||||||||||||||||
| BBS0005-CF900057179090115DD | Longitudinal Hepatitis C (HCV) Drug Treatment Sample Set | United States | 0.5 mL Serum | 1.00 | 10.00 | Special Order. Please Inquire | 50 Y | Male | Non-Hispanic | <-70C | 01-Sep-15 | Genotype | 1 | Special Order. Please Inquire | Unknown | |||||||||||||||||||||||||
| BBS0005-CF900057179121515DD | Longitudinal Hepatitis C (HCV) Drug Treatment Sample Set | United States | 0.5 mL Serum | 1.00 | 10.00 | Special Order. Please Inquire | 50 Y | Male | Non-Hispanic | <-70C | 15-Dec-15 | Genotype | 1 | Special Order. Please Inquire | Unknown | |||||||||||||||||||||||||
| BBS0005-CF900057180041015DD | Longitudinal Hepatitis C (HCV) Drug Treatment Sample Set | United States | 0.5 mL Serum | 1.00 | 1.00 | Special Order. Please Inquire | 60 Y | Male | Non-Hispanic | <-70C | 10-Apr-15 | Genotype | 1b | Special Order. Please Inquire | Unknown | |||||||||||||||||||||||||
| BBS0005-CF900057180060215DD | Longitudinal Hepatitis C (HCV) Drug Treatment Sample Set | United States | 0.5 mL Serum | 1.00 | 11.00 | Special Order. Please Inquire | 60 Y | Male | Non-Hispanic | <-70C | 02-Jun-15 | Genotype | 1b | Special Order. Please Inquire | Unknown | |||||||||||||||||||||||||
| BBS0005-CF900057180090115DD | Longitudinal Hepatitis C (HCV) Drug Treatment Sample Set | United States | 0.5 mL Serum | 1.00 | 13.00 | Special Order. Please Inquire | 61 Y | Male | Non-Hispanic | <-70C | 01-Sep-15 | Genotype | 1b | Special Order. Please Inquire | Unknown | |||||||||||||||||||||||||
| BBS0005-CF900057180110315DD | Longitudinal Hepatitis C (HCV) Drug Treatment Sample Set | United States | 0.5 mL Serum | 1.00 | 11.00 | Special Order. Please Inquire | 61 Y | Male | Non-Hispanic | <-70C | 03-Nov-15 | Genotype | 1b | Special Order. Please Inquire | Unknown | |||||||||||||||||||||||||
| BBS0005-CF900057182042915DD | Longitudinal Hepatitis C (HCV) Drug Treatment Sample Set | United States | 0.5 mL Serum | 1.00 | 2.00 | Special Order. Please Inquire | 53 Y | Male | Non-Hispanic | <-70C | 29-Apr-15 | Genotype | 1a | Special Order. Please Inquire | Unknown | |||||||||||||||||||||||||
| BBS0005-CF900057182092115DD | Longitudinal Hepatitis C (HCV) Drug Treatment Sample Set | United States | 0.5 mL Serum | 1.00 | 1.00 | Special Order. Please Inquire | 53 Y | Male | Non-Hispanic | <-70C | 21-Sep-15 | Genotype | 1a | Special Order. Please Inquire | Unknown | |||||||||||||||||||||||||
| BBS0005-CF900057182123015DD | Longitudinal Hepatitis C (HCV) Drug Treatment Sample Set | United States | 0.5 mL Serum | 1.00 | 7.00 | Special Order. Please Inquire | 54 Y | Male | Non-Hispanic | <-70C | 30-Dec-15 | Genotype | 1a | Special Order. Please Inquire | Unknown | |||||||||||||||||||||||||
| BBS0005-CF900057183032515DD | Longitudinal Hepatitis C (HCV) Drug Treatment Sample Set | United States | 0.5 mL Serum | 1.00 | 11.00 | Special Order. Please Inquire | 68 Y | Female | Non-Hispanic | <-70C | 25-Mar-15 | Genotype | 1a | Special Order. Please Inquire | Unknown | |||||||||||||||||||||||||
| BBS0005-CF900057183052715DD | Longitudinal Hepatitis C (HCV) Drug Treatment Sample Set | United States | 0.5 mL Serum | 1.00 | 5.00 | Special Order. Please Inquire | 68 Y | Female | Non-Hispanic | <-70C | 27-May-15 | Genotype | 1a | Special Order. Please Inquire | Unknown | |||||||||||||||||||||||||
| BBS0005-CF900057183111915DD | Longitudinal Hepatitis C (HCV) Drug Treatment Sample Set | United States | 0.5 mL Serum | 1.00 | 11.00 | Special Order. Please Inquire | 69 Y | Female | Non-Hispanic | <-70C | 19-Nov-15 | Genotype | 1a | Special Order. Please Inquire | Unknown | |||||||||||||||||||||||||
| BBS0005-CF900057184031715DD | Longitudinal Hepatitis C (HCV) Drug Treatment Sample Set | United States | 0.5 mL Serum | 1.00 | 7.00 | Special Order. Please Inquire | 78 Y | Female | Non-Hispanic | <-70C | 17-Mar-15 | Genotype | 3a | Special Order. Please Inquire | Unknown | |||||||||||||||||||||||||
| BBS0005-CF900057184041916DD | Longitudinal Hepatitis C (HCV) Drug Treatment Sample Set | United States | 0.5 mL Serum | 1.00 | 13.00 | Special Order. Please Inquire | 79 Y | Female | Non-Hispanic | <-70C | 19-Apr-16 | Genotype | 3a | Special Order. Please Inquire | Unknown | |||||||||||||||||||||||||
| BBS0005-CF900057184060915DD | Longitudinal Hepatitis C (HCV) Drug Treatment Sample Set | United States | 0.5 mL Serum | 1.00 | 9.00 | Special Order. Please Inquire | 78 Y | Female | Non-Hispanic | <-70C | 09-Jun-15 | Genotype | 3a | Special Order. Please Inquire | Unknown | |||||||||||||||||||||||||
| BBS0005-CF900057862010515DD | Longitudinal Hepatitis C (HCV) Drug Treatment Sample Set | United States | 0.5 mL Serum | 1.00 | 12.00 | Special Order. Please Inquire | 63 Y | Male | Non-Hispanic | <-70C | 05-Jan-15 | Genotype | 1a | Special Order. Please Inquire | Unknown | |||||||||||||||||||||||||
| BBS0005-CF900057862060815DD | Longitudinal Hepatitis C (HCV) Drug Treatment Sample Set | United States | 0.5 mL Serum | 1.00 | 13.00 | Special Order. Please Inquire | 63 Y | Male | Non-Hispanic | <-70C | 08-Jun-15 | Genotype | 1a | Special Order. Please Inquire | Unknown | |||||||||||||||||||||||||
| BBS0005-CF900057862092115DD | Longitudinal Hepatitis C (HCV) Drug Treatment Sample Set | United States | 0.5 mL Serum | 1.00 | 13.00 | Special Order. Please Inquire | 64 Y | Male | Non-Hispanic | <-70C | 21-Sep-15 | Genotype | 1a | Special Order. Please Inquire | Unknown | |||||||||||||||||||||||||
| BBS0005-CF900057862111014DD | Longitudinal Hepatitis C (HCV) Drug Treatment Sample Set | United States | 0.5 mL Serum | 1.00 | 13.00 | Special Order. Please Inquire | 63 Y | Male | Non-Hispanic | <-70C | 10-Nov-14 | Genotype | 1a | Special Order. Please Inquire | Unknown | |||||||||||||||||||||||||
| BBS0005-CF900057863012215DD | Longitudinal Hepatitis C (HCV) Drug Treatment Sample Set | United States | 0.5 mL Serum | 1.00 | 9.00 | Special Order. Please Inquire | 64 Y | Female | Non-Hispanic | <-70C | 22-Jan-15 | Genotype | 1a | Special Order. Please Inquire | Unknown | |||||||||||||||||||||||||
| BBS0005-CF900057863110614DD | Longitudinal Hepatitis C (HCV) Drug Treatment Sample Set | United States | 0.5 mL Serum | 1.00 | 10.00 | Special Order. Please Inquire | 63 Y | Female | Non-Hispanic | <-70C | 06-Nov-14 | Genotype | 1a | Special Order. Please Inquire | Unknown | |||||||||||||||||||||||||
| BBS0005-CF900057864010516DD | Longitudinal Hepatitis C (HCV) Drug Treatment Sample Set | United States | 0.5 mL Serum | 1.00 | 8.00 | Special Order. Please Inquire | 59 Y | Male | Unknown | <-70C | 05-Jan-16 | Genotype | 1a | Special Order. Please Inquire | Unknown | |||||||||||||||||||||||||
| BBS0005-CF900057864011415DD | Longitudinal Hepatitis C (HCV) Drug Treatment Sample Set | United States | 0.5 mL Serum | 1.00 | 11.00 | Special Order. Please Inquire | 58 Y | Male | Unknown | <-70C | 14-Jan-15 | Genotype | 1a | Special Order. Please Inquire | Unknown | |||||||||||||||||||||||||
| BBS0005-CF900057864063015DD | Longitudinal Hepatitis C (HCV) Drug Treatment Sample Set | United States | 0.5 mL Serum | 1.00 | 6.00 | Special Order. Please Inquire | 58 Y | Male | Unknown | <-70C | 30-Jun-15 | Genotype | 1a | Special Order. Please Inquire | Unknown | |||||||||||||||||||||||||
| BBS0005-CF900057864120314DD | Longitudinal Hepatitis C (HCV) Drug Treatment Sample Set | United States | 0.5 mL Serum | 1.00 | 9.00 | Special Order. Please Inquire | 58 Y | Male | Unknown | <-70C | 03-Dec-14 | Genotype | 1a | Special Order. Please Inquire | Unknown | |||||||||||||||||||||||||
| BBS0005-CF900062185011216DD | Longitudinal Hepatitis C (HCV) Drug Treatment Sample Set | United States | 0.5 mL Serum | 1.00 | 7.00 | Special Order. Please Inquire | 63 Y | Male | Non-Hispanic | <-70C | 12-Jan-16 | Genotype | 2b | Special Order. Please Inquire | Unknown | |||||||||||||||||||||||||
| BBS0005-CF900062185041415DD | Longitudinal Hepatitis C (HCV) Drug Treatment Sample Set | United States | 0.5 mL Serum | 1.00 | 3.00 | Special Order. Please Inquire | 62 Y | Male | Non-Hispanic | <-70C | 14-Apr-15 | Genotype | 2b | Special Order. Please Inquire | Unknown | |||||||||||||||||||||||||
| BBS0005-CF900062185091115DD | Longitudinal Hepatitis C (HCV) Drug Treatment Sample Set | United States | 0.5 mL Serum | 1.00 | 6.00 | Special Order. Please Inquire | 63 Y | Male | Non-Hispanic | <-70C | 11-Sep-15 | Genotype | 2b | Special Order. Please Inquire | Unknown | |||||||||||||||||||||||||
| BBS0005-CF900062186012616DD | Longitudinal Hepatitis C (HCV) Drug Treatment Sample Set | United States | 0.5 mL Serum | 1.00 | 15.00 | Special Order. Please Inquire | 66 Y | Male | Hispanic | <-70C | 26-Jan-16 | Genotype | 1b | Special Order. Please Inquire | Unknown | |||||||||||||||||||||||||
| BBS0005-CF900062186042015DD | Longitudinal Hepatitis C (HCV) Drug Treatment Sample Set | United States | 0.5 mL Serum | 1.00 | 11.00 | Special Order. Please Inquire | 65 Y | Male | Hispanic | <-70C | 20-Apr-15 | Genotype | 1b | Special Order. Please Inquire | Unknown | |||||||||||||||||||||||||
| BBS0005-CF900062186061515DD | Longitudinal Hepatitis C (HCV) Drug Treatment Sample Set | United States | 0.5 mL Serum | 1.00 | 9.00 | Special Order. Please Inquire | 66 Y | Male | Hispanic | <-70C | 15-Jun-15 | Genotype | 1b | Special Order. Please Inquire | Unknown | |||||||||||||||||||||||||
| BBS0005-CF900062186091115DD | Longitudinal Hepatitis C (HCV) Drug Treatment Sample Set | United States | 0.5 mL Serum | 1.00 | 12.00 | Special Order. Please Inquire | 66 Y | Male | Hispanic | <-70C | 11-Sep-15 | Genotype | 1b | Special Order. Please Inquire | Unknown | |||||||||||||||||||||||||
| BBS0005-CF900062187011316DD | Longitudinal Hepatitis C (HCV) Drug Treatment Sample Set | United States | 0.5 mL Serum | 1.00 | 5.00 | Special Order. Please Inquire | 39 Y | Male | Non-Hispanic | <-70C | 13-Jan-16 | Genotype | 1a | Special Order. Please Inquire | Unknown | |||||||||||||||||||||||||
| BBS0005-CF900062187072315DD | Longitudinal Hepatitis C (HCV) Drug Treatment Sample Set | United States | 0.5 mL Serum | 1.00 | 2.00 | Special Order. Please Inquire | 39 Y | Male | Non-Hispanic | <-70C | 23-Jul-15 | Genotype | 1a | Special Order. Please Inquire | Unknown | |||||||||||||||||||||||||
| BBS0005-CF900062187100215DD | Longitudinal Hepatitis C (HCV) Drug Treatment Sample Set | United States | 0.5 mL Serum | 1.00 | 5.00 | Special Order. Please Inquire | 39 Y | Male | Non-Hispanic | <-70C | 02-Oct-15 | Genotype | 1a | Special Order. Please Inquire | Unknown | |||||||||||||||||||||||||
| BBS0005-CF900062188082515DD | Longitudinal Hepatitis C (HCV) Drug Treatment Sample Set | United States | 0.5 mL Serum | 1.00 | 5.00 | Special Order. Please Inquire | 57 Y | Male | Non-Hispanic | <-70C | 25-Aug-15 | Genotype | 2b | Special Order. Please Inquire | Unknown | |||||||||||||||||||||||||
| BBS0005-CF900064383011615DD | Longitudinal Hepatitis C (HCV) Drug Treatment Sample Set | United States | 0.5 mL Serum | 1.00 | 15.00 | Special Order. Please Inquire | 69 Y | Female | Hispanic | <-70C | 16-Jan-15 | Genotype | 1b | Special Order. Please Inquire | Unknown | |||||||||||||||||||||||||
| BBS0005-CF900064383061815DD | Longitudinal Hepatitis C (HCV) Drug Treatment Sample Set | United States | 0.5 mL Serum | 1.00 | 15.00 | Special Order. Please Inquire | 69 Y | Female | Hispanic | <-70C | 18-Jun-15 | Genotype | 1b | Special Order. Please Inquire | Unknown | |||||||||||||||||||||||||
| BBS0005-CF900064383092415DD | Longitudinal Hepatitis C (HCV) Drug Treatment Sample Set | United States | 0.5 mL Serum | 1.00 | 11.00 | Special Order. Please Inquire | 69 Y | Female | Hispanic | <-70C | 24-Sep-15 | Genotype | 1b | Special Order. Please Inquire | Unknown | |||||||||||||||||||||||||
| BBS0005-CF900064383120514DD | Longitudinal Hepatitis C (HCV) Drug Treatment Sample Set | United States | 0.5 mL Serum | 1.00 | 10.00 | Special Order. Please Inquire | 68 Y | Female | Hispanic | <-70C | 05-Dec-14 | Genotype | 1b | Special Order. Please Inquire | Unknown | |||||||||||||||||||||||||
| BBS0005-CF900064384021116DD | Longitudinal Hepatitis C (HCV) Drug Treatment Sample Set | United States | 0.5 mL Serum | 1.00 | 10.00 | Special Order. Please Inquire | 60 Y | Male | Hispanic | <-70C | 11-Feb-16 | Genotype | 1a | Special Order. Please Inquire | Unknown | |||||||||||||||||||||||||
| BBS0005-CF900064384030315DD | Longitudinal Hepatitis C (HCV) Drug Treatment Sample Set | United States | 0.5 mL Serum | 1.00 | 2.00 | Special Order. Please Inquire | 60 Y | Male | Hispanic | <-70C | 03-Mar-15 | Genotype | 1a | Special Order. Please Inquire | Unknown | |||||||||||||||||||||||||
| BBS0005-CF900064384062215DD | Longitudinal Hepatitis C (HCV) Drug Treatment Sample Set | United States | 0.5 mL Serum | 1.00 | 12.00 | Special Order. Please Inquire | 60 Y | Male | Hispanic | <-70C | 22-Jun-15 | Genotype | 1a | Special Order. Please Inquire | Unknown | |||||||||||||||||||||||||
| BBS0005-CF900064384100515DD | Longitudinal Hepatitis C (HCV) Drug Treatment Sample Set | United States | 0.5 mL Serum | 1.00 | 11.00 | Special Order. Please Inquire | 60 Y | Male | Hispanic | <-70C | 05-Oct-15 | Genotype | 1a | Special Order. Please Inquire | Unknown | |||||||||||||||||||||||||
| BBS0005-CF900064385101614DD | Longitudinal Hepatitis C (HCV) Drug Treatment Sample Set | United States | 0.5 mL Serum | 1.00 | 5.00 | Special Order. Please Inquire | 58 Y | Male | Non-Hispanic | <-70C | 16-Oct-14 | Genotype | 1a | Special Order. Please Inquire | Unknown | |||||||||||||||||||||||||
| BBS0005-CF900064386021115DD | Longitudinal Hepatitis C (HCV) Drug Treatment Sample Set | United States | 0.5 mL Serum | 1.00 | 12.00 | Special Order. Please Inquire | 58 Y | Male | Hispanic | <-70C | 11-Feb-15 | Genotype | 1a | Special Order. Please Inquire | Unknown | |||||||||||||||||||||||||
| BBS0005-CF900064386072315DD | Longitudinal Hepatitis C (HCV) Drug Treatment Sample Set | United States | 0.5 mL Serum | 1.00 | 12.00 | Special Order. Please Inquire | 58 Y | Male | Hispanic | <-70C | 23-Jul-15 | Genotype | 1a | Special Order. Please Inquire | Unknown | |||||||||||||||||||||||||
| BBS0005-CF900064386100515DD | Longitudinal Hepatitis C (HCV) Drug Treatment Sample Set | United States | 0.5 mL Serum | 1.00 | 12.00 | Special Order. Please Inquire | 59 Y | Male | Hispanic | <-70C | 05-Oct-15 | Genotype | 1a | Special Order. Please Inquire | Unknown | |||||||||||||||||||||||||
| BBS0005-CF900064386111014DD | Longitudinal Hepatitis C (HCV) Drug Treatment Sample Set | United States | 0.5 mL Serum | 1.00 | 11.00 | Special Order. Please Inquire | 58 Y | Male | Hispanic | <-70C | 10-Nov-14 | Genotype | 1a | Special Order. Please Inquire | Unknown | |||||||||||||||||||||||||
| BBS0005-CF900064387040915DD | Longitudinal Hepatitis C (HCV) Drug Treatment Sample Set | United States | 0.5 mL Serum | 1.00 | 4.00 | Special Order. Please Inquire | 59 Y | Female | Non-Hispanic | <-70C | 09-Apr-15 | Genotype | 4 | Special Order. Please Inquire | Unknown | |||||||||||||||||||||||||
| BBS0005-CF900064387060515DD | Longitudinal Hepatitis C (HCV) Drug Treatment Sample Set | United States | 0.5 mL Serum | 1.00 | 7.00 | Special Order. Please Inquire | 60 Y | Female | Non-Hispanic | <-70C | 05-Jun-15 | Genotype | 4 | Special Order. Please Inquire | Unknown | |||||||||||||||||||||||||
| BBS0005-CF900068136030816DD | Longitudinal Hepatitis C (HCV) Drug Treatment Sample Set | United States | 0.5 mL Serum | 1.00 | 11.00 | Special Order. Please Inquire | 58 Y | Male | Non-Hispanic | <-70C | 08-Mar-16 | Genotype | 1a | Special Order. Please Inquire | Unknown | |||||||||||||||||||||||||
| BBS0005-CF900068136041615DD | Longitudinal Hepatitis C (HCV) Drug Treatment Sample Set | United States | 0.5 mL Serum | 1.00 | 1.00 | Special Order. Please Inquire | 57 Y | Male | Non-Hispanic | <-70C | 16-Apr-15 | Genotype | 1a | Special Order. Please Inquire | Unknown | |||||||||||||||||||||||||
| BBS0005-CF900068136070915DD | Longitudinal Hepatitis C (HCV) Drug Treatment Sample Set | United States | 0.5 mL Serum | 1.00 | 5.00 | Special Order. Please Inquire | 58 Y | Male | Non-Hispanic | <-70C | 09-Jul-15 | Genotype | 1a | Special Order. Please Inquire | Unknown | |||||||||||||||||||||||||
| BBS0005-CF900068136111215DD | Longitudinal Hepatitis C (HCV) Drug Treatment Sample Set | United States | 0.5 mL Serum | 1.00 | 9.00 | Special Order. Please Inquire | 58 Y | Male | Non-Hispanic | <-70C | 12-Nov-15 | Genotype | 1a | Special Order. Please Inquire | Unknown | |||||||||||||||||||||||||
| BBS0005-CM900021605081018DD | Longitudinal Hepatitis C (HCV) Drug Treatment Sample Set | United States | 0.5 mL Serum | 1.00 | 5.00 | Special Order. Please Inquire | 60 Y | Male | Non-Hispanic | <-70C | 10-Aug-18 | Abbott Rt-PCR | <12 IU/mL | 10-Aug-18 | Genotype | 2b | Special Order. Please Inquire | Unknown | Date of HCV Diagnosis 8-Dec-17 | Medication Name Epclusa | ||||||||||||||||||||
| BBS0005-CM900021605111618DD | Longitudinal Hepatitis C (HCV) Drug Treatment Sample Set | United States | 0.5 mL Serum | 1.00 | 5.00 | Special Order. Please Inquire | 60 Y | Male | Non-Hispanic | <-70C | 16-Nov-18 | Abbott Rt-PCR | Negative | 16-Nov-18 | Genotype | 2b | Special Order. Please Inquire | Unknown | Medication Name Epclusa | |||||||||||||||||||||
| BBS0005-CM900021606041117DD | Longitudinal Hepatitis C (HCV) Drug Treatment Sample Set | United States | 0.5 mL Serum | 1.00 | 2.00 | Special Order. Please Inquire | 59 Y | Female | Non-Hispanic | <-70C | 11-Apr-17 | Genotype | 1b | Special Order. Please Inquire | Unknown | |||||||||||||||||||||||||
| BBS0005-CM900021607022117DD | Longitudinal Hepatitis C (HCV) Drug Treatment Sample Set | United States | 0.5 mL Serum | 1.00 | 12.00 | Special Order. Please Inquire | 64 Y | Male | Non-Hispanic | <-70C | 21-Feb-17 | Genotype | 1b | Special Order. Please Inquire | Unknown | |||||||||||||||||||||||||
| BBS0005-CM900021607110119DD | Longitudinal Hepatitis C (HCV) Drug Treatment Sample Set | United States | 0.5 mL Serum | 1.00 | 8.00 | Special Order. Please Inquire | Male | Non-Hispanic | <-70C | 01-Nov-19 | Abbott RealTime PCR Assay | IU/mL | Genotype | 1b | Special Order. Please Inquire | Unknown | Harvoni | 2005 | Intravenous drug user | No | No | |||||||||||||||||||
| BBS0005-CM900021608041117DD | Longitudinal Hepatitis C (HCV) Drug Treatment Sample Set | United States | 0.5 mL Serum | 1.00 | 6.00 | Special Order. Please Inquire | 59 Y | Male | Non-Hispanic | <-70C | 11-Apr-17 | Genotype | 1a | Special Order. Please Inquire | Unknown | |||||||||||||||||||||||||
| BBS0005-CM900021608110119DD | Longitudinal Hepatitis C (HCV) Drug Treatment Sample Set | United States | 0.5 mL Serum | 1.00 | 10.00 | Special Order. Please Inquire | Male | Non-Hispanic | <-70C | 01-Nov-19 | Abbott RealTime PCR Assay | IU/mL | Genotype | 1a | Special Order. Please Inquire | Unknown | Harvoni | 2-Mar-17 | Unknown | No | No | |||||||||||||||||||
| BBS0005-CM900021609041717DD | Longitudinal Hepatitis C (HCV) Drug Treatment Sample Set | United States | 0.5 mL Serum | 1.00 | 8.00 | Special Order. Please Inquire | 61 Y | Female | Non-Hispanic | <-70C | 17-Apr-17 | Genotype | 2b | Special Order. Please Inquire | Unknown | |||||||||||||||||||||||||
| BBS0005-CM900021609110119DD | Longitudinal Hepatitis C (HCV) Drug Treatment Sample Set | United States | 0.5 mL Serum | 1.00 | 8.00 | Special Order. Please Inquire | Female | Non-Hispanic | <-70C | 01-Nov-19 | Genotype | 2b | Special Order. Please Inquire | Unknown | ||||||||||||||||||||||||||
| BBS0005-CM900021610022817DD | Longitudinal Hepatitis C (HCV) Drug Treatment Sample Set | United States | 0.5 mL Serum | 1.00 | 12.00 | Special Order. Please Inquire | 55 Y | Male | Non-Hispanic | <-70C | 28-Feb-17 | Genotype | 1a | Special Order. Please Inquire | Unknown | |||||||||||||||||||||||||
| BBS0005-CM900021611030717DD | Longitudinal Hepatitis C (HCV) Drug Treatment Sample Set | United States | 0.5 mL Serum | 1.00 | 10.00 | Special Order. Please Inquire | 59 Y | Male | Non-Hispanic | <-70C | 07-Mar-17 | Genotype | 3 | Special Order. Please Inquire | Unknown | |||||||||||||||||||||||||
| BBS0005-CM900021611110119DD | Longitudinal Hepatitis C (HCV) Drug Treatment Sample Set | United States | 0.5 mL Serum | 1.00 | 12.00 | Special Order. Please Inquire | Male | Non-Hispanic | <-70C | 01-Nov-19 | Genotype | 3 | Special Order. Please Inquire | Unknown | ||||||||||||||||||||||||||
| BBS0005-CM900053716110119DD | Longitudinal Hepatitis C (HCV) Drug Treatment Sample Set | United States | 0.5 mL Serum | 1.00 | 7.00 | Special Order. Please Inquire | Female | Non-Hispanic | <-70C | 01-Nov-19 | Genotype | 3 | Special Order. Please Inquire | Unknown | ||||||||||||||||||||||||||
| BBS0005-CM900080482110119DD | Longitudinal Hepatitis C (HCV) Drug Treatment Sample Set | United States | 0.5 mL Serum | 1.00 | 8.00 | Special Order. Please Inquire | 30 Y | Male | Unknown | <-70C | 01-Nov-19 | Abbott RealTime PCR Assay | <1.08 IU/mL | 19-Jan-18 | Genotype | 2b | Special Order. Please Inquire | Unknown | Epclusa | 67.01 | 134 | 9-Sep-16 | Intravenous drug user | No | Yes | 10.5 kPa ; Liver stiffness 3-Apr-17 | ALT: 70 U/L | AST: 15 U/L | ALP: 64 U/L | Bilirubin (Total): 0.3 mg/dL | Bilirubin (Direct): 0.1 mg/dL 19-Jan-18 | ||||||||||||||
| BBS0005-CM900082413110119DD | Longitudinal Hepatitis C (HCV) Drug Treatment Sample Set | United States | 0.5 mL Serum | 1.00 | 7.00 | Special Order. Please Inquire | Male | Non-Hispanic | <-70C | 01-Nov-19 | Abbott RealTime PCR Assay | IU/mL | Genotype | 3a | Special Order. Please Inquire | Unknown | Epclusa | 74.50 | 300 | 21-Sep-16 | Unknown | Yes | Cirrhosis 17-Oct-16 | No | |||||||||||||||||
| BBS0005-CV900046289092815DD | Longitudinal Hepatitis C (HCV) Drug Treatment Sample Set | Vietnam | 0.5 mL Serum | 1.00 | 12.00 | Special Order. Please Inquire | 39 Y | Male | Non-Hispanic | <-70C | 28-Sep-15 | Genotype | 6 | Special Order. Please Inquire | Unknown | |||||||||||||||||||||||||
| BBS0005-CV900046291061015DD | Longitudinal Hepatitis C (HCV) Drug Treatment Sample Set | Vietnam | 0.5 mL Serum | 1.00 | 9.00 | Special Order. Please Inquire | 36 Y | Male | Non-Hispanic | <-70C | 10-Jun-15 | Genotype | 1 | Special Order. Please Inquire | Unknown | |||||||||||||||||||||||||
| BBS0005-CV900046292070215DD | Longitudinal Hepatitis C (HCV) Drug Treatment Sample Set | Vietnam | 0.5 mL Serum | 1.00 | 9.00 | Special Order. Please Inquire | 36 Y | Male | Non-Hispanic | <-70C | 02-Jul-15 | Genotype | 1 | Special Order. Please Inquire | Unknown | |||||||||||||||||||||||||
| BBS0005-CV900046292072815DD | Longitudinal Hepatitis C (HCV) Drug Treatment Sample Set | Vietnam | 0.5 mL Serum | 1.00 | 10.00 | Special Order. Please Inquire | 36 Y | Male | Non-Hispanic | <-70C | 28-Jul-15 | Genotype | 1 | Special Order. Please Inquire | Unknown | |||||||||||||||||||||||||
| BBS0005-CV900053323070915DD | Longitudinal Hepatitis C (HCV) Drug Treatment Sample Set | Vietnam | 0.5 mL Serum | 1.00 | 8.00 | Special Order. Please Inquire | 42 Y | Male | Non-Hispanic | <-70C | 09-Jul-15 | Genotype | 6 | Special Order. Please Inquire | Unknown | |||||||||||||||||||||||||
| BBS0005-CV900053324112515DD | Longitudinal Hepatitis C (HCV) Drug Treatment Sample Set | Vietnam | 0.5 mL Serum | 1.00 | 9.00 | Special Order. Please Inquire | 49 Y | Male | Non-Hispanic | <-70C | 25-Nov-15 | Genotype | 6 | Special Order. Please Inquire | Unknown | |||||||||||||||||||||||||
| BBS0005-CV900053324121715DD | Longitudinal Hepatitis C (HCV) Drug Treatment Sample Set | Vietnam | 0.5 mL Serum | 1.00 | 10.00 | Special Order. Please Inquire | 49 Y | Male | Non-Hispanic | <-70C | 17-Dec-15 | Genotype | 6 | Special Order. Please Inquire | Unknown | |||||||||||||||||||||||||
| BBS0005-CV900053325051815DD | Longitudinal Hepatitis C (HCV) Drug Treatment Sample Set | Vietnam | 0.5 mL Serum | 1.00 | 13.00 | Special Order. Please Inquire | 52 Y | Male | Non-Hispanic | <-70C | 18-May-15 | Genotype | 6 | Special Order. Please Inquire | Unknown | |||||||||||||||||||||||||
| BBS0005-CV900053325061815DD | Longitudinal Hepatitis C (HCV) Drug Treatment Sample Set | Vietnam | 0.5 mL Serum | 1.00 | 9.00 | Special Order. Please Inquire | 52 Y | Male | Non-Hispanic | <-70C | 18-Jun-15 | Genotype | 6 | Special Order. Please Inquire | Unknown | |||||||||||||||||||||||||
| BBS0005-CV900053326072515DD | Longitudinal Hepatitis C (HCV) Drug Treatment Sample Set | Vietnam | 0.5 mL Serum | 1.00 | 8.00 | Special Order. Please Inquire | 55 Y | Male | Non-Hispanic | <-70C | 25-Jul-15 | Genotype | 6 | Special Order. Please Inquire | Unknown | |||||||||||||||||||||||||
| BBS0005-CV900053326091815DD | Longitudinal Hepatitis C (HCV) Drug Treatment Sample Set | Vietnam | 0.5 mL Serum | 1.00 | 11.00 | Special Order. Please Inquire | 55 Y | Male | Non-Hispanic | <-70C | 18-Sep-15 | Genotype | 6 | Special Order. Please Inquire | Unknown | |||||||||||||||||||||||||
| BBS0005-CV900053327070915DD | Longitudinal Hepatitis C (HCV) Drug Treatment Sample Set | Vietnam | 0.5 mL Serum | 1.00 | 4.00 | Special Order. Please Inquire | 42 Y | Female | Non-Hispanic | <-70C | 09-Jul-15 | Genotype | U/A | Special Order. Please Inquire | Unknown | |||||||||||||||||||||||||
| BBS0005-CV900053328062715DD | Longitudinal Hepatitis C (HCV) Drug Treatment Sample Set | Vietnam | 0.5 mL Serum | 1.00 | 9.00 | Special Order. Please Inquire | 35 Y | Female | Non-Hispanic | <-70C | 27-Jun-15 | Genotype | U/A | Special Order. Please Inquire | Unknown | |||||||||||||||||||||||||
| BBS0005-CV900053329061015DD | Longitudinal Hepatitis C (HCV) Drug Treatment Sample Set | Vietnam | 0.5 mL Serum | 1.00 | 9.00 | Special Order. Please Inquire | 52 Y | Male | Non-Hispanic | <-70C | 10-Jun-15 | Genotype | U/A | Special Order. Please Inquire | Unknown | |||||||||||||||||||||||||
| BBS0005-DA900032216051415DD | Longitudinal Hepatitis C (HCV) Drug Treatment Sample Set | United States | 0.5 mL Serum | 1.00 | 1.00 | Special Order. Please Inquire | 63 Y | Male | Non-Hispanic | <-70C | 14-May-15 | Genotype | 1b | Special Order. Please Inquire | Unknown | |||||||||||||||||||||||||
| BBS0005-DA900032216061115DD | Longitudinal Hepatitis C (HCV) Drug Treatment Sample Set | United States | 0.5 mL Serum | 1.00 | 8.00 | Special Order. Please Inquire | 64 Y | Male | Non-Hispanic | <-70C | 11-Jun-15 | Genotype | 1b | Special Order. Please Inquire | Unknown | |||||||||||||||||||||||||
| BBS0005-DA900032216080615DD | Longitudinal Hepatitis C (HCV) Drug Treatment Sample Set | United States | 0.5 mL Serum | 1.00 | 9.00 | Special Order. Please Inquire | 64 Y | Male | Non-Hispanic | <-70C | 06-Aug-15 | Genotype | 1b | Special Order. Please Inquire | Unknown | |||||||||||||||||||||||||
| BBS0005-DA900032216102915DD | Longitudinal Hepatitis C (HCV) Drug Treatment Sample Set | United States | 0.5 mL Serum | 1.00 | 6.00 | Special Order. Please Inquire | 64 Y | Male | Non-Hispanic | <-70C | 29-Oct-15 | Genotype | 1b | Special Order. Please Inquire | Unknown | |||||||||||||||||||||||||
| BBS0005-DA900032217020515DD | Longitudinal Hepatitis C (HCV) Drug Treatment Sample Set | United States | 0.5 mL Serum | 1.00 | 10.00 | Special Order. Please Inquire | 58 Y | Female | Non-Hispanic | <-70C | 05-Feb-15 | Genotype | 1 | Special Order. Please Inquire | Unknown | |||||||||||||||||||||||||
| BBS0005-DA900032217043015DD | Longitudinal Hepatitis C (HCV) Drug Treatment Sample Set | United States | 0.5 mL Serum | 1.00 | 11.00 | Special Order. Please Inquire | 58 Y | Female | Non-Hispanic | <-70C | 30-Apr-15 | Genotype | 1 | Special Order. Please Inquire | Unknown | |||||||||||||||||||||||||
| BBS0005-DA900032217081414DD | Longitudinal Hepatitis C (HCV) Drug Treatment Sample Set | United States | 0.5 mL Serum | 1.00 | 7.00 | Special Order. Please Inquire | 58 Y | Female | Non-Hispanic | <-70C | 14-Aug-14 | Genotype | 1 | Special Order. Please Inquire | Unknown | |||||||||||||||||||||||||
| BBS0005-DA900032217101614DD | Longitudinal Hepatitis C (HCV) Drug Treatment Sample Set | United States | 0.5 mL Serum | 1.00 | 10.00 | Special Order. Please Inquire | 58 Y | Female | Non-Hispanic | <-70C | 16-Oct-14 | Genotype | 1 | Special Order. Please Inquire | Unknown | |||||||||||||||||||||||||
| BBS0005-DA900032217121114DD | Longitudinal Hepatitis C (HCV) Drug Treatment Sample Set | United States | 0.5 mL Serum | 1.00 | 11.00 | Special Order. Please Inquire | 58 Y | Female | Non-Hispanic | <-70C | 11-Dec-14 | Genotype | 1 | Special Order. Please Inquire | Unknown | |||||||||||||||||||||||||
| BBS0005-DA900032218012915DD | Longitudinal Hepatitis C (HCV) Drug Treatment Sample Set | United States | 0.5 mL Serum | 1.00 | 2.00 | Special Order. Please Inquire | 67 Y | Male | Non-Hispanic | <-70C | 29-Jan-15 | Genotype | 1a | Special Order. Please Inquire | Unknown | |||||||||||||||||||||||||
| BBS0005-DA900032218022615DD | Longitudinal Hepatitis C (HCV) Drug Treatment Sample Set | United States | 0.5 mL Serum | 1.00 | 4.00 | Special Order. Please Inquire | 67 Y | Male | Non-Hispanic | <-70C | 26-Feb-15 | Genotype | 1a | Special Order. Please Inquire | Unknown | |||||||||||||||||||||||||
| BBS0005-DA900032218042415DD | Longitudinal Hepatitis C (HCV) Drug Treatment Sample Set | United States | 0.5 mL Serum | 1.00 | 5.00 | Special Order. Please Inquire | 67 Y | Male | Non-Hispanic | <-70C | 24-Apr-15 | Genotype | 1a | Special Order. Please Inquire | Unknown | |||||||||||||||||||||||||
| BBS0005-DA900032218071715DD | Longitudinal Hepatitis C (HCV) Drug Treatment Sample Set | United States | 0.5 mL Serum | 1.00 | 6.00 | Special Order. Please Inquire | 67 Y | Male | Non-Hispanic | <-70C | 17-Jul-15 | Genotype | 1a | Special Order. Please Inquire | Unknown | |||||||||||||||||||||||||
| BBS0005-DA900032219021015DD | Longitudinal Hepatitis C (HCV) Drug Treatment Sample Set | United States | 0.5 mL Serum | 1.00 | 5.00 | Special Order. Please Inquire | 51 Y | Male | Non-Hispanic | <-70C | 10-Feb-15 | Genotype | 1b | Special Order. Please Inquire | Unknown | |||||||||||||||||||||||||
| BBS0005-DA900032219031015DD | Longitudinal Hepatitis C (HCV) Drug Treatment Sample Set | United States | 0.5 mL Serum | 1.00 | 6.00 | Special Order. Please Inquire | 51 Y | Male | Non-Hispanic | <-70C | 10-Mar-15 | Genotype | 1b | Special Order. Please Inquire | Unknown | |||||||||||||||||||||||||
| BBS0005-DA900032219051115DD | Longitudinal Hepatitis C (HCV) Drug Treatment Sample Set | United States | 0.5 mL Serum | 1.00 | 12.00 | Special Order. Please Inquire | 51 Y | Male | Non-Hispanic | <-70C | 11-May-15 | Genotype | 1b | Special Order. Please Inquire | Unknown | |||||||||||||||||||||||||
| BBS0005-DA900032219080315DD | Longitudinal Hepatitis C (HCV) Drug Treatment Sample Set | United States | 0.5 mL Serum | 1.00 | 9.00 | Special Order. Please Inquire | 52 Y | Male | Non-Hispanic | <-70C | 03-Aug-15 | Genotype | 1b | Special Order. Please Inquire | Unknown | |||||||||||||||||||||||||
| BBS0005-DA900032220021215DD | Longitudinal Hepatitis C (HCV) Drug Treatment Sample Set | United States | 0.5 mL Serum | 1.00 | 2.00 | Special Order. Please Inquire | 62 Y | Male | Non-Hispanic | <-70C | 12-Feb-15 | Genotype | 1b | Special Order. Please Inquire | Unknown | |||||||||||||||||||||||||
| BBS0005-DA900032220031315DD | Longitudinal Hepatitis C (HCV) Drug Treatment Sample Set | United States | 0.5 mL Serum | 1.00 | 2.00 | Special Order. Please Inquire | 62 Y | Male | Non-Hispanic | <-70C | 13-Mar-15 | Genotype | 1b | Special Order. Please Inquire | Unknown | |||||||||||||||||||||||||
| BBS0005-DA900032220050715DD | Longitudinal Hepatitis C (HCV) Drug Treatment Sample Set | United States | 0.5 mL Serum | 1.00 | 6.00 | Special Order. Please Inquire | 62 Y | Male | Non-Hispanic | <-70C | 07-May-15 | Genotype | 1b | Special Order. Please Inquire | Unknown | |||||||||||||||||||||||||
| BBS0005-DA900032220073115DD | Longitudinal Hepatitis C (HCV) Drug Treatment Sample Set | United States | 0.5 mL Serum | 1.00 | 2.00 | Special Order. Please Inquire | 62 Y | Male | Non-Hispanic | <-70C | 31-Jul-15 | Genotype | 1b | Special Order. Please Inquire | Unknown | |||||||||||||||||||||||||
| BBS0005-DA900036748021015DD | Longitudinal Hepatitis C (HCV) Drug Treatment Sample Set | United States | 0.5 mL Serum | 1.00 | 5.00 | Special Order. Please Inquire | 61 Y | Male | Non-Hispanic | <-70C | 10-Feb-15 | Genotype | 1a | Special Order. Please Inquire | Unknown | |||||||||||||||||||||||||
| BBS0005-DA900036748031015DD | Longitudinal Hepatitis C (HCV) Drug Treatment Sample Set | United States | 0.5 mL Serum | 1.00 | 4.00 | Special Order. Please Inquire | 61 Y | Male | Non-Hispanic | <-70C | 10-Mar-15 | Genotype | 1a | Special Order. Please Inquire | Unknown | |||||||||||||||||||||||||
| BBS0005-DA900036748050515DD | Longitudinal Hepatitis C (HCV) Drug Treatment Sample Set | United States | 0.5 mL Serum | 1.00 | 11.00 | Special Order. Please Inquire | 61 Y | Male | Non-Hispanic | <-70C | 05-May-15 | Genotype | 1a | Special Order. Please Inquire | Unknown | |||||||||||||||||||||||||
| BBS0005-DA900036748080415DD | Longitudinal Hepatitis C (HCV) Drug Treatment Sample Set | United States | 0.5 mL Serum | 1.00 | 12.00 | Special Order. Please Inquire | 62 Y | Male | Non-Hispanic | <-70C | 04-Aug-15 | Genotype | 1a | Special Order. Please Inquire | Unknown | |||||||||||||||||||||||||
| BBS0005-DA900036749011916DD | Longitudinal Hepatitis C (HCV) Drug Treatment Sample Set | United States | 0.5 mL Serum | 1.00 | 4.00 | Special Order. Please Inquire | 59 Y | Male | Non-Hispanic | <-70C | 19-Jan-16 | Genotype | 1a | Special Order. Please Inquire | Unknown | |||||||||||||||||||||||||
| BBS0005-DA900036749051215DD | Longitudinal Hepatitis C (HCV) Drug Treatment Sample Set | United States | 0.5 mL Serum | 1.00 | 4.00 | Special Order. Please Inquire | 58 Y | Male | Non-Hispanic | <-70C | 12-May-15 | Genotype | 1a | Special Order. Please Inquire | Unknown | |||||||||||||||||||||||||
| BBS0005-DA900036749060915DD | Longitudinal Hepatitis C (HCV) Drug Treatment Sample Set | United States | 0.5 mL Serum | 1.00 | 3.00 | Special Order. Please Inquire | 58 Y | Male | Non-Hispanic | <-70C | 09-Jun-15 | Genotype | 1a | Special Order. Please Inquire | Unknown | |||||||||||||||||||||||||
| BBS0005-DA900036749102715DD | Longitudinal Hepatitis C (HCV) Drug Treatment Sample Set | United States | 0.5 mL Serum | 1.00 | 4.00 | Special Order. Please Inquire | 59 Y | Male | Non-Hispanic | <-70C | 27-Oct-15 | Genotype | 1a | Special Order. Please Inquire | Unknown | |||||||||||||||||||||||||
| BBS0005-DA900036750041315DD | Longitudinal Hepatitis C (HCV) Drug Treatment Sample Set | United States | 0.5 mL Serum | 1.00 | 5.00 | Special Order. Please Inquire | 46 Y | Male | Non-Hispanic | <-70C | 13-Apr-15 | Genotype | 1a | Special Order. Please Inquire | Unknown | |||||||||||||||||||||||||
| BBS0005-DA900036750051115DD | Longitudinal Hepatitis C (HCV) Drug Treatment Sample Set | United States | 0.5 mL Serum | 1.00 | 10.00 | Special Order. Please Inquire | 46 Y | Male | Non-Hispanic | <-70C | 11-May-15 | Genotype | 1a | Special Order. Please Inquire | Unknown | |||||||||||||||||||||||||
| BBS0005-DA900036750060815DD | Longitudinal Hepatitis C (HCV) Drug Treatment Sample Set | United States | 0.5 mL Serum | 1.00 | 9.00 | Special Order. Please Inquire | 46 Y | Male | Non-Hispanic | <-70C | 08-Jun-15 | Genotype | 1a | Special Order. Please Inquire | Unknown | |||||||||||||||||||||||||
| BBS0005-DA900036750091515DD | Longitudinal Hepatitis C (HCV) Drug Treatment Sample Set | United States | 0.5 mL Serum | 1.00 | 7.00 | Special Order. Please Inquire | 47 Y | Male | Non-Hispanic | <-70C | 15-Sep-15 | Genotype | 1a | Special Order. Please Inquire | Unknown | |||||||||||||||||||||||||
| BBS0005-DA900036751011915DD | Longitudinal Hepatitis C (HCV) Drug Treatment Sample Set | United States | 0.5 mL Serum | 1.00 | 9.00 | Special Order. Please Inquire | 63 Y | Male | Non-Hispanic | <-70C | 19-Jan-15 | Genotype | 1a | Special Order. Please Inquire | Unknown | |||||||||||||||||||||||||
| BBS0005-DA900036751060915DD | Longitudinal Hepatitis C (HCV) Drug Treatment Sample Set | United States | 0.5 mL Serum | 1.00 | 4.00 | Special Order. Please Inquire | 64 Y | Male | Non-Hispanic | <-70C | 09-Jun-15 | Genotype | 1a | Special Order. Please Inquire | Unknown | |||||||||||||||||||||||||
| BBS0005-DA900036751122414DD | Longitudinal Hepatitis C (HCV) Drug Treatment Sample Set | United States | 0.5 mL Serum | 1.00 | 2.00 | Special Order. Please Inquire | 63 Y | Male | Non-Hispanic | <-70C | 24-Dec-14 | Genotype | 1a | Special Order. Please Inquire | Unknown | |||||||||||||||||||||||||
| BBS0005-DA900037342010416DD | Longitudinal Hepatitis C (HCV) Drug Treatment Sample Set | United States | 0.5 mL Serum | 1.00 | 10.00 | Special Order. Please Inquire | 67 Y | Female | Non-Hispanic | <-70C | 04-Jan-16 | Genotype | 1a | Special Order. Please Inquire | Unknown | |||||||||||||||||||||||||
| BBS0005-DA900037342031816DD | Longitudinal Hepatitis C (HCV) Drug Treatment Sample Set | United States | 0.5 mL Serum | 1.00 | 12.00 | Special Order. Please Inquire | 67 Y | Female | Non-Hispanic | <-70C | 18-Mar-16 | Genotype | 1a | Special Order. Please Inquire | Unknown | |||||||||||||||||||||||||
| BBS0005-DA900037342100215DD | Longitudinal Hepatitis C (HCV) Drug Treatment Sample Set | United States | 0.5 mL Serum | 1.00 | 3.00 | Special Order. Please Inquire | 67 Y | Female | Non-Hispanic | <-70C | 02-Oct-15 | Genotype | 1a | Special Order. Please Inquire | Unknown | |||||||||||||||||||||||||
| BBS0005-DA900037342103015DD | Longitudinal Hepatitis C (HCV) Drug Treatment Sample Set | United States | 0.5 mL Serum | 1.00 | 9.00 | Special Order. Please Inquire | 67 Y | Female | Non-Hispanic | <-70C | 30-Oct-15 | Genotype | 1a | Special Order. Please Inquire | Unknown | |||||||||||||||||||||||||
| BBS0005-DA900039265060115DD | Longitudinal Hepatitis C (HCV) Drug Treatment Sample Set | United States | 0.5 mL Serum | 1.00 | 8.00 | Special Order. Please Inquire | 62 Y | Female | Non-Hispanic | <-70C | 01-Jun-15 | Genotype | 1b | Special Order. Please Inquire | Unknown | |||||||||||||||||||||||||
| BBS0005-DA900039265070715DD | Longitudinal Hepatitis C (HCV) Drug Treatment Sample Set | United States | 0.5 mL Serum | 1.00 | 10.00 | Special Order. Please Inquire | 62 Y | Female | Non-Hispanic | <-70C | 07-Jul-15 | Genotype | 1b | Special Order. Please Inquire | Unknown | |||||||||||||||||||||||||
| BBS0005-DA900039265080415DD | Longitudinal Hepatitis C (HCV) Drug Treatment Sample Set | United States | 0.5 mL Serum | 1.00 | 8.00 | Special Order. Please Inquire | 62 Y | Female | Non-Hispanic | <-70C | 04-Aug-15 | Genotype | 1b | Special Order. Please Inquire | Unknown | |||||||||||||||||||||||||
| BBS0005-DA900039265102615DD | Longitudinal Hepatitis C (HCV) Drug Treatment Sample Set | United States | 0.5 mL Serum | 1.00 | 13.00 | Special Order. Please Inquire | 63 Y | Female | Non-Hispanic | <-70C | 26-Oct-15 | Genotype | 1b | Special Order. Please Inquire | Unknown | |||||||||||||||||||||||||
| BBS0005-DA900039266022515DD | Longitudinal Hepatitis C (HCV) Drug Treatment Sample Set | United States | 0.5 mL Serum | 1.00 | 4.00 | Special Order. Please Inquire | 62 Y | Male | Non-Hispanic | <-70C | 25-Feb-15 | Genotype | 1b | Special Order. Please Inquire | Unknown | |||||||||||||||||||||||||
| BBS0005-DA900039266032515DD | Longitudinal Hepatitis C (HCV) Drug Treatment Sample Set | United States | 0.5 mL Serum | 1.00 | 5.00 | Special Order. Please Inquire | 62 Y | Male | Non-Hispanic | <-70C | 25-Mar-15 | Genotype | 1b | Special Order. Please Inquire | Unknown | |||||||||||||||||||||||||
| BBS0005-DA900039266052015DD | Longitudinal Hepatitis C (HCV) Drug Treatment Sample Set | United States | 0.5 mL Serum | 1.00 | 9.00 | Special Order. Please Inquire | 62 Y | Male | Non-Hispanic | <-70C | 20-May-15 | Genotype | 1b | Special Order. Please Inquire | Unknown | |||||||||||||||||||||||||
| BBS0005-DA900039266081215DD | Longitudinal Hepatitis C (HCV) Drug Treatment Sample Set | United States | 0.5 mL Serum | 1.00 | 3.00 | Special Order. Please Inquire | 62 Y | Male | Non-Hispanic | <-70C | 12-Aug-15 | Genotype | 1b | Special Order. Please Inquire | Unknown | |||||||||||||||||||||||||
| BBS0005-DA900039267022615DD | Longitudinal Hepatitis C (HCV) Drug Treatment Sample Set | United States | 0.5 mL Serum | 1.00 | 5.00 | Special Order. Please Inquire | 62 Y | Male | Non-Hispanic | <-70C | 26-Feb-15 | Genotype | 1 | Special Order. Please Inquire | Unknown | |||||||||||||||||||||||||
| BBS0005-DA900039267032615DD | Longitudinal Hepatitis C (HCV) Drug Treatment Sample Set | United States | 0.5 mL Serum | 1.00 | 6.00 | Special Order. Please Inquire | 62 Y | Male | Non-Hispanic | <-70C | 26-Mar-15 | Genotype | 1 | Special Order. Please Inquire | Unknown | |||||||||||||||||||||||||
| BBS0005-DA900039267052115DD | Longitudinal Hepatitis C (HCV) Drug Treatment Sample Set | United States | 0.5 mL Serum | 1.00 | 7.00 | Special Order. Please Inquire | 63 Y | Male | Non-Hispanic | <-70C | 21-May-15 | Genotype | 1 | Special Order. Please Inquire | Unknown | |||||||||||||||||||||||||
| BBS0005-DA900039267081315DD | Longitudinal Hepatitis C (HCV) Drug Treatment Sample Set | United States | 0.5 mL Serum | 1.00 | 10.00 | Special Order. Please Inquire | 63 Y | Male | Non-Hispanic | <-70C | 13-Aug-15 | Genotype | 1 | Special Order. Please Inquire | Unknown | |||||||||||||||||||||||||
| BBS0005-DA900039268012615DD | Longitudinal Hepatitis C (HCV) Drug Treatment Sample Set | United States | 0.5 mL Serum | 1.00 | 6.00 | Special Order. Please Inquire | 57 Y | Female | Non-Hispanic | <-70C | 26-Jan-15 | Genotype | 1a | Special Order. Please Inquire | Unknown | |||||||||||||||||||||||||
| BBS0005-DA900039268032315DD | Longitudinal Hepatitis C (HCV) Drug Treatment Sample Set | United States | 0.5 mL Serum | 1.00 | 10.00 | Special Order. Please Inquire | 57 Y | Female | Non-Hispanic | <-70C | 23-Mar-15 | Genotype | 1a | Special Order. Please Inquire | Unknown | |||||||||||||||||||||||||
| BBS0005-DA900039268061515DD | Longitudinal Hepatitis C (HCV) Drug Treatment Sample Set | United States | 0.5 mL Serum | 1.00 | 8.00 | Special Order. Please Inquire | 57 Y | Female | Non-Hispanic | <-70C | 15-Jun-15 | Genotype | 1a | Special Order. Please Inquire | Unknown | |||||||||||||||||||||||||
| BBS0005-DA900039268122914DD | Longitudinal Hepatitis C (HCV) Drug Treatment Sample Set | United States | 0.5 mL Serum | 1.00 | 3.00 | Special Order. Please Inquire | 57 Y | Female | Non-Hispanic | <-70C | 29-Dec-14 | Genotype | 1a | Special Order. Please Inquire | Unknown | |||||||||||||||||||||||||
| BBS0005-DA900046272022015DD | Longitudinal Hepatitis C (HCV) Drug Treatment Sample Set | United States | 0.5 mL Serum | 1.00 | 13.00 | Special Order. Please Inquire | 67 Y | Female | Non-Hispanic | <-70C | 20-Feb-15 | Genotype | 1b | Special Order. Please Inquire | Unknown | |||||||||||||||||||||||||
| BBS0005-DA900046272032015DD | Longitudinal Hepatitis C (HCV) Drug Treatment Sample Set | United States | 0.5 mL Serum | 1.00 | 7.00 | Special Order. Please Inquire | 67 Y | Female | Non-Hispanic | <-70C | 20-Mar-15 | Genotype | 1b | Special Order. Please Inquire | Unknown | |||||||||||||||||||||||||
| BBS0005-DA900046272051515DD | Longitudinal Hepatitis C (HCV) Drug Treatment Sample Set | United States | 0.5 mL Serum | 1.00 | 11.00 | Special Order. Please Inquire | 67 Y | Female | Non-Hispanic | <-70C | 15-May-15 | Genotype | 1b | Special Order. Please Inquire | Unknown | |||||||||||||||||||||||||
| BBS0005-DA900046272080715DD | Longitudinal Hepatitis C (HCV) Drug Treatment Sample Set | United States | 0.5 mL Serum | 1.00 | 11.00 | Special Order. Please Inquire | 68 Y | Female | Non-Hispanic | <-70C | 07-Aug-15 | Genotype | 1b | Special Order. Please Inquire | Unknown | |||||||||||||||||||||||||
| BBS0005-DA900046273010215DD | Longitudinal Hepatitis C (HCV) Drug Treatment Sample Set | United States | 0.5 mL Serum | 1.00 | 4.00 | Special Order. Please Inquire | 56 Y | Female | Non-Hispanic | <-70C | 02-Jan-15 | Genotype | 1a | Special Order. Please Inquire | Unknown | |||||||||||||||||||||||||
| BBS0005-DA900046273012615DD | Longitudinal Hepatitis C (HCV) Drug Treatment Sample Set | United States | 0.5 mL Serum | 1.00 | 9.00 | Special Order. Please Inquire | 56 Y | Female | Non-Hispanic | <-70C | 26-Jan-15 | Genotype | 1a | Special Order. Please Inquire | Unknown | |||||||||||||||||||||||||
| BBS0005-DA900046273061915DD | Longitudinal Hepatitis C (HCV) Drug Treatment Sample Set | United States | 0.5 mL Serum | 1.00 | 12.00 | Special Order. Please Inquire | 57 Y | Female | Non-Hispanic | <-70C | 19-Jun-15 | Genotype | 1a | Special Order. Please Inquire | Unknown | |||||||||||||||||||||||||
| BBS0005-DA900046273091115DD | Longitudinal Hepatitis C (HCV) Drug Treatment Sample Set | United States | 0.5 mL Serum | 1.00 | 8.00 | Special Order. Please Inquire | 57 Y | Female | Non-Hispanic | <-70C | 11-Sep-15 | Genotype | 1a | Special Order. Please Inquire | Unknown | |||||||||||||||||||||||||
| BBS0005-DA900046274021215DD | Longitudinal Hepatitis C (HCV) Drug Treatment Sample Set | United States | 0.5 mL Serum | 1.00 | 4.00 | Special Order. Please Inquire | 67 Y | Male | Non-Hispanic | <-70C | 12-Feb-15 | Genotype | 1a | Special Order. Please Inquire | Unknown | |||||||||||||||||||||||||
| BBS0005-DA900046274031215DD | Longitudinal Hepatitis C (HCV) Drug Treatment Sample Set | United States | 0.5 mL Serum | 1.00 | 6.00 | Special Order. Please Inquire | 67 Y | Male | Non-Hispanic | <-70C | 12-Mar-15 | Genotype | 1a | Special Order. Please Inquire | Unknown | |||||||||||||||||||||||||
| BBS0005-DA900046274050715DD | Longitudinal Hepatitis C (HCV) Drug Treatment Sample Set | United States | 0.5 mL Serum | 1.00 | 8.00 | Special Order. Please Inquire | 67 Y | Male | Non-Hispanic | <-70C | 07-May-15 | Genotype | 1a | Special Order. Please Inquire | Unknown | |||||||||||||||||||||||||
| BBS0005-DA900046274080415DD | Longitudinal Hepatitis C (HCV) Drug Treatment Sample Set | United States | 0.5 mL Serum | 1.00 | 7.00 | Special Order. Please Inquire | 67 Y | Male | Non-Hispanic | <-70C | 04-Aug-15 | Genotype | 1a | Special Order. Please Inquire | Unknown | |||||||||||||||||||||||||
| BBS0005-DA900046275021315DD | Longitudinal Hepatitis C (HCV) Drug Treatment Sample Set | United States | 0.5 mL Serum | 1.00 | 4.00 | Special Order. Please Inquire | 64 Y | Male | Non-Hispanic | <-70C | 13-Feb-15 | Genotype | 1b | Special Order. Please Inquire | Unknown | |||||||||||||||||||||||||
| BBS0005-DA900046275031315DD | Longitudinal Hepatitis C (HCV) Drug Treatment Sample Set | United States | 0.5 mL Serum | 1.00 | 10.00 | Special Order. Please Inquire | 64 Y | Male | Non-Hispanic | <-70C | 13-Mar-15 | Genotype | 1b | Special Order. Please Inquire | Unknown | |||||||||||||||||||||||||
| BBS0005-DA900046275080715DD | Longitudinal Hepatitis C (HCV) Drug Treatment Sample Set | United States | 0.5 mL Serum | 1.00 | 10.00 | Special Order. Please Inquire | 64 Y | Male | Non-Hispanic | <-70C | 07-Aug-15 | Genotype | 1b | Special Order. Please Inquire | Unknown | |||||||||||||||||||||||||
| BBS0005-DA900046275103015DD | Longitudinal Hepatitis C (HCV) Drug Treatment Sample Set | United States | 0.5 mL Serum | 1.00 | 9.00 | Special Order. Please Inquire | 64 Y | Male | Non-Hispanic | <-70C | 30-Oct-15 | Genotype | 1b | Special Order. Please Inquire | Unknown | |||||||||||||||||||||||||
| BBS0005-DA900046276031215DD | Longitudinal Hepatitis C (HCV) Drug Treatment Sample Set | United States | 0.5 mL Serum | 1.00 | 7.00 | Special Order. Please Inquire | 74 Y | Female | Non-Hispanic | <-70C | 12-Mar-15 | Genotype | 1b | Special Order. Please Inquire | Unknown | |||||||||||||||||||||||||
| BBS0005-DA900046276073115DD | Longitudinal Hepatitis C (HCV) Drug Treatment Sample Set | United States | 0.5 mL Serum | 1.00 | 9.00 | Special Order. Please Inquire | 74 Y | Female | Non-Hispanic | <-70C | 31-Jul-15 | Genotype | 1b | Special Order. Please Inquire | Unknown | |||||||||||||||||||||||||
| BBS0005-DA900046276102315DD | Longitudinal Hepatitis C (HCV) Drug Treatment Sample Set | United States | 0.5 mL Serum | 1.00 | 10.00 | Special Order. Please Inquire | 75 Y | Female | Non-Hispanic | <-70C | 23-Oct-15 | Genotype | 1b | Special Order. Please Inquire | Unknown | |||||||||||||||||||||||||
| BBS0005-DA900053319021315DD | Longitudinal Hepatitis C (HCV) Drug Treatment Sample Set | United States | 0.5 mL Serum | 1.00 | 5.00 | Special Order. Please Inquire | 65 Y | Male | Non-Hispanic | <-70C | 13-Feb-15 | Genotype | 4 | Special Order. Please Inquire | Unknown | |||||||||||||||||||||||||
| BBS0005-DA900053319031315DD | Longitudinal Hepatitis C (HCV) Drug Treatment Sample Set | United States | 0.5 mL Serum | 1.00 | 8.00 | Special Order. Please Inquire | 65 Y | Male | Non-Hispanic | <-70C | 13-Mar-15 | Genotype | 4 | Special Order. Please Inquire | Unknown | |||||||||||||||||||||||||
| BBS0005-DA900053319073115DD | Longitudinal Hepatitis C (HCV) Drug Treatment Sample Set | United States | 0.5 mL Serum | 1.00 | 12.00 | Special Order. Please Inquire | 65 Y | Male | Non-Hispanic | <-70C | 31-Jul-15 | Genotype | 4 | Special Order. Please Inquire | Unknown | |||||||||||||||||||||||||
| BBS0005-DA900053319102315DD | Longitudinal Hepatitis C (HCV) Drug Treatment Sample Set | United States | 0.5 mL Serum | 1.00 | 9.00 | Special Order. Please Inquire | 66 Y | Male | Non-Hispanic | <-70C | 23-Oct-15 | Genotype | 4 | Special Order. Please Inquire | Unknown | |||||||||||||||||||||||||
| BBS0005-DA900053320020816DD | Longitudinal Hepatitis C (HCV) Drug Treatment Sample Set | United States | 0.5 mL Serum | 1.00 | 9.00 | Special Order. Please Inquire | 64 Y | Male | Non-Hispanic | <-70C | 08-Feb-16 | Genotype | 1b | Special Order. Please Inquire | Unknown | |||||||||||||||||||||||||
| BBS0005-DA900053320052815DD | Longitudinal Hepatitis C (HCV) Drug Treatment Sample Set | United States | 0.5 mL Serum | 1.00 | 3.00 | Special Order. Please Inquire | 63 Y | Male | Non-Hispanic | <-70C | 28-May-15 | Genotype | 1b | Special Order. Please Inquire | Unknown | |||||||||||||||||||||||||
| BBS0005-DA900053320062415DD | Longitudinal Hepatitis C (HCV) Drug Treatment Sample Set | United States | 0.5 mL Serum | 1.00 | 5.00 | Special Order. Please Inquire | 63 Y | Male | Non-Hispanic | <-70C | 24-Jun-15 | Genotype | 1b | Special Order. Please Inquire | Unknown | |||||||||||||||||||||||||
| BBS0005-DA900053320111215DD | Longitudinal Hepatitis C (HCV) Drug Treatment Sample Set | United States | 0.5 mL Serum | 1.00 | 6.00 | Special Order. Please Inquire | 64 Y | Male | Non-Hispanic | <-70C | 12-Nov-15 | Genotype | 1b | Special Order. Please Inquire | Unknown | |||||||||||||||||||||||||
| BBS0005-DA900068137060215DD | Longitudinal Hepatitis C (HCV) Drug Treatment Sample Set | United States | 0.5 mL Serum | 1.00 | 7.00 | Special Order. Please Inquire | 71 Y | Female | Non-Hispanic | <-70C | 02-Jun-15 | Genotype | 1b | Special Order. Please Inquire | Unknown | |||||||||||||||||||||||||
| BBS0005-DA900068137070215DD | Longitudinal Hepatitis C (HCV) Drug Treatment Sample Set | United States | 0.5 mL Serum | 1.00 | 8.00 | Special Order. Please Inquire | 71 Y | Female | Non-Hispanic | <-70C | 02-Jul-15 | Genotype | 1b | Special Order. Please Inquire | Unknown | |||||||||||||||||||||||||
| BBS0005-DA900068137090115DD | Longitudinal Hepatitis C (HCV) Drug Treatment Sample Set | United States | 0.5 mL Serum | 1.00 | 5.00 | Special Order. Please Inquire | 71 Y | Female | Non-Hispanic | <-70C | 01-Sep-15 | Genotype | 1b | Special Order. Please Inquire | Unknown | |||||||||||||||||||||||||
| BBS0005-DA900068137112415DD | Longitudinal Hepatitis C (HCV) Drug Treatment Sample Set | United States | 0.5 mL Serum | 1.00 | 8.00 | Special Order. Please Inquire | 71 Y | Female | Non-Hispanic | <-70C | 24-Nov-15 | Genotype | 1b | Special Order. Please Inquire | Unknown | |||||||||||||||||||||||||
| BBS0005-DA900068138012916DD | Longitudinal Hepatitis C (HCV) Drug Treatment Sample Set | United States | 0.5 mL Serum | 1.00 | 12.00 | Special Order. Please Inquire | 60 Y | Female | Non-Hispanic | <-70C | 29-Jan-16 | Genotype | 1b | Special Order. Please Inquire | Unknown | |||||||||||||||||||||||||
| BBS0005-DA900068138081115DD | Longitudinal Hepatitis C (HCV) Drug Treatment Sample Set | United States | 0.5 mL Serum | 1.00 | 4.00 | Special Order. Please Inquire | 59 Y | Female | Non-Hispanic | <-70C | 11-Aug-15 | Genotype | 1b | Special Order. Please Inquire | Unknown | |||||||||||||||||||||||||
| BBS0005-DA900068138091115DD | Longitudinal Hepatitis C (HCV) Drug Treatment Sample Set | United States | 0.5 mL Serum | 1.00 | 11.00 | Special Order. Please Inquire | 60 Y | Female | Non-Hispanic | <-70C | 11-Sep-15 | Genotype | 1b | Special Order. Please Inquire | Unknown | |||||||||||||||||||||||||
| BBS0005-DA900068138110615DD | Longitudinal Hepatitis C (HCV) Drug Treatment Sample Set | United States | 0.5 mL Serum | 1.00 | 10.00 | Special Order. Please Inquire | 60 Y | Female | Non-Hispanic | <-70C | 06-Nov-15 | Genotype | 1b | Special Order. Please Inquire | Unknown | |||||||||||||||||||||||||
| BBS0005-DA900068141021916DD | Longitudinal Hepatitis C (HCV) Drug Treatment Sample Set | United States | 0.5 mL Serum | 1.00 | 12.00 | Special Order. Please Inquire | 71 Y | Female | Non-Hispanic | <-70C | 19-Feb-16 | Genotype | 1b | Special Order. Please Inquire | Unknown | |||||||||||||||||||||||||
| BBS0005-DA900068141090415DD | Longitudinal Hepatitis C (HCV) Drug Treatment Sample Set | United States | 0.5 mL Serum | 1.00 | 4.00 | Special Order. Please Inquire | 70 Y | Female | Non-Hispanic | <-70C | 04-Sep-15 | Genotype | 1b | Special Order. Please Inquire | Unknown | |||||||||||||||||||||||||
| BBS0005-DA900068141100215DD | Longitudinal Hepatitis C (HCV) Drug Treatment Sample Set | United States | 0.5 mL Serum | 1.00 | 10.00 | Special Order. Please Inquire | 70 Y | Female | Non-Hispanic | <-70C | 02-Oct-15 | Genotype | 1b | Special Order. Please Inquire | Unknown | |||||||||||||||||||||||||
| BBS0005-DA900068141113015DD | Longitudinal Hepatitis C (HCV) Drug Treatment Sample Set | United States | 0.5 mL Serum | 1.00 | 9.00 | Special Order. Please Inquire | 70 Y | Female | Non-Hispanic | <-70C | 30-Nov-15 | Genotype | 1b | Special Order. Please Inquire | Unknown | |||||||||||||||||||||||||
| BBS0005-DA900087160031317DD | Longitudinal Hepatitis C (HCV) Drug Treatment Sample Set | United States | 0.5 mL Serum | 1.00 | 8.00 | Special Order. Please Inquire | 65 Y | Female | Non-Hispanic | <-70C | 13-Mar-17 | Roche cobas Ampliprep | Taqman | 1,698,950 IU/mL | 3-May-16 | Genotype | 2b | Special Order. Please Inquire | Unknown | Epclusa | 63.78 | 156 | 14-Jan-15 | Transfusion | No | No | ALT: 34 U/L | AST: 49 U/L | ALP: 114 U/L | Bilirubin (Total): 0.5 mg/dL | Bilirubin (Direct): 0.1 mg/dL | 3-May-2016 | ||||||||||||||
| BBS0005-DA900087160040517DD | Longitudinal Hepatitis C (HCV) Drug Treatment Sample Set | United States | 0.5 mL Serum | 1.00 | 15.00 | Special Order. Please Inquire | 65 Y | Female | Non-Hispanic | <-70C | 05-Apr-17 | Hepatology Test Group 1 | HCV RNA Not Detected | 5-Apr-17 | Genotype | 2b | Special Order. Please Inquire | Unknown | Epclusa | 63.78 | 156 | 14-Jan-15 | Transfusion | No | No | |||||||||||||||
| BBS0005-DA900087160060617DD | Longitudinal Hepatitis C (HCV) Drug Treatment Sample Set | United States | 0.5 mL Serum | 1.00 | 7.00 | Special Order. Please Inquire | 66 Y | Female | Non-Hispanic | <-70C | 06-Jun-17 | Hepatology Test Group 1 | HCV RNA Not Detected | 3-May-17 | Genotype | 2b | Special Order. Please Inquire | Unknown | Epclusa | 63.78 | 156 | 14-Jan-15 | Transfusion | No | No | ALT: 10 U/L | AST: 19 U/L | ALP: 100 U/L | Bilirubin (Total): 0.3 mg/dL | Bilirubin (Direct): 0.1 mg/dL | Creatinine: 1.58 mg/dL | 3-May-2017 | ||||||||||||||
| BBS0005-DA900087160081517DD | Longitudinal Hepatitis C (HCV) Drug Treatment Sample Set | United States | 0.5 mL Serum | 1.00 | 13.00 | Special Order. Please Inquire | 66 Y | Female | Non-Hispanic | <-70C | 15-Aug-17 | U/A | U/A | Genotype | 2b | Special Order. Please Inquire | Unknown | Epclusa | 63.78 | 156 | 14-Jan-15 | Transfusion | No | No | ALT: 14 U/L | AST: 27 U/L | ALP: 100 U/L | Bilirubin (Total): 0.8 mg/dL | Bilirubin (Direct): 0.2 mg/dL | Creatinine: 1.34 mg/dL 28-Jun-17 | |||||||||||||||
| BBS0005-DN900061278090616DD | Longitudinal Hepatitis C (HCV) Drug Treatment Sample Set | 0.5 mL Serum | 1.00 | 12.00 | Special Order. Please Inquire | 67 Y | Female | Non-Hispanic | <-70C | 06-Sep-16 | Genotype | 4r | Special Order. Please Inquire | Unknown | ||||||||||||||||||||||||||
| BBS0005-DN900061278120215DD | Longitudinal Hepatitis C (HCV) Drug Treatment Sample Set | 0.5 mL Serum | 1.00 | 11.00 | Special Order. Please Inquire | Female | Non-Hispanic | <-70C | 02-Dec-15 | Genotype | 4r | Special Order. Please Inquire | Unknown | |||||||||||||||||||||||||||
| BBS0005-DN900061278123015DD | Longitudinal Hepatitis C (HCV) Drug Treatment Sample Set | 0.5 mL Serum | 1.00 | 6.00 | Special Order. Please Inquire | 66 Y | Female | Non-Hispanic | <-70C | 30-Dec-15 | Genotype | 4r | Special Order. Please Inquire | Unknown | ||||||||||||||||||||||||||
| BBS0005-EM900038296010915DD | Longitudinal Hepatitis C (HCV) Drug Treatment Sample Set | Estonia | 0.5 mL Serum | 1.00 | 10.00 | Special Order. Please Inquire | 34 Y | Male | Non-Hispanic | <-70C | 09-Jan-15 | Genotype | 3 | Special Order. Please Inquire | Unknown | |||||||||||||||||||||||||
| BBS0005-EM900038296021015DD | Longitudinal Hepatitis C (HCV) Drug Treatment Sample Set | Estonia | 0.5 mL Serum | 1.00 | 7.00 | Special Order. Please Inquire | 34 Y | Male | Non-Hispanic | <-70C | 10-Feb-15 | Genotype | 3 | Special Order. Please Inquire | Unknown | |||||||||||||||||||||||||
| BBS0005-EM900038296040715DD | Longitudinal Hepatitis C (HCV) Drug Treatment Sample Set | Estonia | 0.5 mL Serum | 1.00 | 9.00 | Special Order. Please Inquire | 35 Y | Male | Non-Hispanic | <-70C | 07-Apr-15 | Genotype | 3 | Special Order. Please Inquire | Unknown | |||||||||||||||||||||||||
| BBS0005-EM900038297021115DD | Longitudinal Hepatitis C (HCV) Drug Treatment Sample Set | Estonia | 0.5 mL Serum | 1.00 | 14.00 | Special Order. Please Inquire | 62 Y | Female | Non-Hispanic | <-70C | 11-Feb-15 | Genotype | 1 | Special Order. Please Inquire | Unknown | |||||||||||||||||||||||||
| BBS0005-EM900038297082914DD | Longitudinal Hepatitis C (HCV) Drug Treatment Sample Set | Estonia | 0.5 mL Serum | 1.00 | 10.00 | Special Order. Please Inquire | 62 Y | Female | Non-Hispanic | <-70C | 29-Aug-14 | Genotype | 1 | Special Order. Please Inquire | Unknown | |||||||||||||||||||||||||
| BBS0005-EM900038297100114DD | Longitudinal Hepatitis C (HCV) Drug Treatment Sample Set | Estonia | 0.5 mL Serum | 1.00 | 13.00 | Special Order. Please Inquire | 62 Y | Female | Non-Hispanic | <-70C | 01-Oct-14 | Genotype | 1 | Special Order. Please Inquire | Unknown | |||||||||||||||||||||||||
| BBS0005-EM900038297102814DD | Longitudinal Hepatitis C (HCV) Drug Treatment Sample Set | Estonia | 0.5 mL Serum | 1.00 | 15.00 | Special Order. Please Inquire | 62 Y | Female | Non-Hispanic | <-70C | 28-Oct-14 | Genotype | 1 | Special Order. Please Inquire | Unknown | |||||||||||||||||||||||||
| BBS0005-EM900038297112614DD | Longitudinal Hepatitis C (HCV) Drug Treatment Sample Set | Estonia | 0.5 mL Serum | 1.00 | 14.00 | Special Order. Please Inquire | 62 Y | Female | Non-Hispanic | <-70C | 26-Nov-14 | Genotype | 1 | Special Order. Please Inquire | Unknown | |||||||||||||||||||||||||
| BBS0005-EM900038298011515DD | Longitudinal Hepatitis C (HCV) Drug Treatment Sample Set | Estonia | 0.5 mL Serum | 1.00 | 7.00 | Special Order. Please Inquire | 42 Y | Male | Non-Hispanic | <-70C | 15-Jan-15 | Genotype | 1 | Special Order. Please Inquire | Unknown | |||||||||||||||||||||||||
| BBS0005-EM900038298021715DD | Longitudinal Hepatitis C (HCV) Drug Treatment Sample Set | Estonia | 0.5 mL Serum | 1.00 | 5.00 | Special Order. Please Inquire | 42 Y | Male | Non-Hispanic | <-70C | 17-Feb-15 | Genotype | 1 | Special Order. Please Inquire | Unknown | |||||||||||||||||||||||||
| BBS0005-EM900038298031915DD | Longitudinal Hepatitis C (HCV) Drug Treatment Sample Set | Estonia | 0.5 mL Serum | 1.00 | 4.00 | Special Order. Please Inquire | 42 Y | Male | Non-Hispanic | <-70C | 19-Mar-15 | Genotype | 1 | Special Order. Please Inquire | Unknown | |||||||||||||||||||||||||
| BBS0005-EM900038298042115DD | Longitudinal Hepatitis C (HCV) Drug Treatment Sample Set | Estonia | 0.5 mL Serum | 1.00 | 5.00 | Special Order. Please Inquire | 42 Y | Male | Non-Hispanic | <-70C | 21-Apr-15 | Genotype | 1 | Special Order. Please Inquire | Unknown | |||||||||||||||||||||||||
| BBS0005-EM900038298070915DD | Longitudinal Hepatitis C (HCV) Drug Treatment Sample Set | Estonia | 0.5 mL Serum | 1.00 | 5.00 | Special Order. Please Inquire | 43 Y | Male | Non-Hispanic | <-70C | 09-Jul-15 | Genotype | 1 | Special Order. Please Inquire | Unknown | |||||||||||||||||||||||||
| BBS0005-EM900038299072514DD | Longitudinal Hepatitis C (HCV) Drug Treatment Sample Set | Estonia | 0.5 mL Serum | 1.00 | 10.00 | Special Order. Please Inquire | 46 Y | Female | Non-Hispanic | <-70C | 25-Jul-14 | Genotype | 2 | Special Order. Please Inquire | Unknown | |||||||||||||||||||||||||
| BBS0005-EM900038299082914DD | Longitudinal Hepatitis C (HCV) Drug Treatment Sample Set | Estonia | 0.5 mL Serum | 1.00 | 11.00 | Special Order. Please Inquire | 47 Y | Female | Non-Hispanic | <-70C | 29-Aug-14 | Genotype | 2 | Special Order. Please Inquire | Unknown | |||||||||||||||||||||||||
| BBS0005-EM900038299102114DD | Longitudinal Hepatitis C (HCV) Drug Treatment Sample Set | Estonia | 0.5 mL Serum | 1.00 | 9.00 | Special Order. Please Inquire | 47 Y | Female | Non-Hispanic | <-70C | 21-Oct-14 | Genotype | 2 | Special Order. Please Inquire | Unknown | |||||||||||||||||||||||||
| BBS0005-EM900038300061814DD | Longitudinal Hepatitis C (HCV) Drug Treatment Sample Set | Estonia | 0.5 mL Serum | 1.00 | 9.00 | Special Order. Please Inquire | 36 Y | Male | Non-Hispanic | <-70C | 18-Jun-14 | Genotype | 3 | Special Order. Please Inquire | Unknown | |||||||||||||||||||||||||
| BBS0005-EM900038300072114DD | Longitudinal Hepatitis C (HCV) Drug Treatment Sample Set | Estonia | 0.5 mL Serum | 1.00 | 12.00 | Special Order. Please Inquire | 36 Y | Male | Non-Hispanic | <-70C | 21-Jul-14 | Genotype | 3 | Special Order. Please Inquire | Unknown | |||||||||||||||||||||||||
| BBS0005-EM900038300091514DD | Longitudinal Hepatitis C (HCV) Drug Treatment Sample Set | Estonia | 0.5 mL Serum | 1.00 | 14.00 | Special Order. Please Inquire | 36 Y | Male | Non-Hispanic | <-70C | 15-Sep-14 | Genotype | 3 | Special Order. Please Inquire | Unknown | |||||||||||||||||||||||||
| BBS0005-EM900046647071714DD | Longitudinal Hepatitis C (HCV) Drug Treatment Sample Set | Estonia | 0.5 mL Serum | 1.00 | 6.00 | Special Order. Please Inquire | 46 Y | Female | Non-Hispanic | <-70C | 17-Jul-14 | Genotype | 3 | Special Order. Please Inquire | Unknown | |||||||||||||||||||||||||
| BBS0005-EM900046647082614DD | Longitudinal Hepatitis C (HCV) Drug Treatment Sample Set | Estonia | 0.5 mL Serum | 1.00 | 14.00 | Special Order. Please Inquire | 46 Y | Female | Non-Hispanic | <-70C | 26-Aug-14 | Genotype | 3 | Special Order. Please Inquire | Unknown | |||||||||||||||||||||||||
| BBS0005-EM900046647101614DD | Longitudinal Hepatitis C (HCV) Drug Treatment Sample Set | Estonia | 0.5 mL Serum | 1.00 | 17.00 | Special Order. Please Inquire | 46 Y | Female | Non-Hispanic | <-70C | 16-Oct-14 | Genotype | 3 | Special Order. Please Inquire | Unknown | |||||||||||||||||||||||||
| BBS0005-EM900046648020215DD | Longitudinal Hepatitis C (HCV) Drug Treatment Sample Set | Estonia | 0.5 mL Serum | 1.00 | 10.00 | Special Order. Please Inquire | 34 Y | Female | Non-Hispanic | <-70C | 02-Feb-15 | Genotype | 3 | Special Order. Please Inquire | Unknown | |||||||||||||||||||||||||
| BBS0005-EM900046648032715DD | Longitudinal Hepatitis C (HCV) Drug Treatment Sample Set | Estonia | 0.5 mL Serum | 1.00 | 12.00 | Special Order. Please Inquire | 34 Y | Female | Non-Hispanic | <-70C | 27-Mar-15 | Genotype | 3 | Special Order. Please Inquire | Unknown | |||||||||||||||||||||||||
| BBS0005-EM900046648121614DD | Longitudinal Hepatitis C (HCV) Drug Treatment Sample Set | Estonia | 0.5 mL Serum | 1.00 | 14.00 | Special Order. Please Inquire | 33 Y | Female | Non-Hispanic | <-70C | 16-Dec-14 | Genotype | 3 | Special Order. Please Inquire | Unknown | |||||||||||||||||||||||||
| BBS0005-EM900046649071514DD | Longitudinal Hepatitis C (HCV) Drug Treatment Sample Set | Estonia | 0.5 mL Serum | 1.00 | 7.00 | Special Order. Please Inquire | 60 Y | Male | Non-Hispanic | <-70C | 15-Jul-14 | Genotype | 3 | Special Order. Please Inquire | Unknown | |||||||||||||||||||||||||
| BBS0005-EM900046649081814DD | Longitudinal Hepatitis C (HCV) Drug Treatment Sample Set | Estonia | 0.5 mL Serum | 1.00 | 15.00 | Special Order. Please Inquire | 60 Y | Male | Non-Hispanic | <-70C | 18-Aug-14 | Genotype | 3 | Special Order. Please Inquire | Unknown | |||||||||||||||||||||||||
| BBS0005-EM900046649101414DD | Longitudinal Hepatitis C (HCV) Drug Treatment Sample Set | Estonia | 0.5 mL Serum | 1.00 | 15.00 | Special Order. Please Inquire | 60 Y | Male | Non-Hispanic | <-70C | 14-Oct-14 | Genotype | 3 | Special Order. Please Inquire | Unknown | |||||||||||||||||||||||||
| BBS0005-EM900046650053116DD | Longitudinal Hepatitis C (HCV) Drug Treatment Sample Set | Estonia | 0.5 mL Serum | 1.00 | 1.00 | Special Order. Please Inquire | 47 Y | Male | Non-Hispanic | <-70C | 31-May-16 | Genotype | 2 | Special Order. Please Inquire | Unknown | |||||||||||||||||||||||||
| BBS0005-EM900046650062816DD | Longitudinal Hepatitis C (HCV) Drug Treatment Sample Set | Estonia | 0.5 mL Serum | 1.00 | 6.00 | Special Order. Please Inquire | 47 Y | Male | Non-Hispanic | <-70C | 28-Jun-16 | Genotype | 2 | Special Order. Please Inquire | Unknown | |||||||||||||||||||||||||
| BBS0005-EM900046650082216DD | Longitudinal Hepatitis C (HCV) Drug Treatment Sample Set | Estonia | 0.5 mL Serum | 1.00 | 8.00 | Special Order. Please Inquire | 47 Y | Male | Non-Hispanic | <-70C | 22-Aug-16 | Genotype | 2 | Special Order. Please Inquire | Unknown | |||||||||||||||||||||||||
| BBS0005-EM900046651060316DD | Longitudinal Hepatitis C (HCV) Drug Treatment Sample Set | Estonia | 0.5 mL Serum | 1.00 | 8.00 | Special Order. Please Inquire | 49 Y | Female | Non-Hispanic | <-70C | 03-Jun-16 | Genotype | 3 | Special Order. Please Inquire | Unknown | |||||||||||||||||||||||||
| BBS0005-EM900046651062816DD | Longitudinal Hepatitis C (HCV) Drug Treatment Sample Set | Estonia | 0.5 mL Serum | 1.00 | 10.00 | Special Order. Please Inquire | 49 Y | Female | Non-Hispanic | <-70C | 28-Jun-16 | Genotype | 3 | Special Order. Please Inquire | Unknown | |||||||||||||||||||||||||
| BBS0005-EM900046651082616DD | Longitudinal Hepatitis C (HCV) Drug Treatment Sample Set | Estonia | 0.5 mL Serum | 1.00 | 12.00 | Special Order. Please Inquire | 50 Y | Female | Non-Hispanic | <-70C | 26-Aug-16 | Genotype | 3 | Special Order. Please Inquire | Unknown | |||||||||||||||||||||||||
| BBS0005-EM900046723010314DD | Longitudinal Hepatitis C (HCV) Drug Treatment Sample Set | Estonia | 0.5 mL Serum | 1.00 | 2.00 | Special Order. Please Inquire | 34 Y | Male | Non-Hispanic | <-70C | 03-Jan-14 | Genotype | 3 | Special Order. Please Inquire | Unknown | |||||||||||||||||||||||||
| BBS0005-EM900046723100413DD | Longitudinal Hepatitis C (HCV) Drug Treatment Sample Set | Estonia | 0.5 mL Serum | 1.00 | 2.00 | Special Order. Please Inquire | 34 Y | Male | Non-Hispanic | <-70C | 04-Oct-13 | Genotype | 3 | Special Order. Please Inquire | Unknown | |||||||||||||||||||||||||
| BBS0005-EM900048603060116DD | Longitudinal Hepatitis C (HCV) Drug Treatment Sample Set | Estonia | 0.5 mL Serum | 1.00 | 13.00 | Special Order. Please Inquire | 46 Y | Female | Non-Hispanic | <-70C | 01-Jun-16 | Genotype | 3 | Special Order. Please Inquire | Unknown | |||||||||||||||||||||||||
| BBS0005-EM900048603070416DD | Longitudinal Hepatitis C (HCV) Drug Treatment Sample Set | Estonia | 0.5 mL Serum | 1.00 | 13.00 | Special Order. Please Inquire | 46 Y | Female | Non-Hispanic | <-70C | 04-Jul-16 | Genotype | 3 | Special Order. Please Inquire | Unknown | |||||||||||||||||||||||||
| BBS0005-EM900048603082916DD | Longitudinal Hepatitis C (HCV) Drug Treatment Sample Set | Estonia | 0.5 mL Serum | 1.00 | 12.00 | Special Order. Please Inquire | 46 Y | Female | Non-Hispanic | <-70C | 29-Aug-16 | Genotype | 3 | Special Order. Please Inquire | Unknown | |||||||||||||||||||||||||
| BBS0005-EM900048604052416DD | Longitudinal Hepatitis C (HCV) Drug Treatment Sample Set | Estonia | 0.5 mL Serum | 1.00 | 6.00 | Special Order. Please Inquire | 39 Y | Male | Non-Hispanic | <-70C | 24-May-16 | Genotype | 3 | Special Order. Please Inquire | Unknown | |||||||||||||||||||||||||
| BBS0005-EM900048604062716DD | Longitudinal Hepatitis C (HCV) Drug Treatment Sample Set | Estonia | 0.5 mL Serum | 1.00 | 5.00 | Special Order. Please Inquire | 39 Y | Male | Non-Hispanic | <-70C | 27-Jun-16 | Genotype | 3 | Special Order. Please Inquire | Unknown | |||||||||||||||||||||||||
| BBS0005-EM900048604082216DD | Longitudinal Hepatitis C (HCV) Drug Treatment Sample Set | Estonia | 0.5 mL Serum | 1.00 | 6.00 | Special Order. Please Inquire | 39 Y | Male | Non-Hispanic | <-70C | 22-Aug-16 | Genotype | 3 | Special Order. Please Inquire | Unknown | |||||||||||||||||||||||||
| BBS0005-EM900048605022516DD | Longitudinal Hepatitis C (HCV) Drug Treatment Sample Set | Estonia | 0.5 mL Serum | 1.00 | 11.00 | Special Order. Please Inquire | 36 Y | Male | Non-Hispanic | <-70C | 25-Feb-16 | Genotype | 3 | Special Order. Please Inquire | Unknown | |||||||||||||||||||||||||
| BBS0005-EM900048605032416DD | Longitudinal Hepatitis C (HCV) Drug Treatment Sample Set | Estonia | 0.5 mL Serum | 1.00 | 5.00 | Special Order. Please Inquire | 36 Y | Male | Non-Hispanic | <-70C | 24-Mar-16 | Genotype | 3 | Special Order. Please Inquire | Unknown | |||||||||||||||||||||||||
| BBS0005-EM900048605052516DD | Longitudinal Hepatitis C (HCV) Drug Treatment Sample Set | Estonia | 0.5 mL Serum | 1.00 | 7.00 | Special Order. Please Inquire | 36 Y | Male | Non-Hispanic | <-70C | 25-May-16 | Genotype | 3 | Special Order. Please Inquire | Unknown | |||||||||||||||||||||||||
| BBS0005-EM900048606032816DD | Longitudinal Hepatitis C (HCV) Drug Treatment Sample Set | Estonia | 0.5 mL Serum | 1.00 | 13.00 | Special Order. Please Inquire | 35 Y | Female | Non-Hispanic | <-70C | 28-Mar-16 | Genotype | 3 | Special Order. Please Inquire | Unknown | |||||||||||||||||||||||||
| BBS0005-EM900048606042516DD | Longitudinal Hepatitis C (HCV) Drug Treatment Sample Set | Estonia | 0.5 mL Serum | 1.00 | 10.00 | Special Order. Please Inquire | 35 Y | Female | Non-Hispanic | <-70C | 25-Apr-16 | Genotype | 3 | Special Order. Please Inquire | Unknown | |||||||||||||||||||||||||
| BBS0005-EM900048606052316DD | Longitudinal Hepatitis C (HCV) Drug Treatment Sample Set | Estonia | 0.5 mL Serum | 1.00 | 9.00 | Special Order. Please Inquire | 35 Y | Female | Non-Hispanic | <-70C | 23-May-16 | Genotype | 3 | Special Order. Please Inquire | Unknown | |||||||||||||||||||||||||
| BBS0005-EM900048607052115DD | Longitudinal Hepatitis C (HCV) Drug Treatment Sample Set | Estonia | 0.5 mL Serum | 1.00 | 7.00 | Special Order. Please Inquire | 24 Y | Male | Non-Hispanic | <-70C | 21-May-15 | Genotype | 3 | Special Order. Please Inquire | Unknown | |||||||||||||||||||||||||
| BBS0005-EM900048607072115DD | Longitudinal Hepatitis C (HCV) Drug Treatment Sample Set | Estonia | 0.5 mL Serum | 1.00 | 5.00 | Special Order. Please Inquire | 24 Y | Male | Non-Hispanic | <-70C | 21-Jul-15 | Genotype | 3 | Special Order. Please Inquire | Unknown | |||||||||||||||||||||||||
| BBS0005-EM900048608050815DD | Longitudinal Hepatitis C (HCV) Drug Treatment Sample Set | Estonia | 0.5 mL Serum | 1.00 | 8.00 | Special Order. Please Inquire | 41 Y | Male | Non-Hispanic | <-70C | 08-May-15 | Genotype | 3 | Special Order. Please Inquire | Unknown | |||||||||||||||||||||||||
| BBS0005-EM900048608060215DD | Longitudinal Hepatitis C (HCV) Drug Treatment Sample Set | Estonia | 0.5 mL Serum | 1.00 | 4.00 | Special Order. Please Inquire | 41 Y | Male | Non-Hispanic | <-70C | 02-Jun-15 | Genotype | 3 | Special Order. Please Inquire | Unknown | |||||||||||||||||||||||||
| BBS0005-EM900048608073115DD | Longitudinal Hepatitis C (HCV) Drug Treatment Sample Set | Estonia | 0.5 mL Serum | 1.00 | 11.00 | Special Order. Please Inquire | 41 Y | Male | Non-Hispanic | <-70C | 31-Jul-15 | Genotype | 3 | Special Order. Please Inquire | Unknown | |||||||||||||||||||||||||
| BBS0005-EM900048676092213DD | Longitudinal Hepatitis C (HCV) Drug Treatment Sample Set | Estonia | 0.5 mL Serum | 1.00 | 5.00 | Special Order. Please Inquire | 52 Y | Female | Non-Hispanic | <-70C | 22-Sep-13 | Genotype | 2 | Special Order. Please Inquire | Unknown | |||||||||||||||||||||||||
| BBS0005-EM900048676103013DD | Longitudinal Hepatitis C (HCV) Drug Treatment Sample Set | Estonia | 0.5 mL Serum | 1.00 | 7.00 | Special Order. Please Inquire | 52 Y | Female | Non-Hispanic | <-70C | 30-Oct-13 | Genotype | 2 | Special Order. Please Inquire | Unknown | |||||||||||||||||||||||||
| BBS0005-EM900048676122713DD | Longitudinal Hepatitis C (HCV) Drug Treatment Sample Set | Estonia | 0.5 mL Serum | 1.00 | 3.00 | Special Order. Please Inquire | Female | Non-Hispanic | <-70C | 27-Dec-13 | Genotype | 2 | Special Order. Please Inquire | Unknown | ||||||||||||||||||||||||||
| BBS0005-EM900048677092613DD | Longitudinal Hepatitis C (HCV) Drug Treatment Sample Set | Estonia | 0.5 mL Serum | 1.00 | 5.00 | Special Order. Please Inquire | Female | Non-Hispanic | <-70C | 26-Sep-13 | Genotype | 3 | Special Order. Please Inquire | Unknown | ||||||||||||||||||||||||||
| BBS0005-EM900048677102813DD | Longitudinal Hepatitis C (HCV) Drug Treatment Sample Set | Estonia | 0.5 mL Serum | 1.00 | 8.00 | Special Order. Please Inquire | 49 Y | Female | Non-Hispanic | <-70C | 28-Oct-13 | Genotype | 3 | Special Order. Please Inquire | Unknown | |||||||||||||||||||||||||
| BBS0005-EM900048677122013DD | Longitudinal Hepatitis C (HCV) Drug Treatment Sample Set | Estonia | 0.5 mL Serum | 1.00 | 7.00 | Special Order. Please Inquire | 49 Y | Female | Non-Hispanic | <-70C | 20-Dec-13 | Genotype | 3 | Special Order. Please Inquire | Unknown | |||||||||||||||||||||||||
| BBS0005-EM900048678092313DD | Longitudinal Hepatitis C (HCV) Drug Treatment Sample Set | Estonia | 0.5 mL Serum | 1.00 | 2.00 | Special Order. Please Inquire | Male | Non-Hispanic | <-70C | 23-Sep-13 | Genotype | 3 | Special Order. Please Inquire | Unknown | ||||||||||||||||||||||||||
| BBS0005-EM900048678102813DD | Longitudinal Hepatitis C (HCV) Drug Treatment Sample Set | Estonia | 0.5 mL Serum | 1.00 | 5.00 | Special Order. Please Inquire | 44 Y | Male | Non-Hispanic | <-70C | 28-Oct-13 | Genotype | 3 | Special Order. Please Inquire | Unknown | |||||||||||||||||||||||||
| BBS0005-EM900048678121913DD | Longitudinal Hepatitis C (HCV) Drug Treatment Sample Set | Estonia | 0.5 mL Serum | 1.00 | 5.00 | Special Order. Please Inquire | 44 Y | Male | Non-Hispanic | <-70C | 19-Dec-13 | Genotype | 3 | Special Order. Please Inquire | Unknown | |||||||||||||||||||||||||
| BBS0005-EM900048680010314DD | Longitudinal Hepatitis C (HCV) Drug Treatment Sample Set | Estonia | 0.5 mL Serum | 1.00 | 13.00 | Special Order. Please Inquire | 48 Y | Male | Non-Hispanic | <-70C | 03-Jan-14 | Genotype | 3 | Special Order. Please Inquire | Unknown | |||||||||||||||||||||||||
| BBS0005-EM900048680100713DD | Longitudinal Hepatitis C (HCV) Drug Treatment Sample Set | Estonia | 0.5 mL Serum | 1.00 | 9.00 | Special Order. Please Inquire | Male | Non-Hispanic | <-70C | 07-Oct-13 | Genotype | 3 | Special Order. Please Inquire | Unknown | ||||||||||||||||||||||||||
| BBS0005-EM900048680111113DD | Longitudinal Hepatitis C (HCV) Drug Treatment Sample Set | Estonia | 0.5 mL Serum | 1.00 | 12.00 | Special Order. Please Inquire | 48 Y | Male | Non-Hispanic | <-70C | 11-Nov-13 | Genotype | 3 | Special Order. Please Inquire | Unknown | |||||||||||||||||||||||||
| BBS0005-EM900056010032015DD | Longitudinal Hepatitis C (HCV) Drug Treatment Sample Set | Estonia | 0.5 mL Serum | 1.00 | 6.00 | Special Order. Please Inquire | 59 Y | Male | Non-Hispanic | <-70C | 20-Mar-15 | Genotype | 2 | Special Order. Please Inquire | Unknown | |||||||||||||||||||||||||
| BBS0005-EM900056010041415DD | Longitudinal Hepatitis C (HCV) Drug Treatment Sample Set | Estonia | 0.5 mL Serum | 1.00 | 5.00 | Special Order. Please Inquire | 59 Y | Male | Non-Hispanic | <-70C | 14-Apr-15 | Genotype | 2 | Special Order. Please Inquire | Unknown | |||||||||||||||||||||||||
| BBS0005-EM900056010060915DD | Longitudinal Hepatitis C (HCV) Drug Treatment Sample Set | Estonia | 0.5 mL Serum | 1.00 | 10.00 | Special Order. Please Inquire | 60 Y | Male | Non-Hispanic | <-70C | 09-Jun-15 | Genotype | 2 | Special Order. Please Inquire | Unknown | |||||||||||||||||||||||||
| BBS0005-EM900056011042216DD | Longitudinal Hepatitis C (HCV) Drug Treatment Sample Set | Estonia | 0.5 mL Serum | 1.00 | 10.00 | Special Order. Please Inquire | 54 Y | Male | Non-Hispanic | <-70C | 22-Apr-16 | Genotype | 2 | Special Order. Please Inquire | Unknown | |||||||||||||||||||||||||
| BBS0005-EM900056011052016DD | Longitudinal Hepatitis C (HCV) Drug Treatment Sample Set | Estonia | 0.5 mL Serum | 1.00 | 12.00 | Special Order. Please Inquire | 54 Y | Male | Non-Hispanic | <-70C | 20-May-16 | Genotype | 2 | Special Order. Please Inquire | Unknown | |||||||||||||||||||||||||
| BBS0005-EM900056011071516DD | Longitudinal Hepatitis C (HCV) Drug Treatment Sample Set | Estonia | 0.5 mL Serum | 1.00 | 14.00 | Special Order. Please Inquire | 54 Y | Male | Non-Hispanic | <-70C | 15-Jul-16 | Genotype | 2 | Special Order. Please Inquire | Unknown | |||||||||||||||||||||||||
| BBS0005-EM900056012040215DD | Longitudinal Hepatitis C (HCV) Drug Treatment Sample Set | Estonia | 0.5 mL Serum | 1.00 | 7.00 | Special Order. Please Inquire | 32 Y | Male | Non-Hispanic | <-70C | 02-Apr-15 | Genotype | 3 | Special Order. Please Inquire | Unknown | |||||||||||||||||||||||||
| BBS0005-EM900056012050415DD | Longitudinal Hepatitis C (HCV) Drug Treatment Sample Set | Estonia | 0.5 mL Serum | 1.00 | 8.00 | Special Order. Please Inquire | 32 Y | Male | Non-Hispanic | <-70C | 04-May-15 | Genotype | 3 | Special Order. Please Inquire | Unknown | |||||||||||||||||||||||||
| BBS0005-EM900056012062915DD | Longitudinal Hepatitis C (HCV) Drug Treatment Sample Set | Estonia | 0.5 mL Serum | 1.00 | 13.00 | Special Order. Please Inquire | 32 Y | Male | Non-Hispanic | <-70C | 29-Jun-15 | Genotype | 3 | Special Order. Please Inquire | Unknown | |||||||||||||||||||||||||
| BBS0005-EM900056013021315DD | Longitudinal Hepatitis C (HCV) Drug Treatment Sample Set | Estonia | 0.5 mL Serum | 1.00 | 10.00 | Special Order. Please Inquire | 37 Y | Male | Non-Hispanic | <-70C | 13-Feb-15 | Genotype | 2 | Special Order. Please Inquire | Unknown | |||||||||||||||||||||||||
| BBS0005-EM900056013031015DD | Longitudinal Hepatitis C (HCV) Drug Treatment Sample Set | Estonia | 0.5 mL Serum | 1.00 | 10.00 | Special Order. Please Inquire | 37 Y | Male | Non-Hispanic | <-70C | 10-Mar-15 | Genotype | 2 | Special Order. Please Inquire | Unknown | |||||||||||||||||||||||||
| BBS0005-EM900056013050515DD | Longitudinal Hepatitis C (HCV) Drug Treatment Sample Set | Estonia | 0.5 mL Serum | 1.00 | 9.00 | Special Order. Please Inquire | 37 Y | Male | Non-Hispanic | <-70C | 05-May-15 | Genotype | 2 | Special Order. Please Inquire | Unknown | |||||||||||||||||||||||||
| BBS0005-EM900056014020916DD | Longitudinal Hepatitis C (HCV) Drug Treatment Sample Set | Estonia | 0.5 mL Serum | 1.00 | 14.00 | Special Order. Please Inquire | 34 Y | Male | Non-Hispanic | <-70C | 09-Feb-16 | Genotype | 3 | Special Order. Please Inquire | Unknown | |||||||||||||||||||||||||
| BBS0005-EM900056014112015DD | Longitudinal Hepatitis C (HCV) Drug Treatment Sample Set | Estonia | 0.5 mL Serum | 1.00 | 10.00 | Special Order. Please Inquire | 34 Y | Male | Non-Hispanic | <-70C | 20-Nov-15 | Genotype | 3 | Special Order. Please Inquire | Unknown | |||||||||||||||||||||||||
| BBS0005-EM900056014121515DD | Longitudinal Hepatitis C (HCV) Drug Treatment Sample Set | Estonia | 0.5 mL Serum | 1.00 | 14.00 | Special Order. Please Inquire | 34 Y | Male | Non-Hispanic | <-70C | 15-Dec-15 | Genotype | 3 | Special Order. Please Inquire | Unknown | |||||||||||||||||||||||||
| BBS0005-EM900056015011316DD | Longitudinal Hepatitis C (HCV) Drug Treatment Sample Set | Estonia | 0.5 mL Serum | 1.00 | 12.00 | Special Order. Please Inquire | 27 Y | Female | Non-Hispanic | <-70C | 13-Jan-16 | Genotype | 3 | Special Order. Please Inquire | Unknown | |||||||||||||||||||||||||
| BBS0005-EM900056015101215DD | Longitudinal Hepatitis C (HCV) Drug Treatment Sample Set | Estonia | 0.5 mL Serum | 1.00 | 8.00 | Special Order. Please Inquire | 27 Y | Female | Non-Hispanic | <-70C | 12-Oct-15 | Genotype | 3 | Special Order. Please Inquire | Unknown | |||||||||||||||||||||||||
| BBS0005-EM900056015111915DD | Longitudinal Hepatitis C (HCV) Drug Treatment Sample Set | Estonia | 0.5 mL Serum | 1.00 | 1.00 | Special Order. Please Inquire | 27 Y | Female | Non-Hispanic | <-70C | 19-Nov-15 | Genotype | 3 | Special Order. Please Inquire | Unknown | |||||||||||||||||||||||||
| BBS0005-EM900056149070615DD | Longitudinal Hepatitis C (HCV) Drug Treatment Sample Set | Estonia | 0.5 mL Serum | 1.00 | 7.00 | Special Order. Please Inquire | 42 Y | Female | Non-Hispanic | <-70C | 06-Jul-15 | Genotype | 3 | Special Order. Please Inquire | Unknown | |||||||||||||||||||||||||
| BBS0005-EM900056149080715DD | Longitudinal Hepatitis C (HCV) Drug Treatment Sample Set | Estonia | 0.5 mL Serum | 1.00 | 16.00 | Special Order. Please Inquire | 42 Y | Female | Non-Hispanic | <-70C | 07-Aug-15 | Genotype | 3 | Special Order. Please Inquire | Unknown | |||||||||||||||||||||||||
| BBS0005-EM900056149100115DD | Longitudinal Hepatitis C (HCV) Drug Treatment Sample Set | Estonia | 0.5 mL Serum | 1.00 | 17.00 | Special Order. Please Inquire | 42 Y | Female | Non-Hispanic | <-70C | 01-Oct-15 | Genotype | 3 | Special Order. Please Inquire | Unknown | |||||||||||||||||||||||||
| BBS0005-EM900056150011116DD | Longitudinal Hepatitis C (HCV) Drug Treatment Sample Set | Estonia | 0.5 mL Serum | 1.00 | 13.00 | Special Order. Please Inquire | 39 Y | Male | Non-Hispanic | <-70C | 11-Jan-16 | Genotype | 3 | Special Order. Please Inquire | Unknown | |||||||||||||||||||||||||
| BBS0005-EM900056150022916DD | Longitudinal Hepatitis C (HCV) Drug Treatment Sample Set | Estonia | 0.5 mL Serum | 1.00 | 12.00 | Special Order. Please Inquire | 39 Y | Male | Non-Hispanic | <-70C | 29-Feb-16 | Genotype | 3 | Special Order. Please Inquire | Unknown | |||||||||||||||||||||||||
| BBS0005-EM900056150113015DD | Longitudinal Hepatitis C (HCV) Drug Treatment Sample Set | Estonia | 0.5 mL Serum | 1.00 | 3.00 | Special Order. Please Inquire | 39 Y | Male | Non-Hispanic | <-70C | 30-Nov-15 | Genotype | 3 | Special Order. Please Inquire | Unknown | |||||||||||||||||||||||||
| BBS0005-EM900056151012216DD | Longitudinal Hepatitis C (HCV) Drug Treatment Sample Set | Estonia | 0.5 mL Serum | 1.00 | 11.00 | Special Order. Please Inquire | 41 Y | Male | Non-Hispanic | <-70C | 22-Jan-16 | Genotype | 3 | Special Order. Please Inquire | Unknown | |||||||||||||||||||||||||
| BBS0005-EM900056151031816DD | Longitudinal Hepatitis C (HCV) Drug Treatment Sample Set | Estonia | 0.5 mL Serum | 1.00 | 16.00 | Special Order. Please Inquire | 41 Y | Male | Non-Hispanic | <-70C | 18-Mar-16 | Genotype | 3 | Special Order. Please Inquire | Unknown | |||||||||||||||||||||||||
| BBS0005-EM900056151122115DD | Longitudinal Hepatitis C (HCV) Drug Treatment Sample Set | Estonia | 0.5 mL Serum | 1.00 | 11.00 | Special Order. Please Inquire | 41 Y | Male | Non-Hispanic | <-70C | 21-Dec-15 | Genotype | 3 | Special Order. Please Inquire | Unknown | |||||||||||||||||||||||||
| BBS0005-EM900056152012216DD | Longitudinal Hepatitis C (HCV) Drug Treatment Sample Set | Estonia | 0.5 mL Serum | 1.00 | 6.00 | Special Order. Please Inquire | 46 Y | Male | Non-Hispanic | <-70C | 22-Jan-16 | Genotype | 2 | 3 | Special Order. Please Inquire | Unknown | |||||||||||||||||||||||||
| BBS0005-EM900056152031816DD | Longitudinal Hepatitis C (HCV) Drug Treatment Sample Set | Estonia | 0.5 mL Serum | 1.00 | 7.00 | Special Order. Please Inquire | 47 Y | Male | Non-Hispanic | <-70C | 18-Mar-16 | Genotype | 2 | 3 | Special Order. Please Inquire | Unknown | |||||||||||||||||||||||||
| BBS0005-EM900056152122915DD | Longitudinal Hepatitis C (HCV) Drug Treatment Sample Set | Estonia | 0.5 mL Serum | 1.00 | 3.00 | Special Order. Please Inquire | 46 Y | Male | Non-Hispanic | <-70C | 29-Dec-15 | Genotype | 2 | 3 | Special Order. Please Inquire | Unknown | |||||||||||||||||||||||||
| BBS0005-EM900056775022216DD | Longitudinal Hepatitis C (HCV) Drug Treatment Sample Set | Estonia | 0.5 mL Serum | 1.00 | 4.00 | Special Order. Please Inquire | 49 Y | Male | Non-Hispanic | <-70C | 22-Feb-16 | Genotype | 3 | Special Order. Please Inquire | Unknown | |||||||||||||||||||||||||
| BBS0005-EM900056775032416DD | Longitudinal Hepatitis C (HCV) Drug Treatment Sample Set | Estonia | 0.5 mL Serum | 1.00 | 9.00 | Special Order. Please Inquire | 49 Y | Male | Non-Hispanic | <-70C | 24-Mar-16 | Genotype | 3 | Special Order. Please Inquire | Unknown | |||||||||||||||||||||||||
| BBS0005-EM900056775052616DD | Longitudinal Hepatitis C (HCV) Drug Treatment Sample Set | Estonia | 0.5 mL Serum | 1.00 | 8.00 | Special Order. Please Inquire | 49 Y | Male | Non-Hispanic | <-70C | 26-May-16 | Genotype | 3 | Special Order. Please Inquire | Unknown | |||||||||||||||||||||||||
| BBS0005-EM900056776020516DD | Longitudinal Hepatitis C (HCV) Drug Treatment Sample Set | Estonia | 0.5 mL Serum | 1.00 | 7.00 | Special Order. Please Inquire | 33 Y | Male | Non-Hispanic | <-70C | 05-Feb-16 | Genotype | 3 | Special Order. Please Inquire | Unknown | |||||||||||||||||||||||||
| BBS0005-EM900056776030816DD | Longitudinal Hepatitis C (HCV) Drug Treatment Sample Set | Estonia | 0.5 mL Serum | 1.00 | 5.00 | Special Order. Please Inquire | 33 Y | Male | Non-Hispanic | <-70C | 08-Mar-16 | Genotype | 3 | Special Order. Please Inquire | Unknown | |||||||||||||||||||||||||
| BBS0005-EM900056776042516DD | Longitudinal Hepatitis C (HCV) Drug Treatment Sample Set | Estonia | 0.5 mL Serum | 1.00 | 5.00 | Special Order. Please Inquire | 33 Y | Male | Non-Hispanic | <-70C | 25-Apr-16 | Genotype | 3 | Special Order. Please Inquire | Unknown | |||||||||||||||||||||||||
| BBS0005-EM900062347072815DD | Longitudinal Hepatitis C (HCV) Drug Treatment Sample Set | Estonia | 0.5 mL Serum | 1.00 | 3.00 | Special Order. Please Inquire | 45 Y | Male | Non-Hispanic | <-70C | 28-Jul-15 | Genotype | 3 | Special Order. Please Inquire | Unknown | |||||||||||||||||||||||||
| BBS0005-EM900062347090715DD | Longitudinal Hepatitis C (HCV) Drug Treatment Sample Set | Estonia | 0.5 mL Serum | 1.00 | 7.00 | Special Order. Please Inquire | 46 Y | Male | Non-Hispanic | <-70C | 07-Sep-15 | Genotype | 3 | Special Order. Please Inquire | Unknown | |||||||||||||||||||||||||
| BBS0005-EM900062347110215DD | Longitudinal Hepatitis C (HCV) Drug Treatment Sample Set | Estonia | 0.5 mL Serum | 1.00 | 8.00 | Special Order. Please Inquire | 46 Y | Male | Non-Hispanic | <-70C | 02-Nov-15 | Genotype | 3 | Special Order. Please Inquire | Unknown | |||||||||||||||||||||||||
| BBS0005-EM900062348082815DD | Longitudinal Hepatitis C (HCV) Drug Treatment Sample Set | Estonia | 0.5 mL Serum | 1.00 | 7.00 | Special Order. Please Inquire | 31 Y | Male | Non-Hispanic | <-70C | 28-Aug-15 | Genotype | 3 | Special Order. Please Inquire | Unknown | |||||||||||||||||||||||||
| BBS0005-EM900062348092515DD | Longitudinal Hepatitis C (HCV) Drug Treatment Sample Set | Estonia | 0.5 mL Serum | 1.00 | 13.00 | Special Order. Please Inquire | 31 Y | Male | Non-Hispanic | <-70C | 25-Sep-15 | Genotype | 3 | Special Order. Please Inquire | Unknown | |||||||||||||||||||||||||
| BBS0005-EM900062348112315DD | Longitudinal Hepatitis C (HCV) Drug Treatment Sample Set | Estonia | 0.5 mL Serum | 1.00 | 15.00 | Special Order. Please Inquire | 31 Y | Male | Non-Hispanic | <-70C | 23-Nov-15 | Genotype | 3 | Special Order. Please Inquire | Unknown | |||||||||||||||||||||||||
| BBS0005-EM900062428102213DD | Longitudinal Hepatitis C (HCV) Drug Treatment Sample Set | Estonia | 0.5 mL Serum | 1.00 | 4.00 | Special Order. Please Inquire | Male | Non-Hispanic | <-70C | 22-Oct-13 | Genotype | 3 | Special Order. Please Inquire | Unknown | ||||||||||||||||||||||||||
| BBS0005-EM900062428112613DD | Longitudinal Hepatitis C (HCV) Drug Treatment Sample Set | Estonia | 0.5 mL Serum | 1.00 | 7.00 | Special Order. Please Inquire | 37 Y | Male | Non-Hispanic | <-70C | 26-Nov-13 | Genotype | 3 | Special Order. Please Inquire | Unknown | |||||||||||||||||||||||||
| BBS0005-EM900062429110613DD | Longitudinal Hepatitis C (HCV) Drug Treatment Sample Set | Estonia | 0.5 mL Serum | 1.00 | 12.00 | Special Order. Please Inquire | 39 Y | Male | Non-Hispanic | <-70C | 06-Nov-13 | Genotype | 3 | Special Order. Please Inquire | Unknown | |||||||||||||||||||||||||
| BBS0005-EM900062429121913DD | Longitudinal Hepatitis C (HCV) Drug Treatment Sample Set | Estonia | 0.5 mL Serum | 1.00 | 8.00 | Special Order. Please Inquire | Male | Non-Hispanic | <-70C | 19-Dec-13 | Genotype | 3 | Special Order. Please Inquire | Unknown | ||||||||||||||||||||||||||
| BBS0005-EM900062430010314DD | Longitudinal Hepatitis C (HCV) Drug Treatment Sample Set | Estonia | 0.5 mL Serum | 1.00 | 13.00 | Special Order. Please Inquire | 31 Y | Female | Non-Hispanic | <-70C | 03-Jan-14 | Genotype | 2 | Special Order. Please Inquire | Unknown | |||||||||||||||||||||||||
| BBS0005-EM900062430100813DD | Longitudinal Hepatitis C (HCV) Drug Treatment Sample Set | Estonia | 0.5 mL Serum | 1.00 | 11.00 | Special Order. Please Inquire | Female | Non-Hispanic | <-70C | 08-Oct-13 | Genotype | 2 | Special Order. Please Inquire | Unknown | ||||||||||||||||||||||||||
| BBS0005-EM900062430110713DD | Longitudinal Hepatitis C (HCV) Drug Treatment Sample Set | Estonia | 0.5 mL Serum | 1.00 | 12.00 | Special Order. Please Inquire | 31 Y | Female | Non-Hispanic | <-70C | 07-Nov-13 | Genotype | 2 | Special Order. Please Inquire | Unknown | |||||||||||||||||||||||||
| BBS0005-EM900062431010214DD | Longitudinal Hepatitis C (HCV) Drug Treatment Sample Set | Estonia | 0.5 mL Serum | 1.00 | 10.00 | Special Order. Please Inquire | 29 Y | Male | Non-Hispanic | <-70C | 02-Jan-14 | Genotype | 3 | Special Order. Please Inquire | Unknown | |||||||||||||||||||||||||
| BBS0005-EM900062431101013DD | Longitudinal Hepatitis C (HCV) Drug Treatment Sample Set | Estonia | 0.5 mL Serum | 1.00 | 7.00 | Special Order. Please Inquire | Male | Non-Hispanic | <-70C | 10-Oct-13 | Genotype | 3 | Special Order. Please Inquire | Unknown | ||||||||||||||||||||||||||
| BBS0005-EM900062431110713DD | Longitudinal Hepatitis C (HCV) Drug Treatment Sample Set | Estonia | 0.5 mL Serum | 1.00 | 10.00 | Special Order. Please Inquire | 29 Y | Male | Non-Hispanic | <-70C | 07-Nov-13 | Genotype | 3 | Special Order. Please Inquire | Unknown | |||||||||||||||||||||||||
| BBS0005-EM900063307013015DD | Longitudinal Hepatitis C (HCV) Drug Treatment Sample Set | Estonia | 0.5 mL Serum | 1.00 | 8.00 | Special Order. Please Inquire | 56 Y | Female | Non-Hispanic | <-70C | 30-Jan-15 | Genotype | 3 | Special Order. Please Inquire | Unknown | |||||||||||||||||||||||||
| BBS0005-EM900063307022515DD | Longitudinal Hepatitis C (HCV) Drug Treatment Sample Set | Estonia | 0.5 mL Serum | 1.00 | 10.00 | Special Order. Please Inquire | 56 Y | Female | Non-Hispanic | <-70C | 25-Feb-15 | Genotype | 3 | Special Order. Please Inquire | Unknown | |||||||||||||||||||||||||
| BBS0005-EM900063307042115DD | Longitudinal Hepatitis C (HCV) Drug Treatment Sample Set | Estonia | 0.5 mL Serum | 1.00 | 7.00 | Special Order. Please Inquire | 56 Y | Female | Non-Hispanic | <-70C | 21-Apr-15 | Genotype | 3 | Special Order. Please Inquire | Unknown | |||||||||||||||||||||||||
| BBS0005-EM900063308050615DD | Longitudinal Hepatitis C (HCV) Drug Treatment Sample Set | Estonia | 0.5 mL Serum | 1.00 | 11.00 | Special Order. Please Inquire | 47 Y | Male | Non-Hispanic | <-70C | 06-May-15 | Genotype | 3 | Special Order. Please Inquire | Unknown | |||||||||||||||||||||||||
| BBS0005-EM900063309010615DD | Longitudinal Hepatitis C (HCV) Drug Treatment Sample Set | Estonia | 0.5 mL Serum | 1.00 | 11.00 | Special Order. Please Inquire | 46 Y | Male | Non-Hispanic | <-70C | 06-Jan-15 | Genotype | 3 | Special Order. Please Inquire | Unknown | |||||||||||||||||||||||||
| BBS0005-EM900063309020515DD | Longitudinal Hepatitis C (HCV) Drug Treatment Sample Set | Estonia | 0.5 mL Serum | 1.00 | 16.00 | Special Order. Please Inquire | 46 Y | Male | Non-Hispanic | <-70C | 05-Feb-15 | Genotype | 3 | Special Order. Please Inquire | Unknown | |||||||||||||||||||||||||
| BBS0005-EM900063309040215DD | Longitudinal Hepatitis C (HCV) Drug Treatment Sample Set | Estonia | 0.5 mL Serum | 1.00 | 14.00 | Special Order. Please Inquire | 46 Y | Male | Non-Hispanic | <-70C | 02-Apr-15 | Genotype | 3 | Special Order. Please Inquire | Unknown | |||||||||||||||||||||||||
| BBS0005-EM900063315010815DD | Longitudinal Hepatitis C (HCV) Drug Treatment Sample Set | Estonia | 0.5 mL Serum | 1.00 | 7.00 | Special Order. Please Inquire | 54 Y | Female | Non-Hispanic | <-70C | 08-Jan-15 | Genotype | 2 | Special Order. Please Inquire | Unknown | |||||||||||||||||||||||||
| BBS0005-EM900063315021615DD | Longitudinal Hepatitis C (HCV) Drug Treatment Sample Set | Estonia | 0.5 mL Serum | 1.00 | 13.00 | Special Order. Please Inquire | 54 Y | Female | Non-Hispanic | <-70C | 16-Feb-15 | Genotype | 2 | Special Order. Please Inquire | Unknown | |||||||||||||||||||||||||
| BBS0005-EM900063315041615DD | Longitudinal Hepatitis C (HCV) Drug Treatment Sample Set | Estonia | 0.5 mL Serum | 1.00 | 13.00 | Special Order. Please Inquire | 54 Y | Female | Non-Hispanic | <-70C | 16-Apr-15 | Genotype | 2 | Special Order. Please Inquire | Unknown | |||||||||||||||||||||||||
| BBS0005-EM900063316050415DD | Longitudinal Hepatitis C (HCV) Drug Treatment Sample Set | Estonia | 0.5 mL Serum | 1.00 | 8.00 | Special Order. Please Inquire | 36 Y | Male | Non-Hispanic | <-70C | 04-May-15 | Genotype | 3 | Special Order. Please Inquire | Unknown | |||||||||||||||||||||||||
| BBS0005-EM900063316060915DD | Longitudinal Hepatitis C (HCV) Drug Treatment Sample Set | Estonia | 0.5 mL Serum | 1.00 | 3.00 | Special Order. Please Inquire | 36 Y | Male | Non-Hispanic | <-70C | 09-Jun-15 | Genotype | 3 | Special Order. Please Inquire | Unknown | |||||||||||||||||||||||||
| BBS0005-EM900063316072815DD | Longitudinal Hepatitis C (HCV) Drug Treatment Sample Set | Estonia | 0.5 mL Serum | 1.00 | 2.00 | Special Order. Please Inquire | 36 Y | Male | Non-Hispanic | <-70C | 28-Jul-15 | Genotype | 3 | Special Order. Please Inquire | Unknown | |||||||||||||||||||||||||
| BBS0005-EM900063317022015DD | Longitudinal Hepatitis C (HCV) Drug Treatment Sample Set | Estonia | 0.5 mL Serum | 1.00 | 8.00 | Special Order. Please Inquire | 48 Y | Female | Non-Hispanic | <-70C | 20-Feb-15 | Genotype | 3 | Special Order. Please Inquire | Unknown | |||||||||||||||||||||||||
| BBS0005-EM900063317112814DD | Longitudinal Hepatitis C (HCV) Drug Treatment Sample Set | Estonia | 0.5 mL Serum | 1.00 | 8.00 | Special Order. Please Inquire | 48 Y | Female | Non-Hispanic | <-70C | 28-Nov-14 | Genotype | 3 | Special Order. Please Inquire | Unknown | |||||||||||||||||||||||||
| BBS0005-EM900063317122314DD | Longitudinal Hepatitis C (HCV) Drug Treatment Sample Set | Estonia | 0.5 mL Serum | 1.00 | 11.00 | Special Order. Please Inquire | 48 Y | Female | Non-Hispanic | <-70C | 23-Dec-14 | Genotype | 3 | Special Order. Please Inquire | Unknown | |||||||||||||||||||||||||
| BBS0005-EM900063318020515DD | Longitudinal Hepatitis C (HCV) Drug Treatment Sample Set | Estonia | 0.5 mL Serum | 1.00 | 13.00 | Special Order. Please Inquire | 37 Y | Male | Non-Hispanic | <-70C | 05-Feb-15 | Genotype | 3 | Special Order. Please Inquire | Unknown | |||||||||||||||||||||||||
| BBS0005-EM900063318111414DD | Longitudinal Hepatitis C (HCV) Drug Treatment Sample Set | Estonia | 0.5 mL Serum | 1.00 | 7.00 | Special Order. Please Inquire | 36 Y | Male | Non-Hispanic | <-70C | 14-Nov-14 | Genotype | 3 | Special Order. Please Inquire | Unknown | |||||||||||||||||||||||||
| BBS0005-EM900063318121114DD | Longitudinal Hepatitis C (HCV) Drug Treatment Sample Set | Estonia | 0.5 mL Serum | 1.00 | 13.00 | Special Order. Please Inquire | 37 Y | Male | Non-Hispanic | <-70C | 11-Dec-14 | Genotype | 3 | Special Order. Please Inquire | Unknown | |||||||||||||||||||||||||
| BBS0005-EM900068554013015DD | Longitudinal Hepatitis C (HCV) Drug Treatment Sample Set | Estonia | 0.5 mL Serum | 1.00 | 9.00 | Special Order. Please Inquire | 42 Y | Male | Non-Hispanic | <-70C | 30-Jan-15 | Genotype | 3 | Special Order. Please Inquire | Unknown | |||||||||||||||||||||||||
| BBS0005-EM900068554110714DD | Longitudinal Hepatitis C (HCV) Drug Treatment Sample Set | Estonia | 0.5 mL Serum | 1.00 | 9.00 | Special Order. Please Inquire | 42 Y | Male | Non-Hispanic | <-70C | 07-Nov-14 | Genotype | 3 | Special Order. Please Inquire | Unknown | |||||||||||||||||||||||||
| BBS0005-EM900068554120514DD | Longitudinal Hepatitis C (HCV) Drug Treatment Sample Set | Estonia | 0.5 mL Serum | 1.00 | 10.00 | Special Order. Please Inquire | 42 Y | Male | Non-Hispanic | <-70C | 05-Dec-14 | Genotype | 3 | Special Order. Please Inquire | Unknown | |||||||||||||||||||||||||
| BBS0005-EM900068555020915DD | Longitudinal Hepatitis C (HCV) Drug Treatment Sample Set | Estonia | 0.5 mL Serum | 1.00 | 12.00 | Special Order. Please Inquire | 55 Y | Male | Non-Hispanic | <-70C | 09-Feb-15 | Genotype | 3 | Special Order. Please Inquire | Unknown | |||||||||||||||||||||||||
| BBS0005-EM900068555111414DD | Longitudinal Hepatitis C (HCV) Drug Treatment Sample Set | Estonia | 0.5 mL Serum | 1.00 | 10.00 | Special Order. Please Inquire | 55 Y | Male | Non-Hispanic | <-70C | 14-Nov-14 | Genotype | 3 | Special Order. Please Inquire | Unknown | |||||||||||||||||||||||||
| BBS0005-EM900068555121114DD | Longitudinal Hepatitis C (HCV) Drug Treatment Sample Set | Estonia | 0.5 mL Serum | 1.00 | 13.00 | Special Order. Please Inquire | 55 Y | Male | Non-Hispanic | <-70C | 11-Dec-14 | Genotype | 3 | Special Order. Please Inquire | Unknown | |||||||||||||||||||||||||
| BBS0005-FC900056200011117DD | Longitudinal Hepatitis C (HCV) Drug Treatment Sample Set | United States | 0.5 mL Serum | 1.00 | 19.00 | Special Order. Please Inquire | 63 Y | Male | Non-Hispanic | <-70C | 11-Jan-17 | Genotype | 1a | Special Order. Please Inquire | Unknown | |||||||||||||||||||||||||
| BBS0005-FC900056200032817DD | Longitudinal Hepatitis C (HCV) Drug Treatment Sample Set | United States | 0.5 mL Serum | 1.00 | 16.00 | Special Order. Please Inquire | 63 Y | Male | Non-Hispanic | <-70C | 28-Mar-17 | Genotype | 1a | Special Order. Please Inquire | Unknown | |||||||||||||||||||||||||
| BBS0005-FC900056200090816DD | Longitudinal Hepatitis C (HCV) Drug Treatment Sample Set | United States | 0.5 mL Serum | 1.00 | 14.00 | Special Order. Please Inquire | 63 Y | Male | Non-Hispanic | <-70C | 08-Sep-16 | Genotype | 1a | Special Order. Please Inquire | Unknown | |||||||||||||||||||||||||
| BBS0005-FC900056200100616DD | Longitudinal Hepatitis C (HCV) Drug Treatment Sample Set | United States | 0.5 mL Serum | 1.00 | 16.00 | Special Order. Please Inquire | 63 Y | Male | Non-Hispanic | <-70C | 06-Oct-16 | Genotype | 1a | Special Order. Please Inquire | Unknown | |||||||||||||||||||||||||
| BBS0005-FC900056200121616DD | Longitudinal Hepatitis C (HCV) Drug Treatment Sample Set | United States | 0.5 mL Serum | 1.00 | 16.00 | Special Order. Please Inquire | 63 Y | Male | Non-Hispanic | <-70C | 16-Dec-16 | Genotype | 1a | Special Order. Please Inquire | Unknown | |||||||||||||||||||||||||
| BBS0005-FC900056201012017DD | Longitudinal Hepatitis C (HCV) Drug Treatment Sample Set | United States | 0.5 mL Serum | 1.00 | 10.00 | Special Order. Please Inquire | 51 Y | Female | Non-Hispanic | <-70C | 20-Jan-17 | Genotype | 1a | Special Order. Please Inquire | Unknown | |||||||||||||||||||||||||
| BBS0005-FC900056201041717DD | Longitudinal Hepatitis C (HCV) Drug Treatment Sample Set | United States | 0.5 mL Serum | 1.00 | 11.00 | Special Order. Please Inquire | 52 Y | Female | Non-Hispanic | <-70C | 17-Apr-17 | Genotype | 1a | Special Order. Please Inquire | Unknown | |||||||||||||||||||||||||
| BBS0005-FC900056201091916DD | Longitudinal Hepatitis C (HCV) Drug Treatment Sample Set | United States | 0.5 mL Serum | 1.00 | 4.00 | Special Order. Please Inquire | 51 Y | Female | Non-Hispanic | <-70C | 19-Sep-16 | Genotype | 1a | Special Order. Please Inquire | Unknown | |||||||||||||||||||||||||
| BBS0005-FC900056201101714DD | Longitudinal Hepatitis C (HCV) Drug Treatment Sample Set | United States | 0.5 mL Serum | 1.00 | 12.00 | Special Order. Please Inquire | 49 Y | Female | Non-Hispanic | <-70C | 17-Oct-14 | Genotype | 1a | Special Order. Please Inquire | Unknown | |||||||||||||||||||||||||
| BBS0005-FC900056201121516DD | Longitudinal Hepatitis C (HCV) Drug Treatment Sample Set | United States | 0.5 mL Serum | 1.00 | 7.00 | Special Order. Please Inquire | 51 Y | Female | Non-Hispanic | <-70C | 15-Dec-16 | Genotype | 1a | Special Order. Please Inquire | Unknown | |||||||||||||||||||||||||
| BBS0005-FC900056202100516DD | Longitudinal Hepatitis C (HCV) Drug Treatment Sample Set | United States | 0.5 mL Serum | 1.00 | 15.00 | Special Order. Please Inquire | 63 Y | Male | Non-Hispanic | <-70C | 05-Oct-16 | Genotype | 1b | Special Order. Please Inquire | Unknown | |||||||||||||||||||||||||
| BBS0005-FC900056202112316DD | Longitudinal Hepatitis C (HCV) Drug Treatment Sample Set | United States | 0.5 mL Serum | 1.00 | 15.00 | Special Order. Please Inquire | 63 Y | Male | Non-Hispanic | <-70C | 23-Nov-16 | Genotype | 1b | Special Order. Please Inquire | Unknown | |||||||||||||||||||||||||
| BBS0005-FD900028250033115DD | Longitudinal Hepatitis C (HCV) Drug Treatment Sample Set | Canada | 0.5 mL Serum | 1.00 | 7.00 | Special Order. Please Inquire | 63 Y | Female | Non-Hispanic | <-70C | 31-Mar-15 | Genotype | 3a | Special Order. Please Inquire | Unknown | |||||||||||||||||||||||||
| BBS0005-FD900028250091515DD | Longitudinal Hepatitis C (HCV) Drug Treatment Sample Set | Canada | 0.5 mL Serum | 1.00 | 8.00 | Special Order. Please Inquire | 63 Y | Female | Non-Hispanic | <-70C | 15-Sep-15 | Genotype | 3a | Special Order. Please Inquire | Unknown | |||||||||||||||||||||||||
| BBS0005-FD900028250101414DD | Longitudinal Hepatitis C (HCV) Drug Treatment Sample Set | Canada | 0.5 mL Serum | 1.00 | 5.00 | Special Order. Please Inquire | 63 Y | Female | Non-Hispanic | <-70C | 14-Oct-14 | Genotype | 3a | Special Order. Please Inquire | Unknown | |||||||||||||||||||||||||
| BBS0005-FD900028250111214DD | Longitudinal Hepatitis C (HCV) Drug Treatment Sample Set | Canada | 0.5 mL Serum | 1.00 | 9.00 | Special Order. Please Inquire | 63 Y | Female | Non-Hispanic | <-70C | 12-Nov-14 | Genotype | 3a | Special Order. Please Inquire | Unknown | |||||||||||||||||||||||||
| BBS0005-FD900028251011415DD | Longitudinal Hepatitis C (HCV) Drug Treatment Sample Set | Canada | 0.5 mL Serum | 1.00 | 9.00 | Special Order. Please Inquire | 69 Y | Female | Non-Hispanic | <-70C | 14-Jan-15 | Genotype | 1 | Special Order. Please Inquire | Unknown | |||||||||||||||||||||||||
| BBS0005-FD900028251063015DD | Longitudinal Hepatitis C (HCV) Drug Treatment Sample Set | Canada | 0.5 mL Serum | 1.00 | 6.00 | Special Order. Please Inquire | 69 Y | Female | Non-Hispanic | <-70C | 30-Jun-15 | Genotype | 1 | Special Order. Please Inquire | Unknown | |||||||||||||||||||||||||
| BBS0005-FD900028251102114DD | Longitudinal Hepatitis C (HCV) Drug Treatment Sample Set | Canada | 0.5 mL Serum | 1.00 | 13.00 | Special Order. Please Inquire | 68 Y | Female | Non-Hispanic | <-70C | 21-Oct-14 | Genotype | 1 | Special Order. Please Inquire | Unknown | |||||||||||||||||||||||||
| BBS0005-FD900033492021715DD | Longitudinal Hepatitis C (HCV) Drug Treatment Sample Set | Canada | 0.5 mL Serum | 1.00 | 12.00 | Special Order. Please Inquire | 60 Y | Male | Non-Hispanic | <-70C | 17-Feb-15 | Genotype | 1b | Special Order. Please Inquire | Unknown | |||||||||||||||||||||||||
| BBS0005-FD900033492080415DD | Longitudinal Hepatitis C (HCV) Drug Treatment Sample Set | Canada | 0.5 mL Serum | 1.00 | 10.00 | Special Order. Please Inquire | 61 Y | Male | Non-Hispanic | <-70C | 04-Aug-15 | Genotype | 1b | Special Order. Please Inquire | Unknown | |||||||||||||||||||||||||
| BBS0005-FD900033492112514DD | Longitudinal Hepatitis C (HCV) Drug Treatment Sample Set | Canada | 0.5 mL Serum | 1.00 | 12.00 | Special Order. Please Inquire | 60 Y | Male | Non-Hispanic | <-70C | 25-Nov-14 | Genotype | 1b | Special Order. Please Inquire | Unknown | |||||||||||||||||||||||||
| BBS0005-FD900033492122314DD | Longitudinal Hepatitis C (HCV) Drug Treatment Sample Set | Canada | 0.5 mL Serum | 1.00 | 13.00 | Special Order. Please Inquire | 60 Y | Male | Non-Hispanic | <-70C | 23-Dec-14 | Genotype | 1b | Special Order. Please Inquire | Unknown | |||||||||||||||||||||||||
| BBS0005-FD900033493012315DD | Longitudinal Hepatitis C (HCV) Drug Treatment Sample Set | Canada | 0.5 mL Serum | 1.00 | 7.00 | Special Order. Please Inquire | 51 Y | Male | Non-Hispanic | <-70C | 23-Jan-15 | Genotype | 1a | Special Order. Please Inquire | Unknown | |||||||||||||||||||||||||
| BBS0005-FD900033493051915DD | Longitudinal Hepatitis C (HCV) Drug Treatment Sample Set | Canada | 0.5 mL Serum | 1.00 | 8.00 | Special Order. Please Inquire | 51 Y | Male | Non-Hispanic | <-70C | 19-May-15 | Genotype | 1a | Special Order. Please Inquire | Unknown | |||||||||||||||||||||||||
| BBS0005-FD900033493110915DD | Longitudinal Hepatitis C (HCV) Drug Treatment Sample Set | Canada | 0.5 mL Serum | 1.00 | 8.00 | Special Order. Please Inquire | 52 Y | Male | Non-Hispanic | <-70C | 09-Nov-15 | Genotype | 1a | Special Order. Please Inquire | Unknown | |||||||||||||||||||||||||
| BBS0005-FD900033493112814DD | Longitudinal Hepatitis C (HCV) Drug Treatment Sample Set | Canada | 0.5 mL Serum | 1.00 | 11.00 | Special Order. Please Inquire | 51 Y | Male | Non-Hispanic | <-70C | 28-Nov-14 | Genotype | 1a | Special Order. Please Inquire | Unknown | |||||||||||||||||||||||||
| BBS0005-FD900033494010215DD | Longitudinal Hepatitis C (HCV) Drug Treatment Sample Set | Canada | 0.5 mL Serum | 1.00 | 12.00 | Special Order. Please Inquire | 62 Y | Female | Non-Hispanic | <-70C | 02-Jan-15 | Genotype | 1 | Special Order. Please Inquire | Unknown | |||||||||||||||||||||||||
| BBS0005-FD900033494020315DD | Longitudinal Hepatitis C (HCV) Drug Treatment Sample Set | Canada | 0.5 mL Serum | 1.00 | 9.00 | Special Order. Please Inquire | 63 Y | Female | Non-Hispanic | <-70C | 03-Feb-15 | Genotype | 1 | Special Order. Please Inquire | Unknown | |||||||||||||||||||||||||
| BBS0005-FD900033494071615DD | Longitudinal Hepatitis C (HCV) Drug Treatment Sample Set | Canada | 0.5 mL Serum | 1.00 | 9.00 | Special Order. Please Inquire | 63 Y | Female | Non-Hispanic | <-70C | 16-Jul-15 | Genotype | 1 | Special Order. Please Inquire | Unknown | |||||||||||||||||||||||||
| BBS0005-FD900033494120414DD | Longitudinal Hepatitis C (HCV) Drug Treatment Sample Set | Canada | 0.5 mL Serum | 1.00 | 13.00 | Special Order. Please Inquire | 62 Y | Female | Non-Hispanic | <-70C | 04-Dec-14 | Genotype | 1 | Special Order. Please Inquire | Unknown | |||||||||||||||||||||||||
| BBS0005-FD900033495012315DD | Longitudinal Hepatitis C (HCV) Drug Treatment Sample Set | Canada | 0.5 mL Serum | 1.00 | 15.00 | Special Order. Please Inquire | 53 Y | Male | Non-Hispanic | <-70C | 23-Jan-15 | Genotype | 2 | Special Order. Please Inquire | Unknown | |||||||||||||||||||||||||
| BBS0005-FD900033495031715DD | Longitudinal Hepatitis C (HCV) Drug Treatment Sample Set | Canada | 0.5 mL Serum | 1.00 | 8.00 | Special Order. Please Inquire | 53 Y | Male | Non-Hispanic | <-70C | 17-Mar-15 | Genotype | 2 | Special Order. Please Inquire | Unknown | |||||||||||||||||||||||||
| BBS0005-FD900033495122314DD | Longitudinal Hepatitis C (HCV) Drug Treatment Sample Set | Canada | 0.5 mL Serum | 1.00 | 12.00 | Special Order. Please Inquire | 53 Y | Male | Non-Hispanic | <-70C | 23-Dec-14 | Genotype | 2 | Special Order. Please Inquire | Unknown | |||||||||||||||||||||||||
| BBS0005-FD900033496011915DD | Longitudinal Hepatitis C (HCV) Drug Treatment Sample Set | Canada | 0.5 mL Serum | 1.00 | 11.00 | Special Order. Please Inquire | 52 Y | Male | Non-Hispanic | <-70C | 19-Jan-15 | Genotype | 1a | Special Order. Please Inquire | Unknown | |||||||||||||||||||||||||
| BBS0005-FD900033496021715DD | Longitudinal Hepatitis C (HCV) Drug Treatment Sample Set | Canada | 0.5 mL Serum | 1.00 | 8.00 | Special Order. Please Inquire | 52 Y | Male | Non-Hispanic | <-70C | 17-Feb-15 | Genotype | 1a | Special Order. Please Inquire | Unknown | |||||||||||||||||||||||||
| BBS0005-FD900033496041415DD | Longitudinal Hepatitis C (HCV) Drug Treatment Sample Set | Canada | 0.5 mL Serum | 1.00 | 9.00 | Special Order. Please Inquire | 52 Y | Male | Non-Hispanic | <-70C | 14-Apr-15 | Genotype | 1a | Special Order. Please Inquire | Unknown | |||||||||||||||||||||||||
| BBS0005-FD900033496092815DD | Longitudinal Hepatitis C (HCV) Drug Treatment Sample Set | Canada | 0.5 mL Serum | 1.00 | 8.00 | Special Order. Please Inquire | 53 Y | Male | Non-Hispanic | <-70C | 28-Sep-15 | Genotype | 1a | Special Order. Please Inquire | Unknown | |||||||||||||||||||||||||
| BBS0005-FD900034511060617DD | Longitudinal Hepatitis C (HCV) Drug Treatment Sample Set | Canada | 0.5 mL Serum | 1.00 | 12.00 | Special Order. Please Inquire | 55 Y | Male | Non-Hispanic | <-70C | 06-Jun-17 | Genotype | 3a | Special Order. Please Inquire | Unknown | |||||||||||||||||||||||||
| BBS0005-FD900034511070417DD | Longitudinal Hepatitis C (HCV) Drug Treatment Sample Set | Canada | 0.5 mL Serum | 1.00 | 9.00 | Special Order. Please Inquire | 55 Y | Male | Non-Hispanic | <-70C | 04-Jul-17 | Genotype | 3a | Special Order. Please Inquire | Unknown | |||||||||||||||||||||||||
| BBS0005-FD900034511110119DD | Longitudinal Hepatitis C (HCV) Drug Treatment Sample Set | Canada | 0.5 mL Serum | 1.00 | 10.00 | Special Order. Please Inquire | Male | Non-Hispanic | <-70C | 01-Nov-19 | Genotype | 3a | Special Order. Please Inquire | Unknown | ||||||||||||||||||||||||||
| BBS0005-FD900034512060817DD | Longitudinal Hepatitis C (HCV) Drug Treatment Sample Set | Canada | 0.5 mL Serum | 1.00 | 14.00 | Special Order. Please Inquire | 51 Y | Male | Non-Hispanic | <-70C | 08-Jun-17 | Genotype | 3a | Special Order. Please Inquire | Unknown | |||||||||||||||||||||||||
| BBS0005-FD900034512070617DD | Longitudinal Hepatitis C (HCV) Drug Treatment Sample Set | Canada | 0.5 mL Serum | 1.00 | 11.00 | Special Order. Please Inquire | 51 Y | Male | Non-Hispanic | <-70C | 06-Jul-17 | Genotype | 3a | Special Order. Please Inquire | Unknown | |||||||||||||||||||||||||
| BBS0005-FD900034512110119DD | Longitudinal Hepatitis C (HCV) Drug Treatment Sample Set | Canada | 0.5 mL Serum | 1.00 | 14.00 | Special Order. Please Inquire | Male | Non-Hispanic | <-70C | 01-Nov-19 | Genotype | 3a | Special Order. Please Inquire | Unknown | ||||||||||||||||||||||||||
| BBS0005-FD900034513030618DD | Longitudinal Hepatitis C (HCV) Drug Treatment Sample Set | Canada | 0.5 mL Serum | 1.00 | 14.00 | Special Order. Please Inquire | Male | Non-Hispanic | <-70C | 06-Mar-18 | Genotype | 3a | Special Order. Please Inquire | Unknown | ||||||||||||||||||||||||||
| BBS0005-FD900034513061317DD | Longitudinal Hepatitis C (HCV) Drug Treatment Sample Set | Canada | 0.5 mL Serum | 1.00 | 13.00 | Special Order. Please Inquire | 55 Y | Male | Non-Hispanic | <-70C | 13-Jun-17 | Genotype | 3a | Special Order. Please Inquire | Unknown | |||||||||||||||||||||||||
| BBS0005-FD900034513071117DD | Longitudinal Hepatitis C (HCV) Drug Treatment Sample Set | Canada | 0.5 mL Serum | 1.00 | 9.00 | Special Order. Please Inquire | 56 Y | Male | Non-Hispanic | <-70C | 11-Jul-17 | Genotype | 3a | Special Order. Please Inquire | Unknown | |||||||||||||||||||||||||
| BBS0005-FD900034513110119DD | Longitudinal Hepatitis C (HCV) Drug Treatment Sample Set | Canada | 0.5 mL Serum | 1.00 | 15.00 | Special Order. Please Inquire | Male | Non-Hispanic | <-70C | 01-Nov-19 | Genotype | 3a | Special Order. Please Inquire | Unknown | ||||||||||||||||||||||||||
| BBS0005-FD900038019012315DD | Longitudinal Hepatitis C (HCV) Drug Treatment Sample Set | Canada | 0.5 mL Serum | 1.00 | 6.00 | Special Order. Please Inquire | 65 Y | Male | Non-Hispanic | <-70C | 23-Jan-15 | Genotype | 1b | Special Order. Please Inquire | Unknown | |||||||||||||||||||||||||
| BBS0005-FD900038019022015DD | Longitudinal Hepatitis C (HCV) Drug Treatment Sample Set | Canada | 0.5 mL Serum | 1.00 | 6.00 | Special Order. Please Inquire | 65 Y | Male | Non-Hispanic | <-70C | 20-Feb-15 | Genotype | 1b | Special Order. Please Inquire | Unknown | |||||||||||||||||||||||||
| BBS0005-FD900038019032015DD | Longitudinal Hepatitis C (HCV) Drug Treatment Sample Set | Canada | 0.5 mL Serum | 1.00 | 6.00 | Special Order. Please Inquire | 65 Y | Male | Non-Hispanic | <-70C | 20-Mar-15 | Genotype | 1b | Special Order. Please Inquire | Unknown | |||||||||||||||||||||||||
| BBS0005-FD900038019083115DD | Longitudinal Hepatitis C (HCV) Drug Treatment Sample Set | Canada | 0.5 mL Serum | 1.00 | 5.00 | Special Order. Please Inquire | 65 Y | Male | Non-Hispanic | <-70C | 31-Aug-15 | Genotype | 1b | Special Order. Please Inquire | Unknown | |||||||||||||||||||||||||
| BBS0005-FD900038020012315DD | Longitudinal Hepatitis C (HCV) Drug Treatment Sample Set | Canada | 0.5 mL Serum | 1.00 | 5.00 | Special Order. Please Inquire | 60 Y | Male | Non-Hispanic | <-70C | 23-Jan-15 | Genotype | 1b | Special Order. Please Inquire | Unknown | |||||||||||||||||||||||||
| BBS0005-FD900038020022015DD | Longitudinal Hepatitis C (HCV) Drug Treatment Sample Set | Canada | 0.5 mL Serum | 1.00 | 8.00 | Special Order. Please Inquire | 60 Y | Male | Non-Hispanic | <-70C | 20-Feb-15 | Genotype | 1b | Special Order. Please Inquire | Unknown | |||||||||||||||||||||||||
| BBS0005-FD900038020041715DD | Longitudinal Hepatitis C (HCV) Drug Treatment Sample Set | Canada | 0.5 mL Serum | 1.00 | 8.00 | Special Order. Please Inquire | 60 Y | Male | Non-Hispanic | <-70C | 17-Apr-15 | Genotype | 1b | Special Order. Please Inquire | Unknown | |||||||||||||||||||||||||
| BBS0005-FD900038020100215DD | Longitudinal Hepatitis C (HCV) Drug Treatment Sample Set | Canada | 0.5 mL Serum | 1.00 | 3.00 | Special Order. Please Inquire | 61 Y | Male | Non-Hispanic | <-70C | 02-Oct-15 | Genotype | 1b | Special Order. Please Inquire | Unknown | |||||||||||||||||||||||||
| BBS0005-FD900038021012815DD | Longitudinal Hepatitis C (HCV) Drug Treatment Sample Set | Canada | 0.5 mL Serum | 1.00 | 4.00 | Special Order. Please Inquire | 69 Y | Male | Unknown | <-70C | 28-Jan-15 | Genotype | 1 | Special Order. Please Inquire | Unknown | |||||||||||||||||||||||||
| BBS0005-FD900038021022415DD | Longitudinal Hepatitis C (HCV) Drug Treatment Sample Set | Canada | 0.5 mL Serum | 1.00 | 7.00 | Special Order. Please Inquire | 69 Y | Male | Unknown | <-70C | 24-Feb-15 | Genotype | 1 | Special Order. Please Inquire | Unknown | |||||||||||||||||||||||||
| BBS0005-FD900038021042315DD | Longitudinal Hepatitis C (HCV) Drug Treatment Sample Set | Canada | 0.5 mL Serum | 1.00 | 4.00 | Special Order. Please Inquire | 70 Y | Male | Unknown | <-70C | 23-Apr-15 | Genotype | 1 | Special Order. Please Inquire | Unknown | |||||||||||||||||||||||||
| BBS0005-FD900038021100715DD | Longitudinal Hepatitis C (HCV) Drug Treatment Sample Set | Canada | 0.5 mL Serum | 1.00 | 3.00 | Special Order. Please Inquire | 70 Y | Male | Unknown | <-70C | 07-Oct-15 | Genotype | 1 | Special Order. Please Inquire | Unknown | |||||||||||||||||||||||||
| BBS0005-FD900038022021015DD | Longitudinal Hepatitis C (HCV) Drug Treatment Sample Set | Canada | 0.5 mL Serum | 1.00 | 9.00 | Special Order. Please Inquire | 29 Y | Female | Non-Hispanic | <-70C | 10-Feb-15 | Genotype | 1a | Special Order. Please Inquire | Unknown | |||||||||||||||||||||||||
| BBS0005-FD900038022031015DD | Longitudinal Hepatitis C (HCV) Drug Treatment Sample Set | Canada | 0.5 mL Serum | 1.00 | 6.00 | Special Order. Please Inquire | 29 Y | Female | Non-Hispanic | <-70C | 10-Mar-15 | Genotype | 1a | Special Order. Please Inquire | Unknown | |||||||||||||||||||||||||
| BBS0005-FD900038022040715DD | Longitudinal Hepatitis C (HCV) Drug Treatment Sample Set | Canada | 0.5 mL Serum | 1.00 | 6.00 | Special Order. Please Inquire | 29 Y | Female | Non-Hispanic | <-70C | 07-Apr-15 | Genotype | 1a | Special Order. Please Inquire | Unknown | |||||||||||||||||||||||||
| BBS0005-FD900038022092215DD | Longitudinal Hepatitis C (HCV) Drug Treatment Sample Set | Canada | 0.5 mL Serum | 1.00 | 3.00 | Special Order. Please Inquire | 29 Y | Female | Non-Hispanic | <-70C | 22-Sep-15 | Genotype | 1a | Special Order. Please Inquire | Unknown | |||||||||||||||||||||||||
| BBS0005-FD900038368012914DD | Longitudinal Hepatitis C (HCV) Drug Treatment Sample Set | Canada | 0.5 mL Serum | 1.00 | 7.00 | Special Order. Please Inquire | Male | Non-Hispanic | <-70C | 29-Jan-14 | Genotype | 1 | Special Order. Please Inquire | Unknown | ||||||||||||||||||||||||||
| BBS0005-FD900038368081613DD | Longitudinal Hepatitis C (HCV) Drug Treatment Sample Set | Canada | 0.5 mL Serum | 1.00 | 7.00 | Special Order. Please Inquire | Male | Non-Hispanic | <-70C | 16-Aug-13 | Genotype | 1 | Special Order. Please Inquire | Unknown | ||||||||||||||||||||||||||
| BBS0005-FD900038368091213DD | Longitudinal Hepatitis C (HCV) Drug Treatment Sample Set | Canada | 0.5 mL Serum | 1.00 | 7.00 | Special Order. Please Inquire | Male | Non-Hispanic | <-70C | 12-Sep-13 | Genotype | 1 | Special Order. Please Inquire | Unknown | ||||||||||||||||||||||||||
| BBS0005-FD900038368100913DD | Longitudinal Hepatitis C (HCV) Drug Treatment Sample Set | Canada | 0.5 mL Serum | 1.00 | 7.00 | Special Order. Please Inquire | Male | Non-Hispanic | <-70C | 09-Oct-13 | Genotype | 1 | Special Order. Please Inquire | Unknown | ||||||||||||||||||||||||||
| BBS0005-FD900038368110613DD | Longitudinal Hepatitis C (HCV) Drug Treatment Sample Set | Canada | 0.5 mL Serum | 1.00 | 7.00 | Special Order. Please Inquire | Male | Non-Hispanic | <-70C | 06-Nov-13 | Genotype | 1 | Special Order. Please Inquire | Unknown | ||||||||||||||||||||||||||
| BBS0005-FD900038369012914DD | Longitudinal Hepatitis C (HCV) Drug Treatment Sample Set | Canada | 0.5 mL Serum | 1.00 | 9.00 | Special Order. Please Inquire | 57 Y | Female | Non-Hispanic | <-70C | 29-Jan-14 | Genotype | 1 | Special Order. Please Inquire | Unknown | |||||||||||||||||||||||||
| BBS0005-FD900038369081613DD | Longitudinal Hepatitis C (HCV) Drug Treatment Sample Set | Canada | 0.5 mL Serum | 1.00 | 7.00 | Special Order. Please Inquire | 56 Y | Female | Non-Hispanic | <-70C | 16-Aug-13 | Genotype | 1 | Special Order. Please Inquire | Unknown | |||||||||||||||||||||||||
| BBS0005-FD900038369091013DD | Longitudinal Hepatitis C (HCV) Drug Treatment Sample Set | Canada | 0.5 mL Serum | 1.00 | 6.00 | Special Order. Please Inquire | Female | Non-Hispanic | <-70C | 10-Sep-13 | Genotype | 1 | Special Order. Please Inquire | Unknown | ||||||||||||||||||||||||||
| BBS0005-FD900038369100913DD | Longitudinal Hepatitis C (HCV) Drug Treatment Sample Set | Canada | 0.5 mL Serum | 1.00 | 8.00 | Special Order. Please Inquire | 57 Y | Female | Non-Hispanic | <-70C | 09-Oct-13 | Genotype | 1 | Special Order. Please Inquire | Unknown | |||||||||||||||||||||||||
| BBS0005-FD900038369110513DD | Longitudinal Hepatitis C (HCV) Drug Treatment Sample Set | Canada | 0.5 mL Serum | 1.00 | 9.00 | Special Order. Please Inquire | 57 Y | Female | Non-Hispanic | <-70C | 05-Nov-13 | Genotype | 1 | Special Order. Please Inquire | Unknown | |||||||||||||||||||||||||
| BBS0005-FD900038370010214DD | Longitudinal Hepatitis C (HCV) Drug Treatment Sample Set | Canada | 0.5 mL Serum | 1.00 | 17.00 | Special Order. Please Inquire | 69 Y | Male | Non-Hispanic | <-70C | 02-Jan-14 | Genotype | 1 | Special Order. Please Inquire | Unknown | |||||||||||||||||||||||||
| BBS0005-FD900038370100413DD | Longitudinal Hepatitis C (HCV) Drug Treatment Sample Set | Canada | 0.5 mL Serum | 1.00 | 8.00 | Special Order. Please Inquire | 69 Y | Male | Non-Hispanic | <-70C | 04-Oct-13 | Genotype | 1 | Special Order. Please Inquire | Unknown | |||||||||||||||||||||||||
| BBS0005-FD900038370103013DD | Longitudinal Hepatitis C (HCV) Drug Treatment Sample Set | Canada | 0.5 mL Serum | 1.00 | 17.00 | Special Order. Please Inquire | 69 Y | Male | Non-Hispanic | <-70C | 30-Oct-13 | Genotype | 1 | Special Order. Please Inquire | Unknown | |||||||||||||||||||||||||
| BBS0005-FD900038370112713DD | Longitudinal Hepatitis C (HCV) Drug Treatment Sample Set | Canada | 0.5 mL Serum | 1.00 | 17.00 | Special Order. Please Inquire | 69 Y | Male | Non-Hispanic | <-70C | 27-Nov-13 | Genotype | 1 | Special Order. Please Inquire | Unknown | |||||||||||||||||||||||||
| BBS0005-FD900038371010314DD | Longitudinal Hepatitis C (HCV) Drug Treatment Sample Set | Canada | 0.5 mL Serum | 1.00 | 9.00 | Special Order. Please Inquire | 61 Y | Male | Non-Hispanic | <-70C | 03-Jan-14 | Genotype | 1 | Special Order. Please Inquire | Unknown | |||||||||||||||||||||||||
| BBS0005-FD900038371032014DD | Longitudinal Hepatitis C (HCV) Drug Treatment Sample Set | Canada | 0.5 mL Serum | 1.00 | 9.00 | Special Order. Please Inquire | 62 Y | Male | Non-Hispanic | <-70C | 20-Mar-14 | Genotype | 1 | Special Order. Please Inquire | Unknown | |||||||||||||||||||||||||
| BBS0005-FD900038371100413DD | Longitudinal Hepatitis C (HCV) Drug Treatment Sample Set | Canada | 0.5 mL Serum | 1.00 | 2.00 | Special Order. Please Inquire | Male | Non-Hispanic | <-70C | 04-Oct-13 | Genotype | 1 | Special Order. Please Inquire | Unknown | ||||||||||||||||||||||||||
| BBS0005-FD900038371110113DD | Longitudinal Hepatitis C (HCV) Drug Treatment Sample Set | Canada | 0.5 mL Serum | 1.00 | 5.00 | Special Order. Please Inquire | 61 Y | Male | Non-Hispanic | <-70C | 01-Nov-13 | Genotype | 1 | Special Order. Please Inquire | Unknown | |||||||||||||||||||||||||
| BBS0005-FD900038371112913DD | Longitudinal Hepatitis C (HCV) Drug Treatment Sample Set | Canada | 0.5 mL Serum | 1.00 | 5.00 | Special Order. Please Inquire | 61 Y | Male | Non-Hispanic | <-70C | 29-Nov-13 | Genotype | 1 | Special Order. Please Inquire | Unknown | |||||||||||||||||||||||||
| BBS0005-FD900040752110119DD | Longitudinal Hepatitis C (HCV) Drug Treatment Sample Set | Canada | 0.5 mL Serum | 1.00 | 12.00 | Special Order. Please Inquire | Male | Non-Hispanic | <-70C | 01-Nov-19 | Genotype | 2 | Special Order. Please Inquire | Unknown | ||||||||||||||||||||||||||
| BBS0005-FD900040752121817DD | Longitudinal Hepatitis C (HCV) Drug Treatment Sample Set | Canada | 0.5 mL Serum | 1.00 | 10.00 | Special Order. Please Inquire | Male | Non-Hispanic | <-70C | 18-Dec-17 | Genotype | 2 | Special Order. Please Inquire | Unknown | ||||||||||||||||||||||||||
| BBS0005-FD900040753022018DD | Longitudinal Hepatitis C (HCV) Drug Treatment Sample Set | Canada | 0.5 mL Serum | 1.00 | 11.00 | Special Order. Please Inquire | Male | Non-Hispanic | <-70C | 20-Feb-18 | Genotype | 2 | Special Order. Please Inquire | Unknown | ||||||||||||||||||||||||||
| BBS0005-FD900040753031518DD | Longitudinal Hepatitis C (HCV) Drug Treatment Sample Set | Canada | 0.5 mL Serum | 1.00 | 12.00 | Special Order. Please Inquire | Male | Non-Hispanic | <-70C | 15-Mar-18 | Genotype | 2 | Special Order. Please Inquire | Unknown | ||||||||||||||||||||||||||
| BBS0005-FD900040753110119DD | Longitudinal Hepatitis C (HCV) Drug Treatment Sample Set | Canada | 0.5 mL Serum | 1.00 | 10.00 | Special Order. Please Inquire | 71 Y | Male | Non-Hispanic | <-70C | 01-Nov-19 | Abbott RealTime PCR Assay | Genotype | 2 | Special Order. Please Inquire | Unknown | Epclusa | 2007 | Transfusions in 1960's; Injections as a child in Germany | No | Yes | 10.3 kPa 29-Jan-18 | ALT: 16 U/L | AST: 31 U/L | ALP: 62 U/L | Bilirubin (Total): 5 umol/L | Bilirubin (Direct): 3 umol/L | Creatinine: 71 umol/L 13-Nov-18 | ||||||||||||||||||
| BBS0005-FD900040754011018DD | Longitudinal Hepatitis C (HCV) Drug Treatment Sample Set | Canada | 0.5 mL Serum | 1.00 | 7.00 | Special Order. Please Inquire | Male | Non-Hispanic | <-70C | 10-Jan-18 | Genotype | 3 | Special Order. Please Inquire | Unknown | ||||||||||||||||||||||||||
| BBS0005-FD900040754030718DD | Longitudinal Hepatitis C (HCV) Drug Treatment Sample Set | Canada | 0.5 mL Serum | 1.00 | 8.00 | Special Order. Please Inquire | Male | Non-Hispanic | <-70C | 07-Mar-18 | Genotype | 3 | Special Order. Please Inquire | Unknown | ||||||||||||||||||||||||||
| BBS0005-FD900040754121317DD | Longitudinal Hepatitis C (HCV) Drug Treatment Sample Set | Canada | 0.5 mL Serum | 1.00 | 7.00 | Special Order. Please Inquire | Male | Non-Hispanic | <-70C | 13-Dec-17 | Genotype | 3 | Special Order. Please Inquire | Unknown | ||||||||||||||||||||||||||
| BBS0005-FD900040755031518DD | Longitudinal Hepatitis C (HCV) Drug Treatment Sample Set | Canada | 0.5 mL Serum | 1.00 | 15.00 | Special Order. Please Inquire | Female | Non-Hispanic | <-70C | 15-Mar-18 | Genotype | 3a | Special Order. Please Inquire | Unknown | ||||||||||||||||||||||||||
| BBS0005-FD900040755040918DD | Longitudinal Hepatitis C (HCV) Drug Treatment Sample Set | Canada | 0.5 mL Serum | 1.00 | 17.00 | Special Order. Please Inquire | Female | Non-Hispanic | <-70C | 09-Apr-18 | Genotype | 3a | Special Order. Please Inquire | Unknown | ||||||||||||||||||||||||||
| BBS0005-FD900043237021215DD | Longitudinal Hepatitis C (HCV) Drug Treatment Sample Set | Canada | 0.5 mL Serum | 1.00 | 4.00 | Special Order. Please Inquire | 65 Y | Male | Non-Hispanic | <-70C | 12-Feb-15 | Genotype | 1 | Special Order. Please Inquire | Unknown | |||||||||||||||||||||||||
| BBS0005-FD900043237031215DD | Longitudinal Hepatitis C (HCV) Drug Treatment Sample Set | Canada | 0.5 mL Serum | 1.00 | 5.00 | Special Order. Please Inquire | 65 Y | Male | Non-Hispanic | <-70C | 12-Mar-15 | Genotype | 1 | Special Order. Please Inquire | Unknown | |||||||||||||||||||||||||
| BBS0005-FD900043237050715DD | Longitudinal Hepatitis C (HCV) Drug Treatment Sample Set | Canada | 0.5 mL Serum | 1.00 | 4.00 | Special Order. Please Inquire | 65 Y | Male | Non-Hispanic | <-70C | 07-May-15 | Genotype | 1 | Special Order. Please Inquire | Unknown | |||||||||||||||||||||||||
| BBS0005-FD900043237102215DD | Longitudinal Hepatitis C (HCV) Drug Treatment Sample Set | Canada | 0.5 mL Serum | 1.00 | 4.00 | Special Order. Please Inquire | 66 Y | Male | Non-Hispanic | <-70C | 22-Oct-15 | Genotype | 1 | Special Order. Please Inquire | Unknown | |||||||||||||||||||||||||
| BBS0005-FD900043238022015DD | Longitudinal Hepatitis C (HCV) Drug Treatment Sample Set | Canada | 0.5 mL Serum | 1.00 | 6.00 | Special Order. Please Inquire | 54 Y | Male | Non-Hispanic | <-70C | 20-Feb-15 | Genotype | 1a | Special Order. Please Inquire | Unknown | |||||||||||||||||||||||||
| BBS0005-FD900043238032015DD | Longitudinal Hepatitis C (HCV) Drug Treatment Sample Set | Canada | 0.5 mL Serum | 1.00 | 7.00 | Special Order. Please Inquire | 54 Y | Male | Non-Hispanic | <-70C | 20-Mar-15 | Genotype | 1a | Special Order. Please Inquire | Unknown | |||||||||||||||||||||||||
| BBS0005-FD900043238041715DD | Longitudinal Hepatitis C (HCV) Drug Treatment Sample Set | Canada | 0.5 mL Serum | 1.00 | 10.00 | Special Order. Please Inquire | 54 Y | Male | Non-Hispanic | <-70C | 17-Apr-15 | Genotype | 1a | Special Order. Please Inquire | Unknown | |||||||||||||||||||||||||
| BBS0005-FD900043238102615DD | Longitudinal Hepatitis C (HCV) Drug Treatment Sample Set | Canada | 0.5 mL Serum | 1.00 | 4.00 | Special Order. Please Inquire | 54 Y | Male | Non-Hispanic | <-70C | 26-Oct-15 | Genotype | 1a | Special Order. Please Inquire | Unknown | |||||||||||||||||||||||||
| BBS0005-FD900043239030915DD | Longitudinal Hepatitis C (HCV) Drug Treatment Sample Set | Canada | 0.5 mL Serum | 1.00 | 8.00 | Special Order. Please Inquire | 69 Y | Female | Non-Hispanic | <-70C | 09-Mar-15 | Genotype | 1a | Special Order. Please Inquire | Unknown | |||||||||||||||||||||||||
| BBS0005-FD900043239040715DD | Longitudinal Hepatitis C (HCV) Drug Treatment Sample Set | Canada | 0.5 mL Serum | 1.00 | 7.00 | Special Order. Please Inquire | 70 Y | Female | Non-Hispanic | <-70C | 07-Apr-15 | Genotype | 1a | Special Order. Please Inquire | Unknown | |||||||||||||||||||||||||
| BBS0005-FD900043239060115DD | Longitudinal Hepatitis C (HCV) Drug Treatment Sample Set | Canada | 0.5 mL Serum | 1.00 | 12.00 | Special Order. Please Inquire | 70 Y | Female | Non-Hispanic | <-70C | 01-Jun-15 | Genotype | 1a | Special Order. Please Inquire | Unknown | |||||||||||||||||||||||||
| BBS0005-FD900043239111815DD | Longitudinal Hepatitis C (HCV) Drug Treatment Sample Set | Canada | 0.5 mL Serum | 1.00 | 8.00 | Special Order. Please Inquire | 70 Y | Female | Non-Hispanic | <-70C | 18-Nov-15 | Genotype | 1a | Special Order. Please Inquire | Unknown | |||||||||||||||||||||||||
| BBS0005-FD900046722082313DD | Longitudinal Hepatitis C (HCV) Drug Treatment Sample Set | Canada | 0.5 mL Serum | 1.00 | 11.00 | Special Order. Please Inquire | Male | Non-Hispanic | <-70C | 23-Aug-13 | Genotype | 3 | Special Order. Please Inquire | Unknown | ||||||||||||||||||||||||||
| BBS0005-FD900046722092313DD | Longitudinal Hepatitis C (HCV) Drug Treatment Sample Set | Canada | 0.5 mL Serum | 1.00 | 12.00 | Special Order. Please Inquire | 51 Y | Male | Non-Hispanic | <-70C | 23-Sep-13 | Genotype | 3 | Special Order. Please Inquire | Unknown | |||||||||||||||||||||||||
| BBS0005-FD900046722111513DD | Longitudinal Hepatitis C (HCV) Drug Treatment Sample Set | Canada | 0.5 mL Serum | 1.00 | 12.00 | Special Order. Please Inquire | 51 Y | Male | Non-Hispanic | <-70C | 15-Nov-13 | Genotype | 3 | Special Order. Please Inquire | Unknown | |||||||||||||||||||||||||
| BBS0005-FD900049675022317DD | Longitudinal Hepatitis C (HCV) Drug Treatment Sample Set | Canada | 0.5 mL Serum | 1.00 | 10.00 | Special Order. Please Inquire | 61 Y | Male | Non-Hispanic | <-70C | 23-Feb-17 | Genotype | 3a | Special Order. Please Inquire | Unknown | |||||||||||||||||||||||||
| BBS0005-FD900049675090716DD | Longitudinal Hepatitis C (HCV) Drug Treatment Sample Set | Canada | 0.5 mL Serum | 1.00 | 8.00 | Special Order. Please Inquire | 60 Y | Male | Non-Hispanic | <-70C | 07-Sep-16 | Genotype | 3a | Special Order. Please Inquire | Unknown | |||||||||||||||||||||||||
| BBS0005-FD900049675100616DD | Longitudinal Hepatitis C (HCV) Drug Treatment Sample Set | Canada | 0.5 mL Serum | 1.00 | 12.00 | Special Order. Please Inquire | 60 Y | Male | Non-Hispanic | <-70C | 06-Oct-16 | Genotype | 3a | Special Order. Please Inquire | Unknown | |||||||||||||||||||||||||
| BBS0005-FD900049675110119DD | Longitudinal Hepatitis C (HCV) Drug Treatment Sample Set | Canada | 0.5 mL Serum | 1.00 | 9.00 | Special Order. Please Inquire | Male | Non-Hispanic | <-70C | 01-Nov-19 | Genotype | 3a | Special Order. Please Inquire | Unknown | ||||||||||||||||||||||||||
| BBS0005-FD900049676051817DD | Longitudinal Hepatitis C (HCV) Drug Treatment Sample Set | Canada | 0.5 mL Serum | 1.00 | 9.00 | Special Order. Please Inquire | 63 Y | Female | Non-Hispanic | <-70C | 18-May-17 | Genotype | 1a | Special Order. Please Inquire | Unknown | |||||||||||||||||||||||||
| BBS0005-FD900049676090816DD | Longitudinal Hepatitis C (HCV) Drug Treatment Sample Set | Canada | 0.5 mL Serum | 1.00 | 11.00 | Special Order. Please Inquire | 62 Y | Female | Non-Hispanic | <-70C | 08-Sep-16 | Genotype | 1a | Special Order. Please Inquire | Unknown | |||||||||||||||||||||||||
| BBS0005-FD900049676100616DD | Longitudinal Hepatitis C (HCV) Drug Treatment Sample Set | Canada | 0.5 mL Serum | 1.00 | 9.00 | Special Order. Please Inquire | 62 Y | Female | Non-Hispanic | <-70C | 06-Oct-16 | Genotype | 1a | Special Order. Please Inquire | Unknown | |||||||||||||||||||||||||
| BBS0005-FD900049676120116DD | Longitudinal Hepatitis C (HCV) Drug Treatment Sample Set | Canada | 0.5 mL Serum | 1.00 | 7.00 | Special Order. Please Inquire | 62 Y | Female | Non-Hispanic | <-70C | 01-Dec-16 | Genotype | 1a | Special Order. Please Inquire | Unknown | |||||||||||||||||||||||||
| BBS0005-FD900049678091916DD | Longitudinal Hepatitis C (HCV) Drug Treatment Sample Set | Canada | 0.5 mL Serum | 1.00 | 13.00 | Special Order. Please Inquire | 57 Y | Male | Non-Hispanic | <-70C | 19-Sep-16 | Genotype | 1a | Special Order. Please Inquire | Unknown | |||||||||||||||||||||||||
| BBS0005-FD900049678102016DD | Longitudinal Hepatitis C (HCV) Drug Treatment Sample Set | Canada | 0.5 mL Serum | 1.00 | 12.00 | Special Order. Please Inquire | 57 Y | Male | Non-Hispanic | <-70C | 20-Oct-16 | Genotype | 1a | Special Order. Please Inquire | Unknown | |||||||||||||||||||||||||
| BBS0005-FD900049678112116DD | Longitudinal Hepatitis C (HCV) Drug Treatment Sample Set | Canada | 0.5 mL Serum | 1.00 | 13.00 | Special Order. Please Inquire | 57 Y | Male | Non-Hispanic | <-70C | 21-Nov-16 | Genotype | 1a | Special Order. Please Inquire | Unknown | |||||||||||||||||||||||||
| BBS0005-FD900049679100316DD | Longitudinal Hepatitis C (HCV) Drug Treatment Sample Set | Canada | 0.5 mL Serum | 1.00 | 11.00 | Special Order. Please Inquire | 58 Y | Female | Non-Hispanic | <-70C | 03-Oct-16 | Genotype | 1a | Special Order. Please Inquire | Unknown | |||||||||||||||||||||||||
| BBS0005-FD900049680010317DD | Longitudinal Hepatitis C (HCV) Drug Treatment Sample Set | Canada | 0.5 mL Serum | 1.00 | 11.00 | Special Order. Please Inquire | 55 Y | Male | Non-Hispanic | <-70C | 03-Jan-17 | Genotype | 1a | Special Order. Please Inquire | Unknown | |||||||||||||||||||||||||
| BBS0005-FD900049680101116DD | Longitudinal Hepatitis C (HCV) Drug Treatment Sample Set | Canada | 0.5 mL Serum | 1.00 | 10.00 | Special Order. Please Inquire | 54 Y | Male | Non-Hispanic | <-70C | 11-Oct-16 | Genotype | 1a | Special Order. Please Inquire | Unknown | |||||||||||||||||||||||||
| BBS0005-FD900049680110816DD | Longitudinal Hepatitis C (HCV) Drug Treatment Sample Set | Canada | 0.5 mL Serum | 1.00 | 10.00 | Special Order. Please Inquire | 54 Y | Male | Non-Hispanic | <-70C | 08-Nov-16 | Genotype | 1a | Special Order. Please Inquire | Unknown | |||||||||||||||||||||||||
| BBS0005-FD900051707050715DD | Longitudinal Hepatitis C (HCV) Drug Treatment Sample Set | Canada | 0.5 mL Serum | 1.00 | 12.00 | Special Order. Please Inquire | 60 Y | Male | Non-Hispanic | <-70C | 07-May-15 | Genotype | 1b | Special Order. Please Inquire | Unknown | |||||||||||||||||||||||||
| BBS0005-FD900051707070215DD | Longitudinal Hepatitis C (HCV) Drug Treatment Sample Set | Canada | 0.5 mL Serum | 1.00 | 10.00 | Special Order. Please Inquire | 60 Y | Male | Non-Hispanic | <-70C | 02-Jul-15 | Genotype | 1b | Special Order. Please Inquire | Unknown | |||||||||||||||||||||||||
| BBS0005-FD900051707121815DD | Longitudinal Hepatitis C (HCV) Drug Treatment Sample Set | Canada | 0.5 mL Serum | 1.00 | 10.00 | Special Order. Please Inquire | 61 Y | Male | Non-Hispanic | <-70C | 18-Dec-15 | Genotype | 1b | Special Order. Please Inquire | Unknown | |||||||||||||||||||||||||
| BBS0005-FD900051708010616DD | Longitudinal Hepatitis C (HCV) Drug Treatment Sample Set | Canada | 0.5 mL Serum | 1.00 | 8.00 | Special Order. Please Inquire | 59 Y | Male | Non-Hispanic | <-70C | 06-Jan-16 | Genotype | 3a | Special Order. Please Inquire | Unknown | |||||||||||||||||||||||||
| BBS0005-FD900051708050515DD | Longitudinal Hepatitis C (HCV) Drug Treatment Sample Set | Canada | 0.5 mL Serum | 1.00 | 5.00 | Special Order. Please Inquire | 58 Y | Male | Non-Hispanic | <-70C | 05-May-15 | Genotype | Special Order. Please Inquire | Unknown | ||||||||||||||||||||||||||
| BBS0005-FD900051708060215DD | Longitudinal Hepatitis C (HCV) Drug Treatment Sample Set | Canada | 0.5 mL Serum | 1.00 | 12.00 | Special Order. Please Inquire | 58 Y | Male | Non-Hispanic | <-70C | 02-Jun-15 | Genotype | 3a | Special Order. Please Inquire | Unknown |